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(TGFβ3). These fibrous HA hydrogels were first investigated through in vitro cell studies with mesenchymal
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pull on fibers. Various methods were then explored to increase cell infiltration; however, cell infiltration into
fibrous HA scaffolds was limited even with the most promising techniques, reducing their potential as in vitro-
cultured cell scaffolds.
To investigate their utility as acellular scaffolds for cartilage repair, fibrous HA hydrogels were implanted after
microfracture in porcine cartilage defects. Scaffold groups included those with or without a degradable HA
fiber component for the delivery of TGFβ3 and with or without an alternate fiber population,
poly(caprolactone) (PCL). After 12 weeks in vivo, it was observed that material choice and the inclusion of
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release of SDF-1 was achieved through incorporation of sulfated HA macromers, and future work includes
investigation of SDF-1-releasing fibrous HA hydrogels in vivo. Ultimately, the investigation of these fibrous
HA hydrogels provided insight towards biomaterial design for cartilage tissue engineering.
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ABSTRACT 
 
ENGINEERED FIBROUS HYALURONIC ACID HYDROGELS FOR 
CARTILAGE REPAIR  
Iris K. Marklein 
Jason A. Burdick 
 
Cartilage, the load-bearing, low-friction articulating surface in diarthrodial joints, has a 
very low regenerative capacity, and clinical methods for cartilage treatment are limited. The 
underlying goal of this thesis was to develop novel fibrous hyaluronic acid (HA)-based hydrogels 
with controlled, tunable material parameters and ultimately to apply these materials as acellular 
scaffolds in vivo for improved cartilage repair. To this end, HA was electrospun with optimized 
parameters to form fibrous hydrogels with a wide range of material properties and the ability to 
entrap, release, and retain activity of biological factors, such as transforming growth factor !3 
(TGF!3). These fibrous HA hydrogels were first investigated through in vitro cell studies with 
mesenchymal stem cells (MSCs). Generally, softer and less adhesive fibers resulted in enhanced 
chondrogenesis, with adhesive ligand concentration dominating cell spreading, focal adhesion 
formation, and the ability of cells to pull on fibers. Various methods were then explored to 
increase cell infiltration; however, cell infiltration into fibrous HA scaffolds was limited even with 
the most promising techniques, reducing their potential as in vitro-cultured cell scaffolds. 
To investigate their utility as acellular scaffolds for cartilage repair, fibrous HA hydrogels 
were implanted after microfracture in porcine cartilage defects. Scaffold groups included those 
with or without a degradable HA fiber component for the delivery of TGF!3 and with or without an 
alternate fiber population, poly("-caprolactone) (PCL). After 12 weeks in vivo, it was observed that 
material choice and the inclusion of TGF!3 had the most significant impact on outcomes; 
specifically, PCL scaffolds without TGF!3 had increased bone remodeling and decreased 
 v 
macroscopic appearance and mechanical properties, whereas MeHA and both TGF!3-releasing 
scaffolds had improved histological scores and type 2 collagen content. To further improve 
potential utility of such a system, studies were also undertaken to include the cell-recruiting 
cytokine stromal derived factor 1-# (SDF-1) along with TGF!3 for improved repair. Controlled, 
specific release of SDF-1 was achieved through incorporation of sulfated HA macromers, and 
future work includes investigation of SDF-1-releasing fibrous HA hydrogels in vivo. Ultimately, the 
investigation of these fibrous HA hydrogels provided insight towards biomaterial design for 
cartilage tissue engineering. 
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CHAPTER 1 
 
Introduction and Overview of Techniques for Cartilage Repair 
 
Adapted from: IL Kim, RL Mauck, and JA Burdick, “Hydrogel Design for Cartilage Tissue 
Engineering: A Case Study with Hyaluronic Acid” Biomaterials, 2011, 32(34): 8771-8782. 
 
1.1 Cartilage 
Cartilage is a soft connective tissue composed of a specialized extracellular matrix and a 
single cell type (i.e. chondrocyte). There are three main types of cartilage: elastic, fibrocartilage, 
and hyaline, and each type has specific biochemical and mechanical properties customized for its 
given function [1-2]. Articular cartilage is the most common type of cartilage in the body and 
covers the articulating surfaces of bones within diarthrodial joints, supporting significant loads and 
providing a smooth, lubricating surface for joint motion. Damage or degeneration to articular 
cartilage, either through traumatic injuries or chronic osteoarthritis, is one of the leading causes of 
pain and disability in adults [3-4]. About 50 million adults over the age of 17 were diagnosed with 
osteoarthritis in 2009 [5], amounting to a total annual cost of 89 to 128 billion [6, 7]. By the year 
2020, the prevalence of osteoarthritis is expected to double [8-10]. The degeneration of articular 
cartilage in osteoarthritis is a complex interplay of multiple factors and can be either a gradual, 
chronic process during aging or occur acutely due to traumatic injury [11-13]. These cartilage 
lesions or areas of degenerated cartilage can cause intermittent or chronic pain and are many 
times accompanied by a reduced range of motion, joint locking, and a weakening of the 
surrounding muscles. 
The depth-dependent composition and structure of articular cartilage gives rise to its 
complex, non-homogeneous mechanical properties. Articular cartilage is generally composed of 
chondrocytes and a dense ECM, which mainly includes type II collagen and proteoglycans [14]. 
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Structurally, articular cartilage is comprised of four different layers that can be distinguished from 
one another by collagen fiber alignment (Figure 1.1) and proteoglycan composition. Moving from 
the articulating surface to the underlying bone, the superficial zone has aligned fibers parallel to 
the surface of the bone, the middle zone has unaligned fibers, the deep zone has aligned fibers 
perpendicular to the surface of the bone and the final calcified zone has little organization and is 
mineralized. Conversely, proteoglycan content is lowest in the superficial zones and increases 
with depth. Each layer also differs in thickness, ECM composition, and cellular morphology [15, 
16].  
The depth-dependent alignment of collagen leads to important tensile and shear 
properties, whereas the depth-dependent proteoglycan content contributes more to the 
compressive properties of each zone, with the surface zone being 10-20 times less stiff than the 
deep zones [17, 18]. Adding to the complexity in these functional properties, the defined collagen 
network restricts swelling of the tissue, while the negatively charged proteoglycans and low tissue 
permeability help the tissue swell and retain water [19]. Water within the tissue is critically 
important as it bears a significant portion of the applied stress under dynamic loading conditions 
[20].  This combination creates a pressurized environment that drastically increases the load
 
                      
Figure 1.1 Depth-dependent collagen alignment and cellular morphology in articular cartilage. 
H&E: hematoxylin and eosin; GAGs: alcian blue stain for glycosaminoglycans. 
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bearing capacity while reducing the frictional coefficient of cartilage [21, 22].  While many studies 
have addressed the overall bulk mechanical properties and composition of the native tissue, few 
have investigated the complexity of native tissue structure and function found in tissue-
engineered cartilage. The unique structure of cartilage, along with its avascular, alymphatic 
nature and low population of cells, makes it a very difficult tissue to heal through either clinical or 
tissue engineering-based strategies. 
 
1.2 Cartilage Repair: Current Clinical Treatments 
 Current clinical methods to treat osteoarthritis are varied, depending on the size, depth, 
and severity of the damaged cartilage area and also factors related to the patient such as age, 
activity level, and the existence of other diseases or health issues [23, 24]. Treatments can 
generally be categorized as palliative, reparative, or restorative, as described in Table 1.1 [25]. 
Palliative treatments focus on relieving pain, and these include joint lavage (i.e. rinsing of the 
joint), debridement (i.e. removal of damaged tissue fragments), and chondral shaving. Palliative 
care is in many cases performed along with reparative procedures, which typically aim to induce 
bleeding from the underlying bone [26, 27]. Common reparative treatments include microfracture, 
subchondral drilling, and spongialization [25]. Of these treatments, microfracture, in which the 
subchondral bone is violated to release blood and bone marrow into the defect, is the most 
commonly used technique [26]. Although both palliative and reparative treatments may reduce 
pain initially, the tissue formed within the original defect is typically inferior to native cartilage, 
degenerating over time and necessitating more involved, restorative techniques [29, 30]. 
Restorative clinical treatments include, but are not limited to, osteochondral 
transplantation, autologous chondrocyte implantation (ACI), and total knee replacements [25, 27]. 
Osteochondral transplantation, in which tissue is harvested from a less load-bearing region and 
grafted into the damaged area, is common but can have issues due to donor site morbidity and 
site-to-site matching. ACI has become increasingly prevalent over the past few years, where 
chondrocytes are harvested from non load-bearing cartilage in a previous surgery and expanded 
in vitro prior to implantation into the damaged cartilage region. ACI can lead to similar issues with 
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osteochondral transplants like donor site morbidity, and the added cost of in vitro cell culture and 
a second surgery for tissue harvest can be prohibitive [28]. Unlike the previously described, 
relatively minimally-invasive strategies, total knee replacements (i.e. joint arthroplasties) are 
invasive procedures in which a portion of bone is removed from the femoral and tibial surfaces, 
which are then replaced with a prosthetic implant. Total knee replacements are generally 
successful in elderly patients (> 70 years), with patient satisfaction rates reported between 90-
95% [27, 31]. However, much higher failure rates have been reported for patients less than 50 
years of age [32], and even total knee replacements are not permanent solutions in many cases 
for both age groups. Thus, there is a strong need for improved clinical treatments to delay or 
eliminate the need of a total knee replacement. 
 
 
       
Table 1.1 Current clinical treatment options for cartilage defects [23-25, 27]. 
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1.3 Cartilage Repair: Tissue Engineering Approaches 
 The general approach for tissue engineering involves the investigation of cells, scaffolds, 
and stimulatory factors. This tissue engineering paradigm has been applied towards engineered 
cartilage, and all three factors have been heavily investigated with insightful findings. Still, much 
work needs to be done in order to achieve a cartilage-like tissue with native mechanical and 
biomechanical properties. Here, we highlight important findings and considerations in all three 
aspects of the tissue engineering paradigm towards cartilage applications. 
 
1.3.1 Cell Source  
Chondrocytes were the first cell type to be thoroughly explored for cartilage tissue 
engineering [33]. These cells are native to articular cartilage and can be harvested through 
excision of cartilage tissue and subsequent digestion of the existing extracellular matrix [34]. 
Chondrocytes remain viable and produce a cartilaginous matrix (high in type II collagen and 
aggrecan) when encapsulated within hydrogels composed of various materials [33]. HA hydrogels 
support cartilaginous matrix production by both auricular and articular chondrocytes [35]; 
interestingly, a very different response was observed for these two types of chondrocytes in HA 
gels, potentially due to their interactions with the HA chemistry or due to the culture environments 
in which they were placed. Although not completely understood, these results indicate a signaling 
process between the hydrogel chemistry and cell type employed. Additionally, there are 
limitations to using chondrocytes for cartilage tissue engineering, as chondrocytes have been 
shown to dedifferentiate when expanded on tissue culture polystyrene (TCPS) [36] and there are 
not nearly enough cells within healthy articular cartilage (5-10% of cartilage tissue) to directly 
implant harvested cells back into the region of interest. Also, Erickson, et al. recently showed that 
cartilage matrix formation in pellet culture is dependent on the age of the chondrocyte donor [37], 
limiting the use of chondrocytes from older and/or diseased cartilage.  
Although much work has focused on reversing or slowing down chondrocyte 
dedifferentiation, there has been a marked shift in the past decade from the use of chondrocytes 
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to applications involving mesenchymal stem cells (MSCs), which can be harvested in a non-
invasive manner from a variety of sources including bone marrow and fat [33]. Ideally, MSCs 
could be harvested from the patient prior to surgery, expanded in vitro, and then the cells 
implanted back into the same patient. Both human and bovine MSCs undergo chondrogenesis in 
hyaluronic acid (HA) hydrogels, supporting upregulation of chondrocyte-specific genes and 
producing cartilage-like matrix rich in aggrecan and type II collagen [38, 39], especially with 
younger MSC donors [37]. It has also been shown, however, by direct comparison in both HA and 
agarose hydrogels that the matrix produced by MSCs is inferior to that of the matrix produced by 
chondrocytes.  Interestingly, these differences were much less pronounced in the HA hydrogels 
[40, 41]. Erickson, et al. also showed that increasing donor age (bovine source) negatively 
impacts cartilaginous matrix deposition by MSCs in both pellet and HA hydrogel culture [37], 
which may be problematic if autologous MSCs are used from older patients. Moreover, 
heterogeneity is difficult to overcome between donors [42] or even from the same donor [43], as 
most harvesting techniques use only attachment to TCPS to isolate MSCs from the bone marrow 
aspirate (which also includes hematopoietic and other types of cells) [44].  
Apart from complications with cell source and heterogeneity, new understanding of MSC 
chondrogenesis has revealed that these cells may have a transient or osteoarthritic phenotype, 
eventually undergoing hypertrophy after prolonged culture [45-51]. Hypertrophy can be reduced 
with co-culture of MSCs and chondrocytes; Bian, et al. showed that the co-culture of MSCs and 
chondrocytes (at a ratio of 4:1) within the same HA hydrogel significantly increased the Young’s 
modulus, dynamic compressive modulus, and collagen and GAG content, while significantly 
decreasing hypertrophic markers, as evidenced by a significant decrease in type X collagen [47, 
52] (Figure 1.2). These effects were not observed when two separate gels (one seeded with 
MSCs and the other seeded with chondrocytes) were cultured in the same well, indicating that 
close proximity is important for co-culture effects exert their influence. Hypertrophy can also be 
reduced by the addition of parathyroid hormone-related protein (PTHrP); PTHrP regulated 
chondrocyte maturation and hypertrophic conversion in the growth plate [47, 52]. Hypertrophy is 
also closely tied with cell-matrix interactions, and proper tuning of material properties, such as
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mechanics or oxygen tension, may stabilize the MSC chondrocyte-like phenotype and reduce 
mineralization [53]. A better understanding of MSC heterogeneity and hypertrophy may be 
needed to achieve the high level of mechanics observed with chondrocytes and of native 
cartilage and to eliminate mineralization of the tissue.  
Although MSCs still hold great promise, other cell types may also be beneficial for future 
exploration, including induced pluripotent stem cells (IPSCs) and embryonic stem cells (ESCs)  
[54]. ESCs are obtained from the inner mass of a blastocyst and are an attractive cell source due 
to their ability to differentiate into all somatic lineages and retain self-renewal capacities after 
many doublings. Elisseeff and coworkers first showed that hESC-derived mesenchymal-like cells 
encapsulated within RGD-modified PEG hydrogels produced cartilaginous matrix high in type II 
collagen [55]. Since then, it has also been shown that combinations of various isoforms of BMP 
            
Figure 1.2 Hypertrophy was reduced in constructs seeded with a mixed population of 
chondrocytes and MSCs (Mixed) in comparison to MSC-only samples (MSC) as seen with 
immunohistochemical staining for type 10A1 collagen on day 42. Adapted from [47] with 
permission. Scale bar in inset: 25 microns. 
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and TGF! drive hESC chondrogenesis in embryoid bodies, pellets, and even monolayer culture 
[56-59]. Still, there are limitations to ESCs, including issues with selection, purification, culture, 
and ethics. IPSCs may be another attractive cell source in the future. These cells are formed 
when somatic cells are reprogrammed through retroviral or other transduction methods with 
several key transcription factors to induce pluripotency [60]. IPSCs are still in the initial stages of 
research and have not been explored extensively for cartilage regeneration. Material design and 
protocols for optimal chondrogenesis specific to ESCs and IPSCs still require much improvement 
before nearing the current advances with MSCs.  
 
1.3.2 Scaffold Design 
Scaffolds for cartilage tissue engineering should ideally meet many requirements, 
including adequate nutrient transport, adhesion to the defect site, minimally invasive implantation 
or injection, and degradability. Moreover, one of the most important requirements for engineered 
cartilage is proper mechanical properties (i.e. sheer, compressive, and tensile), either a prior or 
through tissue formation over time. The complex structure of native cartilage is difficult to mimic, 
and thus a variety of synthetic and natural materials have been investigated as potential scaffolds 
with varying architectures based on fabrication technique. The most commonly used material 
structures for cartilage tissue engineering can be categorized into isotropic hydrogels, sponges, 
and fibrous meshes.  
Sponges or foams are macroporous scaffolds that are most commonly fabricated using 
salt-leaching, freeze-drying, or gas foaming. A variety of materials have been manufactured into 
sponges, including poly (alpha-hydroxy esters) [61, 62], alginate [63], chitosan [64-66], HA [67, 
68], and gelatin [66, 67, 69]. Even with some promising results, the scaffold properties of these 
sponges are highly dependent on manufacturing technique, and long-term construct development 
can be hindered by heterogeneous cell distributions and significant contraction with culture [70, 
71]. Thus, recent work in cartilage tissue engineering has been focused more on isotropic 
hydrogels, and even more recently, fibrous meshes. Isotropic hydrogels are attractive since they 
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can be injected to fill defects of any size and can homogeneously suspend cells within a 3D 
environment immediately during fabrication. Hydrogels have been used as platforms to explore 
the effect of important scaffold parameters, such as mechanical properties, crosslinking density, 
and adhesion, on stem cell differentiation in both 2D and 3D platforms [72]. These variables and 
others have also been investigated towards cartilage applications, and the design, findings and 
considerations with respect to isotropic hydrogels for cartilage repair will be covered in detail in 
Chapter 3. 
Meshes are networks of woven or non-woven fibers; woven meshes tend to have greater 
mechanical properties, and non-woven meshes have high volume to surface area ratios and 
more closely mimic the native extracellular matrix architecture. Electrospinning has recently 
gained much interest due to its ability to create a non-woven mesh of nano-scale polymer fibers, 
allowing for better control over matrix organization [73]. Polycaprolactone (PCL) is one of the 
most commonly electrospun materials; PCL fibers have been shown to support cell infiltration 
(with the incorporation of sacrificial fibers or orbital shaking) [74, 75] and also to support 
chondrogenesis [76, 77], but the stiffness and low swelling capabilities of this material may not be 
ideal for chondrogenesis and cell infiltration. Other electrospun polymers that have been used for 
chondrogenesis include poly(lactic co-glycolic acid), poly(L-lactic acid), poly(vinyl alcohol), and 
chitosan [78-81].  
Electrospun methacrylated HA (MeHA) results in relatively soft fibers and also has 
swelling properties such that it forms a fibrous hydrogel [82, 83]. Fibrous electrospun MeHA 
scaffolds also offer precise control over mechanics (through the extent of modification), cell 
adhesivity (through the amount of conjugated RGD), and fiber alignment (through rotating speed 
of the collecting mandrel) [84], the latter of which may be important due to the depth-dependent 
alignment of collagen fibers, cell morphology, and biochemical composition in cartilage (Figure 
1.3). While much progress has been made in understanding how mechanics, adhesivity, and 
topography affect stem cell differentiation [72], these variables have not been extensively studied 
in a fibrous system, particularly towards a specific application (e.g., cartilage). Thus, the ability to 
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manipulate and control these variables with electrospun MeHA makes it an ideal fibrous system 
for future research in cartilage tissue engineering. 
 
1.3.3 Stimulatory Factors 
Growth factors and mechanical loading represent two important stimulatory factors to 
enhance cartilage formation. Growth factors have a substantial impact on cell behavior, both 
during initial development and long-term tissue maintenance. Specific to cartilage, multiple growth 
factors have been employed to improve chondrogenesis, including isoforms of TGF!, FGF, BMP, 
and IGF [25, 33]. Although each growth factor alone and specific combinations have been shown 
to have unique effects on MSC proliferation and chondrogenesis [85], the TGF! superfamily has 
been used extensively to induce robust chondrogenesis of MSCs and has also been shown to 
reduce hypertrophy even after a transient presence [44, 86-89]. Although in vitro culture can 
        
Figure 1.3 Dry and swollen electrospun MeHA fibers as seen by SEM and confocal microscopy 
(methacrylated rhodamine-incorporated fibers), respectively. Human MSCs interacting with RGD-
conjugated MeHA fibers adapt their morphology to match fiber alignment after 1 day of in vitro 
culture (stained with FITC-phalloidin and DAPI, confocal images). Scale bar: 20 microns (left and 
middle columns), 100 microns (right column). 
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easily be supplemented with exogenous TGF! to induce chondrogenesis, this is much more 
difficult in vivo, as hydrogels must be modified or loaded with a high concentration of TGF! for 
prolonged release.  
Chung, et al. showed that MSC chondrogenesis and matrix production within HA 
hydrogels in vivo was significantly more robust in MSC-seeded hydrogels simply loaded with 
TGF! (100 ng/mL) than in hydrogels without any added TGF!. Several groups have attempted to 
further control this release over a longer period, most commonly by using sequestering peptides 
(such as heparin sulfate) or TGF!-loaded particles encapsulated within the hydrogel [90-92]. 
When TGF!-loaded nanofilm-coated alginate microspheres were encapsulated within 2% w/v 
hMSC-seeded MeHA hydrogels, the TGF! release profile was extended and burst release was 
attenuated [93]. Moreover, constructs with TGF!-loaded nanofilm-coated alginate microspheres 
(MeHA+MS) developed comparable mechanical properties and cartilage matrix content when 
compared to MeHA hydrogels continuously supplemented with exogenous TGF!, whereas 
constructs without microspheres (MeHA-MS) or exogenous TGF! developed inferior mechanics 
and matrix formation. In vivo, MeHA+MS constructs resulted in superior cartilage formation 
compared to both MeHA-MS samples and MeHA hydrogels loaded with a bolus dose of 100 
ng/mL TGF! [93] (Figure 1.4). TGF!-specific sequestering and protecting peptides used 
previously in PEG hydrogels could also be grafted onto the HA backbone as another way to 
achieve prolonged release and amplify these findings [92]. 
Mechanical stimulation is critical for normal development and maintenance of articular 
cartilage content and function [94, 95]. Hydrostatic pressure, an indirect mechanical stimulus, has 
been shown repeatedly to improve chondrogenesis and cartilage regeneration in a variety of 
systems [96-100]. Direct mechanical loading (compressive or tensile) of MSC-seeded hydrogels 
seems to be dependent on the specific loading regimen. For instance, a continuous compressive 
loading regime for PEG and agarose hydrogels significantly decreased mechanical properties 
and cartilage formation at early times (2 and 3 weeks, respectively) [101-104]. However, when 
compressive loading was applied after 3 weeks of preliminary static culture (e.g. delayed 
loading), the mechanical properties of the agarose hydrogels improved significantly over those of
 12 
 
either continuous loading or static culture [101]. This response was also observed with ESCs in 
PEG gels [104], implicating that stem cells may need a static culture period for proliferation,  
differentiation, and initial matrix accumulation before responding positively to loading in certain 
hydrogel environments.  
Hydrogel environments may likewise alter cellular mechanosensitivity and responsivity of 
cells to various loading regimes as well.  Unlike agarose or PEG gels, the mechanical properties 
 
Figure 1.4 (A) Nanofilm-coated microspheres retain FITC-labeled BSA after 7 days within MeHA 
hydrogels, scale bar: 50 microns. (B) TGF! release profiles after direct encapsulation in HA (T in 
HA) and for free microspheres (uncoated and coated) and coated microspheres within HA 
hydrogels. (C) Matrix production was enhanced in TGF!-loaded microsphere group (MS+T) 
compared to samples with a bolus dose of TGF! (T only) assessed by immunohistochemical 
staining for types I and II collagen and chondroitin sulfate 56 days after subcutaneous 
implantation, scale bar: 200 microns. Adapted from [93] with permission. 
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for bovine MSC-seeded MeHA hydrogels improved significantly after continuous loading, in 
comparison to moduli for identical samples under delayed loading and static culture conditions, 
reaching an equilibrium modulus of 587 kPa and a dynamic modulus of 4.4 MPa. The different 
responses to compressive loading within MSC-seeded HA gels and other systems like agarose 
and PEG may be due to specific receptor mediated interactions with HA, including CD44 and 
RHAMM [105]. Although the underlying mechanisms remain unclear, compressive mechanical 
loading significantly enhanced mechanical properties within HA hydrogels and is a promising 
technique for future studies. 
 
1.4 Cartilage Repair: Recent Advances in Biomaterial-based Clinical Treatments 
Since clinical treatments to repair cartilage damage are relatively limited, the addition of 
biomaterial scaffolds to existing clinical treatments has become a prevalent field of research. The 
scaffolds can also be implanted or injected directly into the cartilage defect site and can provide 
additional stability or stimulatory cues, such as release of growth factors. One such technique is 
matrix autologous chondrocyte implantation (MACI), which utilizes a scaffold along with 
autologous chondrocytes to increase cell retention [106, 107]. Multiple short- and mid-term 
clinical studies have reported improved outcomes on a relatively small number of patients [108-
111]. However, long-term studies with large cohorts are still lacking, and thus the real potential 
and results from this treatment method are still unclear. Moreover, like with ACI, issues with 
donor site morbidity and the high expense of in vitro cell culture can be prohibitive for this 
technique.  
Another promising biomaterial-based technique is autologous matrix-induced 
chondrogenesis (AMIC), in which an acellular collagen scaffold is implanted into a cartilage defect 
directly after microfracture. Clinically, AMIC has been shown to improve various outcome scores 
(i.e. IKDC, Lysholm, Tegner and VAS pain scores) in a retrospective clinical study [112-114]. Still, 
this material lacks versatility, and other materials have recently been investigated in combination 
with microfracture in in vivo animal models with promising outcomes. For instance, a viscous 
hyaluronic acid solution injected into cartilage defects after microfracture has been shown to 
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improve histological outcomes after 3 months in rabbits [115]. Similarly, the application of a 
photo-crosslinked poly (ethylene glycol) PEG hydrogel with hyaluronic acid with microfracture 
showed improvements in human patients based on MRI imaging and patient self-evaluated 
clinical outcomes [116]. As PEG is a relatively inert material, the improved patient scores were 
attributed to better filling of the defect and higher initial mechanical properties with the PEG/HA 
hydrogel. Recently, a 12-week study in rabbits using a nanofibrous, self-assembling material 
based on peptide amphiphiles combined with microfracture showed improved tissue structure, 
type 2 collagen deposition, and significantly higher scoring with the inclusion of a TGF!-binding 
domain [117].  
Biomaterial scaffolds can also be applied or implanted after creation of an osteochondral 
defect. Similar to combining scaffolds with microfracture in chondral defects, this technique relies 
on released blood and bone marrow for cells, growth factors, and other stimulatory molecules for 
tissue growth within the implanted scaffold. Within osteochondral defects, a variety of materials 
have been shown to promote increased cartilage matrix formation, including alginate, poly(lactic-
co-glycolic acid) (PLGA), fibrin glue, poly (vinyl alcohol) (PVA), and chondroitin sulfate (CS) [118-
120]. Recently, the Elisseeff group implanted nanofibrous scaffolds composed either of PVA or 
CS fibers into rat osteochondral defects. Both scaffold groups showed improved proteoglycan 
and type 2 collagen deposition compared to the empty group (i.e. no treatment) [120]. Even with 
all these advances in materials applied either with microfracture in chondral defects or in 
osteochondral defects, much work remains to fully understand how specific material parameters, 
such as degradation and mechanical properties, affect outcomes in these biomaterial-based 
clinical strategies. 
 
 With these limitations of clinical and tissue engineering strategies for cartilage treatment, 
this thesis contributes to our understanding of cartilage repair strategies through the development 
and application of an engineered fibrous, hyaluronic acid-based hydrogel with tunable material 
parameters. The impact of the material parameters and findings discussed in this thesis can be 
applied to other biomaterial systems for the general advancement of cartilage tissue engineering. 
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Chapter 2 
 
Research Overview 
 
2.1 Specific Aims & Hypotheses 
Hyaline cartilage is the most prevalent form of cartilage throughout the body, serving as a 
load-bearing, low-friction articulating surface in diarthrodial joints. Osteoarthritis and acute trauma 
can result in significant cartilage degeneration and pain; unfortunately, cartilage has a low 
regenerative capacity mainly due to its avascular and alymphatic nature. Clinical methods to treat 
cartilage are limited, and in many cases these methods only delay the need for more extreme 
therapies (i.e. total knee replacements). For these reasons, biomaterial-based approaches are 
being heavily investigated, with a focus on engineering biomaterial scaffolds towards cartilage 
repair either through the long-term in vitro development of cell-seeded scaffolds or through direct 
implantation in combination with existing clinical methods, such as microfracture. This thesis 
describes the development and application of a tunable, fibrous hyaluronic acid (HA)-based 
biomaterial scaffold for cartilage repair through both in vitro and in vivo studies.  
 
The overall goal of this work is to develop and apply a novel biomaterial to better understand the 
effect and impact of material parameters (e.g., degradation, mechanics, and growth factor 
release) on in vitro and in vivo cartilage development and regeneration. Four hypotheses are 
outlined below that encompass various components of this project, leading to a better 
understanding of the utility of such scaffolds for cartilage repair. 
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Specific hypothesis 1: HA macromers can be electrospun into fibrous hydrogel scaffolds with a 
range of material properties and the ability to encapsulate and release proteins.   
Specific Aim 1: To develop and characterize the electrospinning of HA macromers into 
fibrous scaffolds. HA macromers with varying type (e.g., stable and degradable) and extent of 
modification will be synthesized and characterized. These modified HA macromers will then be 
electrospun with a wide range of parameters to assess the effect of these variables on stable 
fiber formation. Finally, both type and extent of HA modification and rotational mandrel speed will 
be altered to control release of an encapsulated model protein and to fabricate depth-dependently 
aligned scaffolds, respectively. 
 
Specific hypothesis 2: Variations in fiber mechanics, fiber adhesivity, and cell-seeding method will 
affect MSC response (i.e. spreading, proliferation, chondrogenesis, and infiltration) in vitro. 
Specific Aim 2: To investigate the effects of mechanics, adhesion, and cell-seeding 
method of fibrous HA scaffolds on MSC response in vitro. HA macromers will be modified 
and electrospun to form fibers with varying mechanical properties and adhesivity. MSC response 
to these variables will be investigated in vitro, with a focus on cell spreading, proliferation, and 
chondrogenic gene expression. Cell-seeding method and post-fabrication techniques will then be 
explored to improve cellular infiltration. 
 
Specific hypothesis 3: Variations in fibrous scaffold chemistry and growth factor release will affect 
cartilage repair when investigated in an in vivo cartilage defect model. 
Specific Aim 3: To translate fibrous scaffolds to in vivo studies and analyze the effects of 
scaffold properties and TGF!3 release in an in vivo cartilage defect model. Fibrous HA- and 
PCL-based fibrous scaffolds will be developed and characterized. Specifically, differences in 
degradation, mechanical properties, and TGF!3 release will be validated through in vitro studies 
using multi-polymer scaffolds. Next, these scaffold parameters will be investigated in an in vivo 
cartilage defect model. Assessment outcomes of in vivo studies will include gross appearance, 
mechanical properties, defect fill, subchondral bone repair, histology, and scoring. 
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Specific hypothesis 4: The addition of sulfated HA macromers will allow for specific, sustained 
release of SDF-1 and TGF!3 from both isotropic and fibrous HA hydrogels. 
Specific Aim 4: To exhibit specific, controlled release of SDF-1 and TGF!3 through the 
incorporation of sulfated HA macromers. Sulfated HA macromers will be synthesized, 
characterized, and then incorporated into both isotropic and fibrous HA hydrogels. Multiple 
biomolecules (i.e. SDF-1 and TGF!3) will be encapsulated within HA hydrogels to exhibit specific 
control over release profiles based on their ability to bind to charged scaffolds through 
electrostatic interactions.  
 
2.2 Research Overview 
 Osteoarthritis and other cartilage-related injuries affect a significant portion of the U.S. 
population, and cartilage unfortunately has a low regenerative capacity. The motivation for the 
development of new clinical treatment methods, such as autologous matrix-induced 
chondrogenesis (AMIC), is clear from the limited techniques for cartilage repair currently 
available, as described in Chapters 1 and 3. AMIC combines microfracture with a decellularized 
collagen scaffold to stabilize the blood clot and also to provide a scaffold within which cells can 
adhere, migrate, and produce new extracellular matrix. However, this collagen scaffold lacks 
versatility and may not be an optimal material for this application.  Overall, this thesis outlines the 
development and application of an engineered biomaterial scaffold for improved outcomes for in 
vivo cartilage repair. 
 Chapter 4 describes the synthesis of modified HA macromers and the development of the 
HA electrospinning system. Acceptable ranges for various electrospinning parameters will be 
assessed, and these findings will be used throughout for the fabrication of the biomaterial used 
throughout this thesis. Chapters 5 and 6 then move to in vitro studies with cells (i.e. mesenchymal 
stem cells or MSCs). Specifically, Chapter 5 focuses on differences in fiber mechanics and 
adhesive ligand density to elicit differences in MSC spreading, proliferation, traction forces, and 
chondrogenic gene expression. These studies were all performed with MSCs seeded onto thin 
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fibrous HA films, whereas Chapter 6 utilizes various cell-seeding methods and post-fabrication 
techniques to improve cellular infiltration into thick, fibrous HA hydrogels.  
The difficulties with achieving sufficient cell infiltration with fibrous scaffolds detailed in 
Chapter 6 provides motivation for the use of acellular scaffolds for cartilage repair as described in 
Chapters 7 and 8. Chapter 7 details the fabrication and characterization of multiple fibrous HA- 
and PCL-based scaffold groups, validating differences in scaffold degradation, mechanical 
properties, and TGF!3 release. Chapter 8 then investigates these scaffolds and variables in an in 
vivo cartilage defect model, with outcomes including mechanical properties, defect fill, 
subchondral bone repair, and histology.  
Chapter 9 transitions towards the addition of another biomolecule (i.e. SDF-1) for 
increased recruitment of cells to the defect site for improved extracellular matrix synthesis. To this 
end, Chapter 9 details the synthesis, characterization, and incorporation of sulfated HA 
macromers into fibrous and isotropic hydrogels to specifically control release of known heparin-
binding proteins, such as SDF-1. These findings will then be incorporated towards ongoing and 
future in vivo work with fibrous HA scaffolds that release multiple biomolecules (i.e. both SDF-1 
and TGF!3) to enhance both cell recruitment and matrix production. Finally, Chapter 10 outlines 
these and other future directions and also summarizes the conclusions, limitations, and impact of 
this thesis. 
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CHAPTER 3 
 
Hydrogel Design for Cartilage Tissue Engineering: A Case Study with 
Hyaluronic Acid 
 
Adapted from: IL Kim, RL Mauck, and JA Burdick, “Hydrogel Design for Cartilage Tissue 
Engineering: A Case Study with Hyaluronic Acid” Biomaterials, 2011, 32(34): 8771-8782. 
 
3.1 Introduction 
 Hyaline cartilage is the most prevalent form of cartilage throughout the body, serving as a 
low-friction and wear-resistant articulating surface in load-bearing, diarthrodial joints. 
Unfortunately, trauma and a variety of diseases can lead to damaged hyaline cartilage, and the 
avascular and alymphatic nature of cartilage significantly impedes the body’s natural ability to 
repair and regenerate [1, 2]. Current clinical methods to repair defective cartilage include 
autologous chondrocyte implantation (ACI), mosaicplasty, and microfracture, all of which are 
limited in their ability to regenerate functional cartilage both in terms of composition and 
mechanics [3]. Due to these shortcomings, research in recent years has focused on tissue 
engineering solutions in which the regeneration of cartilage is pursued through combinations of 
cells (e.g., chondrocytes or stem cells), scaffolds (e.g., hydrogels, sponges, and meshes), and 
stimulatory growth factors and bioreactors to guide tissue formation [4]. Even with promising 
advances in this field, functional properties comparable to native cartilage have not been realized, 
particularly when engineered constructs are evaluated in relevant large animal models.  
Scaffolds intended for cartilage regeneration should fulfill many requirements, including 
adequate nutrient transport, adhesion to the defect site, minimally invasive implantation or 
injection, and degradability [5]. Furthermore, one of the most important requirements is the ability 
to provide the proper mechanical function (i.e., compressive, shear, and tensile properties), either 
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a priori or through directed tissue formation. Both synthetic and natural materials have been 
explored as potential scaffolds in a variety of forms, including hydrogels, sponges, and fibrous 
meshes, for cartilage regeneration. Of these various material structures, the most commonly 
explored is hydrogels, which are water-swollen networks crosslinked by either covalent or 
physical methods. Hydrogels are particularly attractive because they can be non-invasively 
injected, fill defects of any size, and can homogenously suspend cells within a 3D environment 
[4].  The focus of this chapter will be on the evolution of hydrogels for cartilage tissue engineering 
applications, using a class of materials based on hyaluronic acid (HA) as an example to highlight 
many of the specific criteria used in material design for this application.  
 
3.2 Hydrogels Used in Cartilage Repair 
Hydrogels are useful in tissue engineering as they present cells a 3-D context for tissue 
formation and defect repair.  These water-swollen networks provide a local microenvironment that 
can signal to cells through various chemical and mechanical signals and serve as a permeable 
matrix for the diffusion of soluble factors [6]. Hydrogels have been widely used for biomedical and 
tissue engineering applications, and there are a plethora of both synthetic and natural systems 
used for these purposes.  This section will provide a broad overview of commonly used hydrogel 
materials for cartilage tissue engineering. 
Synthetic hydrogels provide a well-defined, controllable scaffold to encapsulated cells 
and can be beneficial in elucidating the effects of isolated variables in material design. 
Poly(ethylene glycol) (PEG) hydrogels form the most prevalent class of synthetic materials for 
cartilage tissue engineering; PEG hydrogels are relatively inert and biocompatible and have been 
shown to support cartilage tissue formation by both chondrocytes and mesenchymal stem cells 
[7, 8]. PEG has been modified to include lactic acid groups, RGD [9, 10], and decorin moieties 
[11] to enhance degradation, viability, and chondrogenesis, respectively. Even with these 
modifications, PEG does not support chondrogenesis and cartilage-specific matrix production to 
the same degree as some natural materials, including alginate [12] and HA [13]. In response, 
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PEG has been combined with a variety of natural materials and even modified with collagen-
mimetic peptides to enhance chondrogenesis [14-16]. 
Natural materials are commonly used for cartilage tissue engineering due to their 
abundance, and because they possess many intrinsic pro-chondrogenic properties and are 
commonly involved in native cellular processes. Agarose and alginate, both polysaccharide-
based and derived from seaweed, were two of the first materials used as hydrogels for cartilage 
tissue engineering [17]. Agarose has been shown to support chondrogenesis and resulted in the 
highest sGAG to DNA ratio when compared to type I collagen, alginate, fibrin, and polyglycolic 
acid [18]. Agarose gels have been employed extensively in cartilage tissue engineering and have 
helped to elucidate the effects of mechanical loading, TGF! exposure, and differences between 
chondrocytes and MSCs [19-21]. Alginate is generally crosslinked with bivalent cations, 
commonly Ca2+, and can support chondrogenesis [22, 23] in a variety of 3D forms (beads and 
discs). RGD peptides have been incorporated into alginate gels to provide controllable cell 
adhesion sites; however, this system inhibits and/or reduces chondrogenesis of MSCs [22]. 
Moreover, other limitations to alginate include low mechanical stability and slow degradation. 
Natural hydrogels based on proteins, such as collagen and fibrin, are also common for 
cartilage regeneration. Collagen is an abundant protein within native articular cartilage and 
provides intrinsic cell-binding motifs and enzyme-specific degradation, but collagen gels are very 
soft and can contract during culture [24]. Fibrin is another commonly used natural protein that has 
pro-chondrogenic properties and rapid degradation [25]. This rapid degradation is theoretically 
beneficial for in vivo studies, but results in inferior tissue in vivo [26] and makes long-term in vitro 
studies difficult to conduct [27]. Polypeptides that mimic native proteins have also been studied 
for cartilage regeneration. Elastin-like polypeptides (ELPs) consist of artificial repetitive 
polypeptides that can hydrophobically self-associate above a characteristic transition temperature 
[28]. The repeating amino acid sequence is versatile and can be tuned to include RGD for cellular 
adhesion, lysines for crosslinking, histidine tags for in vivo tracking, and silk peptide sequences 
(SELPs). ELPs have been shown to support chondrogenesis during in vitro studies, and SELPs 
have even been studied in rabbit and goat cartilage defect models with promising results. Kisiday 
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and coworkers have also used KLD-based self-assembling peptides to prolong TGF! delivery 
and study the effects of dynamic compressive loading on MSC chondrogenesis in vitro, and these 
peptide hydrogels have also been analyzed within a rabbit cartilage defect model [29-32]. 
HA-based hydrogels are one of the most extensively studied natural materials for 
cartilage tissue engineering. HA is a linear polysaccharide found natively in adult articular 
cartilage that is involved in many cellular processes, including proliferation, morphogenesis, 
inflammation, and wound repair [33]. Furthermore, HA is also important to cartilage formation and 
is differentially regulated during limb bud formation and mesenchymal cell condensation [34]. HA 
hydrogels support chondrocyte matrix deposition and chondrogenic differentiation of 
mesenchymal stem cells (MSCs). Moreover, in direct comparison to PEG hydrogels, HA 
hydrogels enable more robust MSC chondrogenesis and cartilaginous matrix formation both in 
vitro and in vivo [13]. HA is also easily functionalized into formats that are both 
photopolymerizable and/or hydrolytically degradable [35, 36], and can include MMP-sensitive 
peptides and RGD sequences for cell-mediated degradation [37] and cellular adhesion [38], 
respectively. With its natural pro-chondrogenic properties and facile tunability, HA hydrogels are a 
promising scaffold for cartilage regeneration and will be the focus of the remainder of this article. 
 
3.3 Macromer Synthesis and Network Formation 
Although photoinitiated, redox, and thermal mechanisms are all common systems for 
radical polymerization, this review will focus on photoinitiated polymerization due to its common 
use for hydrogel formation in cell encapsulation [39]. Photoinitiated polymerizations generally 
include a double-bond containing macromer, a photoinitiator, and a light source. When light 
excites the photoinitiator, radicals are produced which then initiate the formation of kinetic chains 
through the double bonds in the macromer (i.e., propagation). The rate of initiation (Ri) is 
dependent on the initiator efficiency, initiator concentration, and light intensity, and the rate of 
propagation can be approximated by a second-order reaction, dependent on both the double 
bond concentration and the radical concentration [39]. As the reaction progresses, a pseudo-
steady state of radical consumption can be assumed (Ri = Rt), where the rate of propagation is 
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dependent on Ri, the monomer concentration, and the propagation and termination kinetic 
constants (kp and kt, respectively).  This leads to a fairly complex reaction behavior even when 
steady state is assumed.  
The reaction behavior during photoinitiated polymerizations can potentially be harmful to 
cells, and many groups have explored the effects of various photoinitiators and light intensities to 
enhance cell viability. Burdick, et al. showed that the temperature increase resulting from 
photoinitiated polymerization was readily controlled by changing the light intensity, with a drop in 
surface temperature from 46°C to 33°C when light intensity was decreased from 100 mW/cm2 to 
25 mW/cm2 [40]. However, this was with a highly crosslinked system; with hydrogels, temperature 
increases are minor and have not been deemed detrimental to cell viability.  The water-soluble 
photoinitiator Irgacure 2959 (I2959, 2-hydroxy-1-[4-(hydroxyethoxy) phenyl]-2-methyl-1-
            
Figure 3.1 Chemical structures of various modifications of the hyaluronic acid (HA) backbone that 
impart a range of reaction behavior and functionality into formed HA hydrogels. 
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propanone) has been widely adopted due to its ability to support gel formation while maintaining 
cell viability when exposed to 8 mW/cm2 UV light for 10 minutes at concentrations less than or 
equal to 0.05% w/v; other initiator systems are generally more toxic to cells [41, 42]. This system 
of I2959 with low intensity UV light is currently the most extensively used for hydrogel formation 
and is the basis for HA gelation in most of the following studies discussed.   
 The primary hydroxyl groups on the HA backbone can easily be modified to include 
functional groups that allow for covalent crosslinking, degradation, and controlled adhesion 
(Figure 3.1). Incorporating a methacrylate [43, 44] (MeHA) or acrylate [38] (AHA) functional group 
onto the HA backbone allows for photoinitiated crosslinking. Other commonly conjugated 
functional groups include methacrylated lactic acid (MeLAHA) [35], methacrylated caprolactone 
(MeCLHA) [36], and hydroxyethylmethacrylate (HeMAHA) [45, 46].  A cys-containing RGD can 
also easily be grafted through a Michael-type addition reaction between the thiol and an acrylate 
or methacrylate functional group on HA [37, 38]. This ease of modification and versatility of HA 
make it an attractive hydrogel material for tissue engineering applications.  Details on synthesis 
mechanisms are provided in the above referenced articles. 
 
3.4 Network Density and Degradation: Effects on Mechanics and Diffusion 
A combination of the macromer molecular weight, % of primary hydroxyl groups 
methacrylated (% modification), concentration (% w/v) in the precursor solution, and extent of 
reactive groups consumed during reaction, all combine to determine the mechanics and network 
density of formed HA hydrogels. These variables can be used to impart specific properties into 
the HA hydrogels [47]. Burdick, et al. found that combinations of varying HA macromer molecular 
weight and % w/v of the precursor solution resulted in moduli ranging from about 2 to 100 kPa, 
and a later study found that of the formulations investigated, 2% w/v 50 kDa molecular weight 
MeHA hydrogels resulted in the best type II collagen and chondroitin sulfate expression for 
encapsulated auricular chondrocytes [48]. Erickson, et al. later screened 1, 2, and 5% w/v bovine 
MSC-seeded MeHA hydrogels, and found that MSCs within 5% w/v MeHA hydrogels significantly 
upregulated type II collagen mRNA expression and resulted in the highest overall proteoglycan
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content in comparison to lower % w/v hydrogels. However, the high network density impeded the 
distribution of the deposited matrix (Figure 3.2) and resulted in inferior bulk mechanics in 
comparison to the other conditions. Indeed, the 1% w/v hydrogel, although not optimal for matrix 
production and possessing the lowest initial mechanical properties, resulted in the highest 
equilibrium compressive modulus (0.12 MPa) and dynamic modulus (1.05 MPa) of all conditions 
after 6 weeks of in vitro culture [49].  Thus, it is important to balance the initial properties with the 
ability to accumulate matrix within these hydrogel systems to obtain the best final properties in 
engineered tissues, towards their utility in clinical applications. 
In a following study, a higher cell seeding density of 60 million cells/mL (60M) was 
compared to the standard 20 million cells/mL (20M) within 1% w/v MeHA hydrogels, and the 60M 
group reached a significantly higher equilibrium compressive modulus and dynamic modulus in 
    
Figure 3.2 Network density (1, 2, and 5% w/v MeHA) influences distribution and connectivity of 
matrix deposited by mesenchymal stem cells (MSCs). Alcian blue staining of proteo- glycans 
(top), picrosirius red staining of collagens (middle), and immunostaining of type II collagen 
(bottom) in sections from MeHA and control agarose hydrogels on day 42. Adapted from [58] with 
permission. Scale bar: 250 microns. 
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comparison to the 20M group (p<0.05), presumably due- to increased cell-cell proximity and 
matrix connectivity [50]. Interestingly, the sGAG concentration was only ~25% greater and the 
collagen content was actually halved in the 60M group, implying that the increase in mechanics 
was more likely due to enhanced collagen organization and connectivity [51, 52]. Also important 
to note, the restricting effect of higher network densities was not overcome even by a 3-fold 
increase in cell density as the mechanical properties did not increase in 60M compared to 20M in 
2% w/v and 5% w/v MeHA hydrogels. To further improve nutrient and matrix distribution, gentle 
mixing using an orbital shaker was employed on 60M 1% w/v MeHA hydrogels. Samples under 
dynamic culture reached an equilibrium compressive modulus of over 1 MPa and a dynamic 
modulus of 6 MPa after 9 weeks of culture, well above the moduli of samples under static culture  
(p<0.001) and within the range of mechanical properties for native bovine articular cartilage [50]. 
This series of studies displays the importance of nutrient and matrix diffusion and the need for a 
hydrogel with sufficiently low network density to allow for high permeability. While these studies 
demonstrate the potential of HA hydrogels, these experiments must be replicated with human 
MSCs to be clinically relevant. 
Tuning hydrogel degradation can also be used to alter nutrient and matrix distribution. 
Although hydrogels are initially a valuable cell-carrier and useful for mechanical support, ideally 
the artificial polymer network will degrade at a rate fast enough to allow for optimal matrix 
distribution and organization, but slow enough to provide support as needed. Mixtures of MeHA 
with both MeLAHA and MeCLHA (hydrolytically degradable forms of HA, see Figure 3.1), formed 
by changing % w/v of each component while keeping overall % w/v constant, allows for tunable 
degradation profiles. While keeping overall % w/v constant, mixtures of MeHA with increasing 
amounts of hydrolytically-degradable MeLAHA enhanced the distribution of matrix components  
[35] (Figure 3.3). Chung, et al. later screened mixtures of MeHA with MeCLHA, varying both 
overall % w/v (1% w/v, 2% w/v, and 5% w/v) and also varying the ratio of MeHA to MeCLHA [36]. 
The 1:1 MeHA:MeCLHA hydrogel (overall 2% w/v) retained the pro-chondrogenic benefits of 
higher network density (as discussed previously) while gradually decreasing network density and 
increasing matrix connectivity as the MeCLHA component degraded. Interestingly, the lower %
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w/v gels (1% w/v MeHA) led to greater contraction than the gradually decreasing formulation; 
thus, the rate of hydrogel degradation may also play a role in maintenance of construct size.  
Moreover, recent work has used specific MMP-cleavable crosslinkable sequences to form HA 
hydrogels that allow for cell-mediated degradation [37, 38]. Although not yet explored for cartilage 
regeneration in HA hydrogels, MMP-sensitive PEG hydrogels show significant upregulation of 
type II collagen and aggrecan and enhanced diffusion of deposited matrix in comparison to MMP-
insensitive PEG gels [53]. MMP-degradable HA hydrogels are thus a promising avenue for future 
cartilage-focused studies. 
 
3.5 Conclusions 
 While many promising advances have been made in understanding the biology behind 
healthy and diseased cartilage and also in methods to enhance chondrogenesis and matrix 
formation of chondrocytes and MSCs in hydrogel scaffolds, engineering cartilage tissue in vitro 
that possesses the full range of native properties remains a difficult proposition. Our group and 
many others in the field have made marked progress in forming engineered cartilage tissue 
 
Figure 3.3 Increasing ratio of degradable component (MeLAHA) in fixed overall % w/v 
MeHA:MeLAHA hydrogels enhances distribution of MSC-deposited chondroitin sulfate after 14 
days (CS = chondroitin sulfate, H&E = hematoxylin and eosin). Adapted from [44] with 
permission. Scale bar: 100 microns. 
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based on HA and stem cells that reproduces some of the key features of the native tissue. 
Through the investigation of important scaffold properties, including macromer density, 
mechanical properties, and growth factor release, mechanical and biochemical properties similar 
to native cartilage have been achieved in vitro with bovine MSCs encapsulated in HA hydrogels. 
Still, similar studies with human MSCs have not achieved the appropriate level of mechanical 
properties even with considerable modifications to scaffold design. Thus, it may be beneficial to 
revisit a more fundamental level of research and first try to resolve other issues, including cell 
source and better markers for in vitro chondrogenesis. With the addition of these new tools and 
more thorough assessments in large animal models, previously studied systems may reach 
native levels of matrix composition and mechanics to form functional, durable, and stable tissue 
engineered articular cartilage. This would significantly improve the health and mobility of 
countless patients worldwide suffering from the negative symptoms of acute cartilage damage 
and the ravages of progressive osteoarthritis. 
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CHAPTER 4 
 
Synthesis and Electrospinning of Modified Hyaluronic Acid Macromers 
 
4.1 Introduction 
Hyaluronic acid (HA) is a non-sulfated glycosaminoglycan found natively in many tissues 
and is involved in multiple cellular processes, including proliferation, tissue morphogenesis, and 
inflammation [1]. Specific to cartilage, HA is differentially regulated during limb bud formation and 
mesenchymal cell condensation during development and remains afterward as a component in 
native adult articular cartilage [2]. HA can be chemically modified to crosslink into hydrogels [3], 
and these isotropic, water-swollen networks have been shown to significantly enhance 
chondrogenesis of encapsulated mesenchymal stem cells (MSCs) in direct comparison to MSCs 
encapsulated within PEG hydrogels [4]. Indeed, MSCs have been shown to interact with HA 
through CD44 and CD168 cell-surface receptors, and blocking these interactions significantly 
decreased MSC chondrogenesis [5]. Although initial studies have demonstrated promise for 
cartilage tissue engineering, one significant disadvantage of isotropic hydrogels is the nano-scale 
porosity, which can significantly impede cell-cell contacts, nutrient diffusion, and matrix 
distribution and organization [6].  
Electrospinning materials into fibrous scaffolds may be a possible strategy to overcome 
these limitations with isotropic hydrogels. Electrospinning has gained much interest over the past 
decade due to its ability to create scaffolds that mimic the native extracellular matrix [7]. 
Moreover, the fibrous scaffolds created through this process have a high surface area to volume 
ratio, allowing for cell-cell contacts and control over matrix organization [8]. This process utilizes a 
voltage source to impart charge to a polymer solution as it is extruded through a spinneret. As the 
electrostatic repulsions of the charged polymer chains increase, the leading solution edge at the 
spinneret tip changes from a rounded meniscus to a Taylor cone. Eventually the electrostatic 
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repulsions become strong enough to overcome the surface tension at the Taylor cone, and a fiber 
jet is ejected towards a grounded or oppositely charged collecting surface. The solvent 
evaporates as the fiber jet travels through the atmosphere, resulting in the deposition of dry, 
polymer fibers [9].  
A variety of synthetic and natural materials, including poly(!-caprolactone) (PCL), 
poly(lactic-co-glycolic acid) (PLGA), collagen, and chitosan, have been successfully electrospun 
to form fibrous scaffolds with a wide range of physical properties [8-10]. Although electrospinning 
is a relatively simple process, many variables, such as flow rate, solution composition, ambient 
temperature, ambient humidity, and voltage, significantly affect the resulting fiber formation and 
morphology. Generally, these variables need to be tuned specifically to the particular polymer and 
solvent of choice, which can be a difficult process for certain polymer/solvent combinations. 
Electrospinning HA (and other charge polysaccharides) has proven problematic due to the high 
viscosity and surface tension of HA solutions even at low concentrations [11]. As a result, HA is 
commonly dissolved in strong acids, strong bases, or organic solvents for electrospinning [11-13], 
and Um, et al. even designed a complex “electro-blowing” airflow and heating system to achieve 
stable jet formation [14]. These harsh solvents can be especially damaging for applications 
utilizing encapsulated growth factors; thus, the HA electrospinning system utilized throughout this 
thesis incorporates a high molecular weight “carrier” polymer which permits use of dI H2O as the 
solvent. 
This chapter thoroughly describes the scaffold material that forms the basis of this thesis 
(i.e. fibrous HA-based scaffolds). Specifically, we first detail the synthesis of HA modified with 
methacrylates (MeHA) and hydroxyethyl methacrylates (HeMA-HA) and then describe the 
development and characterization of the HA electrospinning system, with an emphasis on the 
effects of various parameters, including humidity, solvent choice, and solution composition on 
electrospinning jet stability and resulting fiber formation. 
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4.2 Materials and Methods 
4.2.1 MeHA Synthesis 
  HA was modified with methacrylate groups to allow for free radical-initiated covalent 
crosslinking as described in [3]. To synthesize 35% modified MeHA, a 1% w/v solution of sodium 
hyaluronate (NaHy, 64 kDa, Lifecore) in dI H2O was dissolved at 4°C prior to addition of 2.2 mL 
methacrylic anhydride (Sigma) (Figure 4.1A). The solution was allowed to react 24 hours on ice 
within a pH range of 7.5-9. After the 24-hour period, another 1.1 mL of methacrylic anhydride was 
added to the reaction, and the pH was kept between 7.5-9 for another 5 hours. For synthesis of 
100% modified MeHA, the volume of methacrylic anhydride was doubled at both steps, and the
 
        
Figure 4.1 (A) Reaction scheme of MeHA synthesis and (B) representative 1H NMR spectra of 
MeHA. Labeled peaks in (B) correspond to labels on MeHA chemical structure in (A). 
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pH was kept within a range of 8.5-9.5. After the second reaction period, the solution was dialyzed 
against dI H2O (6-8 kDa molecular weight cut off, SpectrumLabs) for 5-6 days and then freeze-
dried. The extent of modification was characterized through 1H NMR (Figure 4.1B). 
 
4.2.2 HeMA-HA Synthesis 
 HA was modified with HeMA groups to allow for radical-initiated covalent crosslinking, as 
well as hydrolytic degradation through ester group hydrolysis as described in [15]. First, the 
hydroxyl group in HeMA was converted to a carboxylic acid (i.e. HeMA-COOH) via an 
esterification reaction with succinic anhydride in the presence of N-methylimidazole. Next, a 
                
Figure 4.2 (A) Reaction scheme of HeMA-HA synthesis and (B) representative 1H NMR spectra 
of HeMA-HA. Labeled peaks in (B) correspond to labels on HeMA-HA chemical structure in (A). 
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tetrabutylammonium salt of HA (HA-TBA) was formed by mixing NaHy with a Dowex ion 
exchange resin (Sigma) for 5-6 hours at room temperature, vacuum filtering out the resin, and 
then titrating the resulting solution with tetrabutylammonium hydroxide (Sigma) to a pH of 7.02-
7.05. To synthesize HeMA-HA, a 2% w/v solution of HA-TBA in anhydrous dimethyl sulfoxide was 
reacted with HeMA-COOH in the presence of 4-dimethylaminopyridine and di-tert-butyl 
dicarbonate under anhydrous conditions for 20 hours at 45°C (Figure 4.2A). The resulting HeMA-
HA solution was then purified through dialysis (6-8 kDa molecular weight cut off, SpectrumLabs) 
against dI H2O for 2-3 weeks at 4°C. After freeze-drying, the extent of modification was 
characterized using 1H NMR (Figure 4.2B). 
 
4.2.3 Fabrication of Fibrous HA Scaffolds 
 Multiple HA solutions for electrospinning were investigated, consisting of HA macromer 
content ranging from 1 to 4% w/v, poly(ethylene oxide) (PEO, Sigma, 900 kDa) content ranging 
from 1 to 3% w/v, and 0.05% w/v Irgacure 2959 dissolved in dI H2O. Electrospinning solutions 
were dissolved over a period of 24-48 hours to ensure the polymers were completely dissolved. 
To electrospin, a syringe was connected to a 12”-long 18G blunt-ended stainless steel needle 
positioned 12-18 cm away from the grounded aluminum mandrel (Figure 4.3A). The flow rate and 
applied voltage were kept between 1.0 to 2.0 mL/hr and 18 to 30 kV, respectively. After 
electrospinning, samples were purged with N2 in an airtight container and then crosslinked with 
10 mW/cm2 UV light (320-390 nm collimated, Omnicure S1000 UV Spot Cure Systems). 
Crosslinking time depended on the relative thickness of the fibrous scaffold; thin samples (i.e. 
less than 200-300 µm) were polymerized for 10 minutes, and thick scaffolds (i.e. greater than 
200-300 µm) were polymerized for 15 minutes on either side for a total of 30 minutes. After 
crosslinking, samples were stored with desiccant either at room temperature or -20°C (for HeMA-
HA-containing scaffolds). Due to the hydrophilicity of HA, swelling of these fibrous HA scaffolds 
results in a “fibrous hydrogel” scaffold, where the macroscopic fibers are themselves water-
swollen networks (Figure 4.3B). 
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4.2.4 Imaging of Fibrous Scaffolds 
 Dry fibrous scaffolds were imaged using scanning electron microscopy (SEM, JEOL 
7500F HRSEM, Penn Regional Nanotechnology Facility). To visualize swollen scaffolds, 
methacrylated rhodamine dye (MeRho, Polysciences) was incorporated into electrospinning 
solutions prior to scaffold fabrication. Fibrous samples with MeRho were swollen in PBS at 37°C 
for 48 hours prior to imaging with confocal microscopy (Zeiss Axioobserver Inverted microscope, 
Penn CDB Microscopy Core). 
 
4.2.5 Encapsulation and Release of FITC-BSA from HA Fibers  
 To measure the release of encapsulated proteins from HA fibers, fluorescein 
isothiocyanate-conjugated bovine serum albumin (FITC-BSA, Sigma) was dissolved at 0.5% w/v 
into the HA electrospinning solution. The resulting solution was then electrospun and crosslinked 
as described previously, and the mat was then cut into 0.5 x 0.5 cm squares. Samples were 
placed into 1.5 mL Eppendorf tubes, swollen with 1 mL of PBS, and incubated at 37°C. Releasate 
was collected and refreshed at desired timepoints. Samples were stored at -20°C until the final 
timepoint, at which point relative FITC-BSA levels were quantified using a microplate reader 
(Tecan infinite m200) with 480 and 520 nm for excitation and emission wavelengths, respectively. 
 
Figure 4.3 Schematic of (A) HA electrospinning system and post-fabrication processing and (B) 
“gel-within-a-gel” structure of HA fibers (adapted from [16]). 
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4.2.6 Fabrication of Depth-dependently Aligned HA Scaffolds 
 To alter the degree of fiber alignment, the rotational speed of the collecting mandrel was 
varied between 0.2 m/s for unaligned scaffolds, 5 m/s for scaffolds partial alignment, and 10 m/s 
for fully aligned scaffolds. These scaffolds were then imaged dry with SEM, and the degree of 
fiber alignment was quantified in ImageJ (NIH) by measuring the angle between each fiber and 
an arbitrary line drawn over the image. For fabrication of scaffolds with depth-dependent 
alignment, the mandrel rotation speed was set at 0.2 m/s for the first 4 hours and then switched to 
10 m/s during the remaining 12 hours of electrospinning. Samples were then crosslinked and 
imaged as described previously. 
 
4.3 Results and Discussion 
 To achieve our goal of obtaining fibrous HA scaffolds, the work in this chapter first 
describes the synthesis and electrospinning of modified HA macromers. Successful 
electrospinning of HA requires extensive optimization due to the significant effects of ambient 
humidity, solution composition, and other processing parameters on fiber formation. Here, we 
outline the development of the HA electrospinning system for optimal jet stability and consistent 
fiber formation. We also take advantage of the synthetic versatility of HA and the ability to change 
the rotational speed of the collection mandrel to control the release of an encapsulated model 
protein (i.e. BSA) and to create depth-dependently aligned scaffolds that mimic the native 
architecture of cartilage, respectively.  
 
4.3.1 HA Macromer Synthesis and Characterization 
 HA, a naturally occurring glycosaminoglycan, is readily modified due to an abundance of 
both carboxyl and hydroxyl groups along the HA backbone. In this work, HA was modified with 
both methacrylates and hydroxyethyl methacrylates to form MeHA and HeMA-HA, respectively. 
The extent of modification for both macromers was characterized through 1H NMR, as shown in 
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both Figures 4.1B and 4.2B. The signal from the protons within the methacrylate group (two 
peaks at ~6.2 and ~5.75 ppm) was normalized to the peak from the acetyl group (at ~2.0 ppm) to 
give the percent of primary hydroxyl groups modified (i.e. extent of modification).  
 
4.3.2 Effect of Humidity on Electrospinning HA 
 The electrospinning of many polymer/solvent combinations has been shown to be 
dependent on ambient humidity, with both extremely low and high humidity levels negatively 
affecting successful fiber formation [17-19]. Similarly, the ability to successfully fabricate uniform 
fibrous HA scaffolds was found to be highly dependent on ambient humidity. Specifically, there 
was a threshold humidity level of ~40%, above which fibrous scaffolds could no longer be formed 
most likely due to a combination of jet instability (i.e. intermittent electrospraying) and incomplete 
solvent evaporation before collection. Although undetectable to the eye during the electrospinning 
process, evidence of intermittent electrospraying was apparent when the resulting fibers were
 
 
Figure 4.4 SEM images of fibrous HA scaffolds electrospun with varying (A) ambient humidity 
levels and (B) ethanol concentrations. 
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imaged with SEM. Subtle craters or pockets were visible under low magnification, and high 
magnification SEM images revealed seemingly “wet” fibers with increased welding at fiber-fiber 
functions within these areas (Figure 4.4A). At even higher levels of humidity, jet instability (i.e. 
intermittent electrospraying) was detectable by eye during electrospinning, and SEM revealed 
distinct regions of completely dissolved fibers. To possibly reduce this dependence on humidity, 
ethanol was incorporated into the electrospinning solutions. However, retention of fibrous 
morphology was worse with ethanol incorporation compared to the original dI H2O solvent (Figure 
4.4B). Thus, for the remainder of the thesis, samples were electrospun from dI H2O strictly at 
humidity levels of 35% or less.  
 
4.3.3 Effect of Solution Composition and Flow Rate on Fiber Formation 
 The following parameters were explored during the development of the HA 
electrospinning system: solution composition, flow rate, voltage, and distance between the needle 
tip and collection surface (collection distance). The solution composition had the most significant 
effect on jet stability and fiber formation, whereas the flow rate, voltage, and collection distance 
could be varied within a wide range (i.e. between 1.0 to 1.4 mL/hr, +21 to +26 kV, and 14 to 20 
cm, respectively) with no apparent effect on jet stability or fiber formation (Figure 4.5B). These 
parameter ranges for successful fiber formation were utilized in the following chapters to tune the 
HA electrospinning system both for different applications (e.g. increasing flow rate to increase HA 
content in dual polymer scaffolds) and also, when necessary, to account for varying ambient 
conditions (i.e. humidity and temperature). 
Since PEO was added as an inert carrier polymer to allow for electrospinning of aqueous 
HA solutions, the highest HA:PEO ratio possible would be preferable to investigate fibrous HA 
scaffolds. To increase the ratio of HA to PEO from the original 2:3 HA:PEO (i.e. 2% w/v HA and 
3% w/v PEO), various solution compositions were dissolved, electrospun, and imaged with SEM.  
Decreasing the PEO content without increasing the HA content (i.e. 2% w/v HA and 1% w/v PEO) 
resulted in beaded fibers (Figure 4.5A). However, a decrease in PEO content combined with an 
increase in HA content (i.e. 4% w/v HA and 1% w/v PEO) resulted in a relatively stable jet with
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homogeneous, smooth fibers (Figure 4.5A). Still, as described earlier, small changes in ambient 
humidity affected overall jet stability, and the electrospinning jet for the 4% w/v HA and 1% w/v 
PEO formulation became unstable at humidity levels above ~25%. Thus, the PEO content was 
increased further (i.e. 4% w/v HA and 1.5-2% w/v PEO) for the stable, consistent formation of 
smooth fibers, and this formulation was used for all subsequent chapters (with the exception of 
Chapter 6). These findings indicate that although the long PEO chains (900 kDa) play the 
predominant role in reaching sufficient chain entanglement to form a fiber jet, the shorter HA 
chains can still be a significant contribution towards fiber formation. 
 
 
            
Figure 4.5 SEM images of fibrous HA scaffolds electrospun (A) from solutions with varying HA 
and PEO %w/v and (B) with different flow rates. 
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4.3.4 FITC-BSA Release 
 The ability to alter the release of encapsulated growth factors and other molecules from 
biomaterials has been a widely investigated field for tissue engineering applications [20]. As 
stated previously, one major benefit of electrospinning an aqueous solution of HA is the ability to 
dissolve growth factors directly into the electrospinning solution for encapsulation with minimal 
effects on growth factor stability. To investigate the ability to alter release of encapsulated protein 
through differences in extent and type of HA modification, FITC-BSA was encapsulated in fibrous 
MeHA scaffolds (both 35% and 100% modified MeHA) and HeMA-HA scaffolds (both 10% and 
80% modified HeMA-HA). Although degradation of these fibrous groups were not characterized 
here, both the degree and type of HA modification have been shown previously to significantly 
affect degradation profiles in isotropic hydrogels, with lower modifications and HeMA-HA 
generally degrading more rapidly than higher modifications and MeHA, respectively [15].  
For fibrous scaffolds, release of encapsulated FITC-BSA from highly modified (i.e. 100% 
modified) MeHA scaffolds was significantly delayed at early timepoints compared to low modified 
(i.e. 35% modified) MeHA scaffolds (Figure 4.6A). However, this difference became less 
pronounced over time, and after 2 weeks the cumulative average FITC-BSA released from both 
low and high modified MeHA conditions was nearly the same. Compared to the MeHA release 
 
Figure 4.6 Release of encapsulated FITC-BSA from (A) 35% and 100% modified MeHA scaffolds 
and (B) a combination of MeHA and HeMA-HA scaffolds of varying modifications. 
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profiles, the observed difference between FITC-BSA release from 10% modified and 80% 
modified HeMA-HA fibers remained significant over the entire 2 weeks, with more FITC-BSA 
released from fibers composed of a less crosslinked network (i.e. 10% modified HeMA-HA) 
(Figure 4.6B). Release of FITC-BSA from both HeMA-HA groups was significantly higher overall 
in comparison to FITC-BSA released from MeHA fibers, suggesting that fiber degradation was 
necessary to release all or most of the encapsulated protein. 
 
    
Figure 4.7 (A) SEM images of dry fibrous HA scaffolds (left column) and confocal images of 
swollen, MeRho-incorporated fibrous HA scaffolds (right column) with varying degrees of 
alignment. (B) Quantification of degree of fiber alignment (i.e. measurement of angle between 
each fiber and a line drawn relatively perpendicular to the direction of alignment, if any). 
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4.3.5 Fiber Alignment and Depth-dependently Aligned Scaffolds 
 Articular cartilage is a highly complex tissue, with depth-dependent biochemical, 
structural, and mechanical properties. Structurally, the network of collagen fibers is aligned along 
the articulating surface (i.e. the superficial zone), becomes disorganized and randomly-aligned in 
the middle zone, and then aligns perpendicular to the articulating surface in the deep zone and 
beyond to help anchor the cartilage to the underlying bone [21]. Even though many cartilage 
tissue engineering strategies utilize the encapsulation of cells within isotropic hydrogels, these 
systems do not mimic the depth-dependent microarchitecture of cartilage which is fundamental to 
achieve the complex mechanical properties of native cartilage [22]. A distinct advantage of 
electrospinning is the ability to control fiber alignment; to showcase this ability with our HA 
electrospinning system, we created depth-dependently aligned fibrous scaffolds to mimic the 
native microarchitecture of cartilage. As shown in Figure 4.7, the rotational speed of the collection 
mandrel was increased in order to increase fiber alignment (i.e. 0.2 m/s for unaligned, 5 m/s for a
 
    
Figure 4.8 Schematic of the fabrication of depth-dependently aligned scaffolds, and SEM and 
confocal images of both sides of dry and swollen depth-dependently aligned scaffolds, 
respectively. 
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medium degree of alignment, and 10 m/s for aligned), and these differences in fiber alignment 
were retained after scaffold crosslinking and swelling. Switching the mandrel speed during the 
electrospinning process (i.e. 0.2 m/s for 4 hours and then 10 m/s for 16 hours) created depth-
dependently aligned scaffolds, as seen from both SEM and confocal microscopy images (Figure 
4.8).  
 
4.4 Conclusions 
 Although significant progress has been made in the field of biomaterials and tissue 
engineering, the lack of cell-cell communication, nutrient diffusion, and matrix organization within 
isotropic gels impedes long-term construct maturation (i.e. development of appropriate 
biochemical and mechanical properties) [6, 23]. Electrospinning may overcome this limitation, as 
this unique fabrication process forms fibrous scaffolds with high surface area to volume ratios [8, 
9]. This chapter describes the synthesis of modified HA macromers and the development of the 
HA electrospinning system used throughout this thesis. By incorporating a relatively inert carrier 
polymer (PEO), an aqueous solution of HA was successfully electrospun utilizing a wide range of 
voltages, flow rates, and collection distances. To further exploit the tunability of the HA 
electrospinning system, we demonstrated that varying the type and extent of modification of HA 
significantly affected the release of a model protein and also created depth-dependently aligned 
scaffolds to mimic the microarchitecture of native cartilage. With the fabrication technique 
developed in this chapter, the remainder of this thesis will be focused on the translation of these 
fibrous HA scaffolds for cartilage tissue engineering through both in vitro and in vivo studies. 
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CHAPTER 5 
 
Fibrous Hyaluronic Acid Hydrogels that Direct MSC Chondrogenesis 
through Mechanical and Adhesive Cues 
 
Adapted from: IL Kim, S Khetan, BM Baker, CS Chen, and JA Burdick, “Fibrous Hyaluronic Acid 
Hydrogels that Direct MSC Chondrogenesis through Mechanical and Adhesive Cues“ 
Biomaterials, 2013, 34(22): 5571-5580. 
 
5.1 Introduction 
Mesenchymal stem cells (MSCs) are commonly used in tissue engineering applications 
due to their availability, ability to expand, and capacity to differentiate into multiple cell types. It is 
now widely appreciated that features of the extracellular matrix microenvironment are influential in 
directing MSC response [1, 2]. Two key parameters are matrix mechanics and cellular adhesivity, 
which have been thoroughly investigated using non-fibrous hydrogels. For example, the elastic 
modulus of hydrogels presented either as flat, 2-dimensional substrates [3, 4] or as 
encapsulating, 3-dimensional environments [5] have been shown to dictate stem cell fate. 
Likewise, the degree of cellular adhesion to the environment (e.g., through changes in ligand 
density) regulates integrin clustering, cytoskeletal organization, overall morphology, and, 
specifically in the case of stem cells, differentiation [5-8]. Moreover, RGD density has been shown 
to influence both chondrogenesis and osteogenesis in alginate hydrogels without significant 
changes to cell morphology [9, 10]. Although studies focusing on either matrix mechanics or 
integrin binding have demonstrated that each have profound effects on cytoskeletal organization, 
focal adhesion, and MSC differentiation, the extent to which they act synergistically is less clear 
[11].  
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An important clinical application for MSCs under widespread investigation is cartilage 
repair. Mature hyaline cartilage is avascular and alymphatic, with cells comprising only about 5% 
of the tissue volume [12]. As a result, trauma or injury to articular cartilage usually leads to 
progressive tissue degeneration and eventual depletion of healthy cartilage, which can induce 
pain and discomfort. Current clinical methods to repair defective cartilage are limited in their 
ability to regenerate functional cartilage both in terms of composition and mechanics [13]. Due to 
these shortcomings, recent research has focused on the use of tissue engineering approaches to 
repair cartilage tissue. Particular attention has been given to isotropic, non-fibrous hydrogels as 
cell carriers due to their high water content and potential for injection into defect sites. MSCs are 
a common cell source for cartilage tissue engineering strategies, and many groups have tuned 
hydrogel properties to best support MSC chondrogenesis. Specifically, MSC shape and 
cytoskeletal organization have been shown to significantly regulate chondrogenesis [14, 15] and 
higher RGD densities negatively affected MSC chondrogenesis in a non-fibrous, bulk hydrogel 
context [10, 16]. However, even with significant advances in hydrogel development, these 
systems lack the depth-dependent, complex mechanical properties of native cartilage [17], 
motivating the development of additional scaffold approaches.  
As an alternative to hydrogels, electrospinning of materials into fibrous scaffolds is 
gaining interest in cartilage repair due to their ability to mimic the nanofibrous nature of the 
extracellular matrix, as well as their ability to direct matrix organization [18]. Fibers composed of 
polycaprolactone (PCL), one of the most commonly used materials in electrospinning systems, 
have been shown to support not only cell infiltration (with the incorporation of sacrificial fibers or 
orbital shaking), [19, 20] but also MSC chondrogenesis [21-23]. Other electrospun polymers that 
have been used for chondrogenesis include poly(lactic co-glycolic acid), poly(L-lactic acid), 
poly(vinyl alcohol), and chitosan [24-27]. Despite the promise of electrospun scaffolds in cartilage 
repair, the majority of studies examining the effects of fiber properties on MSC chondrogenesis 
have focused on the effects of fiber diameter [26, 28]. Recently, a study with core-shell poly(ether 
sulfone)-PCL electrospun fibers, in which all material variables were held constant except for 
mechanics, indicated that lower fiber mechanics increased chondrogenesis of embryonic 
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mesenchymal progenitors [29], further motivating investigation of the influence of fiber 
parameters on MSC chondrogenesis.  
 Here, we investigate the chondrogenic differentiation of MSCs on electrospun hyaluronic 
acid (HA) substrates. HA is an attractive material for cartilage repair applications due to its 
biological significance; it is involved in many cellular processes including proliferation, 
morphogenesis, inflammation, and wound repair [30, 31]. HA is also important during cartilage 
development and is differentially regulated during limb bud formation and mesenchymal cell 
condensation [32]. In direct comparison to PEG hydrogels, HA hydrogels enabled more robust 
hMSC chondrogenesis and cartilaginous matrix formation both in vitro and in vivo [33]. Finally, 
HA is synthetically versatile; methacrylate groups can easily be conjugated to the HA backbone 
through the hydroxyl groups, and the resulting methacrylated HA (MeHA) is photocrosslinkable 
[30, 34]. Specifically, electrospun MeHA can be crosslinked into cell-adhesive fibers [35, 36], and 
fibrous MeHA scaffolds offer tunable control over mechanics (through the extent of HA 
modification) and cell adhesivity (through the amount of conjugated RGD). The objective of this 
work was to understand how variations in these parameters, in the context of a swollen fibrous 
system, influence hMSC interactions and chondrogenesis. 
 
5.2 Materials and Methods 
5.2.1 Macromer Synthesis and Scaffold Fabrication 
 MeHA was synthesized as in [34], with either ~35 or ~100% of the primary hydroxyl 
groups modified with methacrylates. Briefly, 300 mL of a 1% w/v solution of HA (Lifecore, 64 kDa) 
was reacted on ice with either 0.67 mL (for 35% modified) or 2.23 mL (for 100% modified) 
methacrylic anhydride (Sigma) with maintenance of pH at ~7.5-9 for 1.5 days. The products were 
then dialyzed for 72 hours, lyophilized, and the extent of modification was determined with 1H 
NMR (Bruker). Cysteine-containing RGD peptides (GCGYGRGDSPG, Genscript) were 
conjugated to MeHA via Michael addition between thiols on the peptides and methacrylates on 
MeHA. For RGD conjugation, MeHA was dissolved at a final concentration of 2% w/v in a pH 8 
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triethanolamine buffer (Sigma). RGD was added to this solution at varying concentrations (0.3 
mM for “low”, 1 mM for “medium”, or 3 mM for “high”), and the solution was reacted overnight at 
37°C, dialyzed for 48 hours, and lyophilized.  
MeHA solutions for electrospinning were composed of 4% w/v MeHA, 2% w/v 
poly(ethylene oxide) (PEO, Sigma, 900 kDa), and 0.5% w/v Irgacure 2959 in deionized water. To 
electrospin (schematic in Figure 1A), a syringe was connected to a 12” long 18G blunt-ended 
needle positioned 14 cm away from a grounded aluminum mandrel. Using a high voltage power 
source (Gamma High Voltage Research) and a syringe pump (KD Scientific), the potential 
difference between the needle and mandrel was adjusted to +21 kV and the solution flow rate 
was set to a 1.0 mL/hr. After collection, electrospun fibers were purged under nitrogen and then 
crosslinked for 10 minutes with 10 mW/cm2 UV light (320-390 nm collimated, Omnicure S1000 
UV Spot Cure Systems). Prior to mechanical testing or cell seeding, samples were swollen in 
PBS at 37°C for 24 - 48 hours. 
 
5.2.2 Scaffold Imaging and Fiber Diameter Measurements 
To measure the diameters of MeHA fibers, samples were electrospun onto foil or 
methacrylated glass coverslips for dry and swollen measurements, respectively. Glass coverslips 
were methacrylated as in [37]. Briefly, 22 x 22 mm coverslips were plasma coated for 3 minutes 
to activate the surface, 100 µL of 3-(trimethoxysilyl)propyl methacrylate (Sigma) was applied to 
the coverslip surface, and the samples were incubated for 1 hour at 100°C followed by 10 
minutes at 110°C. After electrospinning, samples were crosslinked as described and analyzed in 
both dry and swollen states. Dry fibers were imaged using scanning electron microscopy (SEM, 
JEOL 7500F HRSEM, Penn Regional Nanotechnology Facility). To visualize swollen fibers under 
confocal microscopy, a methacrylated rhodamine dye (MeRho, Polysciences) was incorporated 
prior to electrospinning. Samples were swollen in PBS for 48 hours at 37°C and imaged using 
confocal microscopy (Zeiss Axioobserver Inverted microscope, Penn CDB Microscopy Core). 
Fiber diameters (n = 4, 30-40 fibers measured per sample) were measured from the resulting 
SEM and confocal images for dry and swollen fibers, respectively, using ImageJ (NIH). 
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5.2.3 Mechanical Testing of Single Fibers and Bulk Fibrous Hydrogels 
In order to measure the moduli of single fibers using atomic force microscopy (AFM), the 
three-point bending method on single fibers outlined by Tan, et al. was adapted [38]. PDMS 
troughs were fabricated with both a height and trough width of 200 µm (schematic in Figure 2A) 
and methacrylated using a modified version of the glass methacrylation protocol described 
previously. The methacrylated PDMS troughs were then attached to the grounded mandrel 
parallel to the long axis, and 35% modified and 100% modified MeHA macromers either without 
RGD or with the highest RGD density (i.e., 3 mM during conjugation) were electrospun onto the 
troughs. The mandrel was rotating at a speed of 10 m/s during collection to align the fibers 
perpendicular to the troughs.  
For fluorescence imaging, MeRho was again incorporated into the solutions prior to 
electrospinning, and the samples were imaged using a fluorescence microscope. For AFM 
testing, samples were crosslinked as described before and swollen in a 1% w/v black fabric dye 
(RIT) solution overnight for visualization under brightfield. Contact-mode AFM (Asylum MFP-3D, 
University of Pennsylvania Nano/Bio Interface Center) was then performed using a 25 µm, silicon 
bead AFM tip with a spring constant of 0.06 N/m (Novascan). Only single fibers perpendicular to 
the direction of the troughs were measured, as differences in fiber angle or testing multiple fibers 
at once would confound the measurements. Images were taken of each trough to measure the 
distance between trough edges, and the average fiber diameter was used to calculate the 
modulus of each fiber. 10-12 fibers per condition were measured. The force and displacement (!) 
measurements were then used to calculate the modulus of the fibers based on the equations 
used in Tan, et al. [38].  
For mechanical testing of bulk, fibrous hydrogels, both 35% modified and 100% modified 
MeHA were electrospun for 4 hours. After crosslinking, fibrous mats were trimmed to create 
samples 4 mm in diameter, and samples were swollen in PBS at 37°C for 24 hours prior to 
testing. Unconfined compression testing was performed on swollen samples using a dynamic 
mechanical analyzer (Q800 TA Instruments) at a strain rate of 10%/min, and moduli were 
calculated at a strain from 10% to 20% (n = 4-6). 
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5.2.4 Cell Seeding and Spreading, Proliferation, and Focal Adhesion Formation 
For in vitro studies, fibers were collected onto methacrylated glass coverslips, 
crosslinked, and swollen as described above. Both 35% and 100% modified MeHA macromers 
were electrospun with varying amounts of RGD (0.3, 1, and 3 mM during peptide conjugation). 
hMSCs were seeded onto the fibrous scaffolds in growth media ("-MEM with 20% FBS, 1% L-
glutamine, and 1X penicillin/streptomycin) by direct addition of the cell suspension onto the 
fibrous sample and subsequent overnight incubation. For assessment of cell spreading, 
proliferation, and focal adhesion formation, hMSCs were seeded onto the scaffolds at a density of 
15, 20, or 25 thousand cells per cm2 corresponding to the high (3 mM), medium (1 mM), and low 
(0.3 mM) RGD density groups, respectively. The varied cell densities were used based on 
differential initial cell adhesion, to obtain comparable initial cell numbers between groups. After 
overnight incubation, cell-seeded scaffolds were cultured in chemically-defined chondrogenic 
differentiation media (CM+) consisting of high glucose DMEM with 1X penicillin/streptomycin, 0.1 
mM dexamethasone, 50 mg/ml ascorbate 2-phosphate, 40 mg/ml L-proline, 100 mg/ml sodium 
pyruvate, 1X ITS+ (6.25 mg/ml insulin, 6.25 mg/ml transferrin, 6.25 ng/ml selenous acid, 1.25 
mg/ml bovine serum albumin, and 5.35 mg/ml linoleic acid), and 10 ng/mL TGF-#3 (R&D 
Systems). After 1, 7, and 14 days of culture, samples were fixed in 4% phosphate-buffered 
formalin and stained for actin cytoskeleton (phalloidin), nuclei (DAPI), and vinculin (primary 
monoclonal mouse anti-human vinculin, Sigma, and secondary FITC-conjugated goat anti-
mouse, Invitrogen) (n = 4). Cell areas and proliferation were determined (>100 cells per condition) 
with ImageJ using the actin and DAPI staining, respectively.  
 
5.2.5 Chondrogenic Gene Expression 
For gene expression studies, fibers were collected onto methacrylated PDMS (to allow 
for samples with larger areas, and subsequently, a greater number of cells per sample). hMSCs 
were seeded onto these fibrous scaffolds at the same cell densities stated above and cultured in 
CM+. After 14 days of culture, the samples were rinsed with PBS and scraped off the underlying 
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PDMS into 1.5 mL Eppendorf tubes containing Trizol reagent (Invitrogen). The samples were 
manually homogenized, and RNA was extracted using manufacturer’s instructions. RNA 
concentration was determined using a ND-1000 spectrophotometer (Nanodrop Technologies). 
After 1 microgram of RNA from each sample was reverse transcribed, PCR was performed on an 
Applied Biosystems 7300 Real-Time PCR system (n = 4). Relative gene expression for Type I 
collagen, Type II collagen, aggrecan, and sox-9 was calculated using the $$CT method with 
GAPDH as a housekeeping gene. Sequences used for primers and probes can be found in [39].  
 
5.2.6 Analysis of Cell-induced Bead Displacements 
For bead displacement studies, fluorescent polystyrene beads (Suncoast Yellow and 
Yellow Green, Bangs Laboratories) were incorporated into the macromer solutions prior to 
electrospinning. Samples were electrospun onto methacrylated circular coverslips. After 
crosslinking and swelling of the samples overnight, hMSCs were seeded at a density of 1, 2, or 4 
thousand cells/cm2 corresponding to the high, medium, and low RGD density groups, 
respectively, as described above. Bead displacements were measured after 24 hours using an 
adaptation of the method described by Legant, et al. [40]. Briefly, after overnight culture in growth 
media, cells were stained with calcein AM (Invitrogen), and the samples were transferred to an 
Attofluor® Cell Chamber (Invitrogen) and maintained at 37°C and 5% CO2 during imaging. 
Confocal microscopy was used to obtain z-stacks of the cells and surrounding fluorescent beads 
before and after cell lysis, induced by the addition of 5% w/v SDS. Samples were allowed to 
equilibrate after SDS addition for 20-30 minutes prior to imaging. Tecplot, Hypermesh, and 
MATLAB were then used to quantify bead displacements from resulting z-stacks. Bead 
displacements were sorted by distance from the cell boundary, and the displacements of beads 
15 µm or closer to the cell were included in the average (n = 10-12).  
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5.2.7 Statistical Analysis 
For comparison of two groups, a student’s t-test with a p-value of 0.05 was used to 
measure statistical significance. For analyses with more than one comparison, a one-way 
ANOVA was performed followed by a Bonferroni post hoc test. For graphs and text, values are 
reported as mean ± standard error.  
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Figure 5.1 (A) Schematic of electrospinning system. Hyaluronic acid macromer fibers (containing 
photoinitiator) are crosslinked with UV light after electrospinning. (B) Diameters of dry and 
swollen MeHA fibers (n = 30-40) fabricated from either 35 or 100% modification MeHA. (C) 
Representative SEM images of dry MeHA fibers (top and middle rows) and confocal images of 
swollen MeHA fibers (bottom row, with methacrylated rhodamine for visualization). Scale bars: 10 
µm for top row, 2 µm for middle row, 20 µm for bottom row, and 5 µm for inset of bottom row. 
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5.3. Results 
5.3.1 MeHA Fibrous Scaffold Fabrication and Characterization 
Both 35% and 100% modified MeHA macromers were synthesized, conjugated with 
RGD, electrospun, and crosslinked successfully into fibrous scaffolds (Figure 1). Fiber 
morphology was consistent throughout all studies, with no apparent beading or spraying 
observed in SEM or confocal images. Fiber diameters of dry fibers were 186 ± 7 nm for 35% 
modified MeHA and 177 ± 6 nm for 100% modified MeHA, with a notable increase in fiber 
diameter upon swelling to 601 ± 36 and 744 ± 45 nm for 100% and 35% modified MeHA, 
respectively (Figure 1B). The fiber diameters of swollen scaffolds were constant and did not
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Figure 5.2 (A) Schematic of contact-mode AFM on single fibers suspended over PDMS troughs. 
Image is not to scale. (B) Fluorescence image of swollen HA fibers (with methacrylated 
rhodamine for visualization) suspended over a PDMS trough. Scale bar = 50 µm. (C) Three-point 
bending moduli of soft and stiff single fibers (n = 10-12). (D) Compressive moduli of bulk, fibrous 
hydrogels composed of soft or stiff fibers (n = 4-6). *denotes statistical significance (p<0.05). 
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change over 14 days incubation in PBS (data not shown), indicating that nearly all swelling 
occurred during the first 24 hours. Based on initial sample weight and volumetric swelling ratios 
(data not shown) and assuming a homogeneous network, the overall RGD densities within the 
swollen, fibrous scaffolds were estimated to be 0.27 mM, 0.90 mM, and 2.7 mM for the “low”, 
“medium”, and “high” RGD groups. These estimates are based on the overall scaffold volume 
(i.e., including the void spaces between fibers), although RGD is localized to the fibers.  
To mechanically characterize the MeHA fibers, both 35% modified and 100% modified 
MeHA solutions were electrospun onto PDMS troughs and clearly visualized with fluorescence 
microscopy, as shown in Figure 2B. The average trough length was much greater than the 
diameter of the bead tip, fulfilling a necessary condition for the validity of the model [38]. Most 
fibers were perpendicular to the PDMS troughs, which was achieved through the high rotating 
speed of the grounded mandrel. The resulting bending moduli for fibers without RGD were 1.06 ± 
0.06 and 8.60 ± 1.18 GPa for 35% modified and 100% modified MeHA fibers, respectively (Figure 
2C). For single fibers of the same % modification, there were no significant differences in bending 
moduli between fibers without RGD and fibers with the highest RGD density (1.17 ± 0.29 and 
7.29 ± 1.11 GPa for 35% modified and 100% modified MeHA, respectively). Bulk compressive 
moduli were generally much lower than bending moduli of single fibers, with values of 2.53 ± 0.25 
kPa for 35% modified fibrous samples and 3.46 ± 0.12 kPa for 100% modified fibrous samples 
(Figure 2D). The differences in both single fiber bending moduli and bulk compressive moduli 
were statistically significant between 35% modified and 100% modified MeHA fibers, and here 
forward, the 35% and 100% modified MeHA conditions are referred to as ‘soft’ and ‘stiff’, 
respectively. 
 
5.3.2 hMSC Adhesion, Spreading, and Proliferation on Fibers 
When hMSCs were seeded onto fibrous MeHA scaffolds of varying fiber mechanics and 
RGD densities, initial adhesion (i.e., the number of cells that were adhered 24 hours after see 
ding) was  dependent on both the cell seeding ensity and RGD density (data not shown). With the 
same cell- seeding density of 15%103 cells/cm2, the initial number of cells adhering after 24 hours 
 64 
       
 
Figure 5.3 hMSCs cultured in CM+ and stained with TRITC-phalloidin after 1, 7, and 14 days of 
in vitro culture. Scale bar: 400 µm. 
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increased with RGD density (e.g., 6.55%103 cells/cm2, 8.82%103 cells/cm2, and 11.8%103 
cells/cm2, for low, medium, and high RGD modified soft fibers, respectively). For this reason, cell-
seeding densities were modified to account for differences in initial adhesion in order to begin all 
in vitro studies (with the exception of fiber  displacement studies) with a similar cell density across 
all groups. Over 14 days of culture in CM+, hMSCs increased in spread area on higher RGD 
density scaffolds (Figure 3). Histograms of cell area (quantified after 24 hours of culture) were 
normalized to the total number of measurements per condition and reported as a % of total cells 
(Figure 4A). As observed in the actin-stained images, the average cell area increased with
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Figure 5.4 (A) hMSC cell spread area after 24 hours, quantified with TRITC-phalloidin staining 
and reported as normalized frequency (%) (n = 100-120). (B) hMSC proliferation, as measured by 
quantification of nuclei, for 1, 7, or 14 days of culture in CM+ (n = 4), with changes in fiber RGD 
density and modulus. Normalized proliferative index calculated as nuclei density at the specified 
time point normalized to the average nuclei density after one day of culture. *denotes statistical 
significance (p<0.05). 
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increasing RGD density for both fiber stiffnesses. hMSCs seeded on scaffolds with low RGD 
density were uniformly less spread, whereas hMSCs on the high RGD groups exhibited greater 
average spread areas, as well as greater variance in spreading. There were no significant 
differences in cell spreading between hMSCs on soft and on stiff fibers when presented the same 
RGD density. Multicellular aggregates were more apparent with longer incubation times and 
higher RGD densities.  
Proliferation was determined by quantifying the density of cell nuclei at each time point 
relative to day one values for each group. Thus, a value less than 1 signifies a decrease in cell 
density with time, whereas a value greater than 1 signifies an increase in cell density with time. 
Proliferation was dependent on RGD density; the cell populations corresponding to the two higher 
RGD densities exhibited significant increases in proliferation relative to the lowest RGD density 
(Figure 4B). However, hMSC proliferation between fiber stiffness conditions was relatively similar, 
with the exception of a significant increase due to stiffness at the highest RGD density after 7 
days of culture. Nonetheless, it is important to note that proliferation was overall limited, as no 
groups reached a normalized proliferation index of 2 (i.e., cell doubling) after 14 days of culture 
even with the highest amount of RGD. Vinculin organization after 24 hours followed expected 
trends based on cell spreading, with more numerous vinculin-rich adhesions near the cell 
periphery of well-spread cells (higher RGD densities) and more diffuse organization in rounded 
cells (lower RGD densities) (Figure 5). There were no discernible differences in vinculin 
organization between different stiffnesses of the same RGD density and this trend persisted 
throughout the 14 days of culture in CM+ (data not shown).  
 
5.3.3 hMSC Chondrogenesis  
In contrast to hMSC spreading, proliferation, and focal adhesion formation, which were all 
unaffected by changes in fiber stiffness, hMSC gene expression after 14 days of culture in CM+ 
was dependent on both fiber mechanics and RGD density (Figure 6). Type II collagen, aggrecan,  
and sox-9 are markers for chondrogenic differentiation, whereas Type I collagen indicates 
transformation to a more fibrotic phenotype. Gene expression profiles were determined using the
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$$CT method normalized to GAPDH expression. RGD density had a profound effect on hMSC 
gene expression profiles. For instance, the lowest RGD density, soft fiber group resulted in a 
405k-, 6.66-, and 3.58-fold increase in gene expression of Type II collagen, aggrecan, and sox-9, 
respectively, whereas the highest RGD, soft fiber group resulted in a 233-fold increase in Type II 
collagen and a decrease in both aggrecan and sox-9 (values of 0.94 and 0.23, respectively). 
Although the dependence of hMSC gene expression on fiber mechanics was not as pronounced 
as that of RGD density, chondrogenic gene expression was consistently higher with soft fibers 
when compared to stiff fibers, and this difference was statistically significant for aggrecan at the 
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Figure 5.5 Vinculin localization (green), actin cytoskeleton (red), and nuclei (blue) staining for 
hMSCs cultured for 24 hours on fibrous scaffolds with varied RGD density and modulus. Scale 
bar: 50 µm. !
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lowest RGD density. Additionally, Type I collagen was consistently up-regulated with stiff fibers 
when compared to soft fibers, although the differences were not statistically significant.  
 
5.3.4 hMSC-induced Dead Displacements 
An indirect method to evaluate cell-mediated traction forces was used to assess whether 
hMSCs displaced fibers. Average bead displacements were calculated based on confocal z-
stacks of fluorescent beads before and after cell lysis; bead displacements can serve as a proxy 
for traction forces across different RGD densities as long as fiber mechanics are held constant. 
Contraction-mediated bead displacements, and thus presumably traction forces, generally 
increased with RGD density, though this trend was more pronounced for the soft fiber condition 
compared to the stiff fiber condition (Figure 7A). Most of the average bead displacements were 
relatively small (<0.5 µm), but those corresponding to the high RGD density, soft fiber condition 
!!!!!!!!!!!! !
 
Figure 5.6 hMSC gene expression of chondrogenic markers after 14 days of culture in CM+ on 
fibrous scaffolds with varied RGD density and modulus. * denotes statistical significance (p<0.05) 
between indicated groups, and v denotes statistical significance (p<0.05) when compared to 
other RGD densities within the same fiber stiffness condition. 
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exhibited a significantly greater average bead displacement (1.2 µm) relative to the low and 
medium RGD densities, soft fiber conditions (Figure 7B). Stiff fibers generally resulted in lower 
bead displacements in comparison to soft fibers, but no conclusions can be drawn on differences 
in cell traction forces between soft and stiff fibers.  
 
5.4 Discussion 
Matrix mechanics and adhesivity (i.e., incorporation of ligands for integrin binding) have 
been studied extensively in non-fibrous settings, primarily via seeding of cells atop flat, 2-
dimensional substrates. In the case of cartilage, both of these variables have been shown to 
affect chondrocyte redifferentiation in a non-fibrous, 3-dimensional context [41]. Specifically, 
chondrocytes that had dedifferentiated during expansion on TCPS exhibited enhanced 
redifferentiation when encapsulated within bulk hydrogels of lower RGD densities and lower
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Figure 5.7 (A) hMSC bead displacements after 24 hours of culture on fibrous scaffolds with 
varied RGD density and modulus (n = 10-12). Color-coded scale bar is for bead displacements 
and in units of µm. Scale bar: 40 µm. (B) Average bead displacement values for beads within 15 
µm of the cell boundary for hMSCs cultured on either soft or stiff fibrous scaffolds with varied 
RGD density. *denotes statistical significance (p<0.05) when compared to all other conditions. 
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equilibrium moduli. Moreover, the presence of RGD has been shown to negatively affect 
chondrogenesis of MSCs in bulk hydrogels [10, 16]. In contrast to these non-fibrous hydrogel 
systems, cartilage possesses a fibrillar structure with depth-dependent anisotropy, and thus 
fibrous scaffolds may be a more appropriate setting to investigate the effects of the 
microenvironment on MSC chondrogenesis. For these reasons, fibrous HA scaffolds were 
developed here as a system to investigate the effects of both mechanics and RGD density on 
MSC response, since we can controllably tune both parameters within fibers composed of a 
biologically relevant material.  
Due to the high viscosity and surface tension of HA solutions, electrospinning of HA 
alone typically requires harsh solvents or complicated electro-blowing systems [42-44]. PEO was 
thus used as a carrier polymer to successfully and stably electrospin HA into fibrous scaffolds. 
Since HA is hydrophilic and was electrospun at a low molecular weight, it was necessary to 
crosslink prior to swelling to retain the fibrous nature. Crosslinking was achieved through a 
photoinitiated radical polymerization of methacrylates along the macromer backbone. The final 
crosslinking density was controlled through HA modification (35% versus 100%), corresponding 
to nearly an order of magnitude difference in post-swelling single fiber bending moduli (1 GPa 
versus 8.6 GPa, respectively). Both the “soft” and “stiff” fiber populations swelled significantly (on 
average, the fiber diameters increased 3- and 4-fold relative to the dry state for 100% modified 
and 35% modified MeHA fibers, respectively). The moduli of both fiber conditions, while relatively 
high (in the GPa range), are comparable to values reported for single fibers of electrospun 
collagen, PLGA, and PCL [38, 45-48]. The relatively high moduli may also be a result of the 
densely crosslinked nature of the HA macromer chains, since the fibers are crosslinked while dry. 
Furthermore, the moduli of both fibrous systems dropped significantly when measured in bulk 
instead of on the single fiber level, most likely due to the large amount of void space within the 
scaffold.  
To ensure a similar initial cell density (i.e., the density of cells that adhered to the scaffold 
during overnight incubation) between groups, various cell seeding densities (i.e., the number of 
cells added to each well) were tested. The initial cell density was dependent on both the number 
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of cells added to the scaffold-containing well and the RGD density; thus, hMSCs were seeded 
onto fibrous HA scaffolds at increasing initial cell densities for decreased RGD densities. 
Throughout the 2 weeks of culture in CM+, hMSCs responded to RGD density but were 
insensitive to the fiber mechanics investigated in terms of cell spreading, proliferation, 
cytoskeletal organization, and focal adhesion formation (Figures 3, 4 and 5). The apparent lack of 
hMSC response (other than in gene expression profiles) between the two fiber stiffness groups 
may be due to the fibrous topography. Topography can have significant effects on hMSC 
response; fibrous PCL scaffolds were shown to enhance hMSC chondrogenesis in comparison to 
porous PCL scaffolds [23], and nanoscale grooves and ridges have been shown to affect hMSC 
spreading and differentiation [49-51]. The fibrous architecture, in comparison to flat 2-dimensional 
surfaces [3], may increase the ability of cells to spread and pull, even with softer matrices.  
Chondrogenesis is typically characterized by up-regulation of Type II collagen, aggrecan, 
and sox-9 and down-regulation of Type I collagen. Despite similarities in adhesion, spreading, 
and proliferation, the gene expression analysis presented here suggests that cells sense the 
difference in fiber mechanics, as the soft fiber condition generally promoted a greater degree of 
chondrogenesis. RGD density was a critical regulator of this lineage commitment, since 
statistically significant increases for all pro-chondrogenic genes were observed only at lower RGD 
densities. Type I collagen was more highly expressed with the stiffer fibers and higher RGD 
density conditions. These findings correlate well with previous studies performed with non-fibrous 
bulk hydrogels, with lower elastic moduli and lower RGD densities resulting in either improved 
hMSC chondrogenesis or chondrocyte redifferentiation [10, 41].  
Traction forces are another important indicator of how cells interact with their surrounding 
matrix. Cell-mediated traction forces correlate directly with cytoskeletal tension, which has been 
shown to regulate cellular functions ranging from proliferation to differentiation [52, 53]. A 
modified method from [54] was implemented to measure bead displacements and to obtain a 
relative measure of cell-mediated traction forces. For cells interacting with fibrous scaffolds, 
absolute traction forces are difficult to calculate since fibrous scaffolds are heterogeneous and 
non-uniform networks, complicating the correlation of bead displacement and force used in the 
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aforementioned method. However, within a group of fibers of the same stiffness, differences in 
bead displacements can be correlated with differences in traction forces. hMSCs interacting with 
MeHA fibers caused greater average bead displacements, and thus presumably traction forces, 
with increasing RGD densities. These differences were statistically significant for the soft fiber 
condition but not the stiff fiber condition, although the trend was still apparent in the latter case. 
Similarities in cell spreading and focal adhesion formation between the conditions suggest that 
cells on stiff fibers are exerting traction forces to some extent, but that the bead displacements 
are lower since the fibers are stiffer.  
Finally, the fibrous system developed here focuses on cell studies using hMSCs seeded 
on top of the material. Although this does constitute a quasi-3D system, as cells can extend into 
the underlying fibrous network, the cells are not completed embedded within a fibrous matrix, 
which may better mimic the natural presentation of the extracellular matrix in vivo. Additionally, 
the range of fiber mechanics studied may not have been great enough to influence changes in 
cell behavior in many of the metrics used in this work. Despite these limitations, this study 
presents a system with which to probe MSC interactions with fibrous materials.  
 
5.5 Conclusions 
This work demonstrates the processing of HA into fibrous hydrogels with tunable 
mechanics and adhesivity using an electrospinning process. Adhesivity had a strong influence on 
hMSC response, with higher RGD densities leading to increases in cell spreading, proliferation, 
and focal adhesion formation. Both parameters were found to influence hMSC chondrogenesis, 
as seen through gene expression profiles, potentially by differentially enabling cytoskeletal 
organization and the resulting ability of cells to exert tractions on the fibers. Given these findings, 
we believe that fibrous HA hydrogels are a promising alternative to non-fibrous hydrogels for 
future cartilage regeneration strategies. The following chapter will further elaborate on this system 
and will investigate the outcomes of long-term in vitro culture, infiltration, and maturation of MSC-
seeded fibrous HA scaffolds. 
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CHAPTER 6 
 
The Influence of Fibrous HA Hydrogel Cell Seeding Method on MSC 
Infiltration and Chondrogenesis 
 
6.1 Introduction 
The previous chapters introduced the processing capabilities and tunability of material 
properties within a new class of fibrous hyaluronic acid (HA) hydrogels, which are fabricated 
through electrospinning. Electrospinning has become increasingly utilized over the past decade 
as a method to create scaffolds that mimic the fibrous architecture and structure of native 
extracellular matrix. Most tissue engineering approaches that use electrospun scaffolds rely on 
cell seeding and infiltration after scaffold fabrication, particularly since the incorporation of cells 
during the electrospinning process has resulted in mixed reports on cell viability [1-3]. Here, we 
investigate the seeding of fibrous HA hydrogels with mesenchymal stem cells (MSCs) towards 
the evolution of these scaffolds for 3D in vitro tissue engineering of cartilage tissue. 
One of the most significant challenges towards the use of fibrous scaffolds for tissue 
engineering has been insufficient cell infiltration in vitro [4, 5]. Limited scaffold porosity is 
generally viewed as the most significant impediment to cell infiltration, and in response, much 
research has been focused on techniques to increase the porosity of electrospun scaffolds [6-8]. 
Although fibrous scaffolds generally have a high surface area to volume ratio, the actual pore size 
and interconnectivity can be relatively low, especially with sub-micron diameter fibers [7, 9]. 
Indeed, Barhate, et al. found that electrospun scaffolds composed of sub-micron diameter fibers 
had pore sizes of 1-10 µm and would not allow penetration of particles larger than 1 µm [10]. 
Even though cells do seem to be able to migrate through fibrous scaffolds with average pore 
sizes smaller than the cells themselves [11], increased scaffold porosity is closely tied to 
improved cell infiltration [12]. One simple method to alter scaffold porosity is to increase average 
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fiber diameter, as fibrous scaffolds with sub-micron fibers have significantly decreased porosity 
due to a denser packing of fibers [13] and inhibit cellular infiltration in comparison to fibers with 
larger diameters [14].  
The incorporation and subsequent removal of salt particles, ice crystals, and sacrificial 
fibers have all been used to significantly increase scaffold porosity. Salt-leaching is a common 
technique to create macroporous, non-fibrous scaffolds [8, 15]. When translating this method to 
electrospinning, Nam, et al. utilized a coaxial spinneret to spin fibers with a core of polymer and 
sheath of salt particles, since purely mixing salt particles into the electrospinning solution may 
cause blockage of the spinneret and damage fiber integrity [16]. After electrospinning, the salt 
particles were leached out as the scaffold swelled, resulting in a scaffold with high porosity. 
Similar to salt-leaching, ice crystals can be incorporated to increase scaffold porosity. Fibers are 
electrospun onto a hollow collecting mandrel covered with ice crystals, as the mandrel core is 
filled with either liquid nitrogen or dry ice [17, 18]. Although both approaches have resulted in 
increased cellular infiltration, salt-leaching or the use of ice crystals can lead to macroscopic 
heterogeneity, delaminating, and a decrease in scaffold mechanical properties and structure.  
To increase porosity without disturbing fiber organization or scaffold integrity, Baker, et al. 
pioneered the incorporation of sacrificial fibers. In this study, a dual-jet electrospinning system 
was used to create a poly(!-caprolactone) (PCL)/poly(ethylene oxide) (PEO) composite; the PEO 
fibers immediately dissolved upon swelling, increasing scaffold porosity and allowing cells to 
migrate significantly further over 12 weeks of culture [12]. Other techniques to increase scaffold 
porosity include the use of grounded collectors with complex or rotating geometries [19, 20], 
creating an array of pores through the scaffold through photopatterning [21] or laser ablation [22], 
or “wet electrospinning”, in which electrospun fibers are collected in a grounded solvent bath [23].  
Even with significant advances in increasing scaffold porosity, infiltration can still require 
extended periods of culture, and the introduction of other factors to direct migration or increase 
cell migration speed may be useful. Moreover, Sundararaghavan, et al. found that cells on 
electrospun fibers migrated preferentially along the axis of fiber alignment, even when under the 
presence of orthogonal or opposing chemotactic gradients [24]. This observed directional 
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migration along fibers might imply that cells preferentially adhere and migrate along the scaffold 
surface rather than infiltrate into the scaffold, regardless of scaffold porosity. To overcome this, 
stimulating factors to enhance migration may be helpful, such as the use of an orbital shaker [25] 
or gradients of an adhesive ligand (i.e. RGD) [26]. In this chapter, we investigate these and other 
techniques for improved scaffold porosity and cellular infiltration of fibrous hyaluronic acid (HA) 
hydrogels.   
 
6.2 Materials and Methods 
6.2.1 Macromer Synthesis and Fibrous Scaffold Fabrication 
  Methacrylated hyaluronic acid (MeHA) was synthesized as described previously (Chapter 
4) and then conjugated with cysteine-containing RGD peptides (GCGYGRGDSPG, Genscript). 
Briefly, MeHA was dissolved at 2% w/v in a 0.2 M, pH 8.0 triethanolamine buffer (Sigma) 
containing 0.3 (i.e. “Low”), 1 (i.e. “Medium”), or 3 mM (i.e. “High”) RGD peptides and reacted 
overnight at 37°C. The resulting MeHA-RGD solution was then dialyzed and freeze-dried. The 
electrospinning solution was composed of 2% w/v MeHA-RGD and 3% w/v poly(ethylene oxide) 
(PEO, Sigma, 900 kDa) with 0.05% w/v Irgacure 2959 (Sigma) in dI H2O which was dissolved 
over 2 nights. The resulting MeHA/PEO solution was electrospun at a voltage of +22.5 kV, flow 
rate of 1.2 mL/hr, and a needle tip to grounded collector distance of 16 cm. After electrospinning, 
fibrous scaffolds were purged under nitrogen and crosslinked with UV light (320-390 nm 
collimated, Omnicure S1000 UV Spot Cure Systems) for 15 minutes on both sides.  
 
6.2.2 Static and Dynamic Cell Seeding of Fibrous HA Scaffolds 
 For cell studies, fibrous HA scaffolds were cut into 5 x 25 mm strips to fit within a custom 
clamping system. The clamps were on either end of the fibrous strips and served to suspend the 
strips in the tissue culture dish, allow for identification of orientation, and to increase ease of 
handling (Figure 6.1A). Human mesenchymal stem cells (MSCs, Lonza) were trypsinized and re-
suspended in growth media ("-MEM with 20% FBS, 1% L- glutamine, and 1X 
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penicillin/streptomycin). For the “direct” seeding method, a concentrated solution of 10 million 
cells/mL in 100 µL was added directly to one side of the scaffold, and after 2 hours, the scaffold 
was flipped and a fresh solution of MSCs in growth media was added to the other side (with the 
same volume and concentration of cells as the first seeding solution). MSCs were freshly 
trypsinized and re-suspended directly before the second seeding step so that MSCs were not 
kept in suspension for a prolonged period of time. After another 2 hours, 20 mL of standard 
growth media was added to immerse the scaffolds completely. For the “static” condition, samples 
were then placed directly in the incubator. Under “dynamic” conditions, the scaffolds were placed 
on an orbital shaker (~20-25 rpm) in the incubator overnight (Figure 6.2A). For the “cell solution” 
seeding method, 2 million MSCs were trypsinized and re-suspended in 20 mL of growth media, 
which was then added to the dish containing the clamping system with scaffolds. Static and 
dynamic conditions were then followed as described for the direct seeding method. 
 For samples cultured longer than 24 hours, samples were switched to chemically-defined 
chondrogenic differentiation media (CM+), which consisted of high glucose DMEM with 1X 
penicillin/streptomycin, 0.1 mM dexamethasone, 50 mg/ml ascorbate 2-phosphate, 40 mg/ml L-
proline, 100 mg/ml sodium pyruvate, 1X ITS+ (6.25 mg/ml insulin, 6.25 mg/ml transferrin, 6.25 
ng/ml selenous acid, 1.25 mg/ml bovine serum albumin, and 5.35 mg/ml linoleic acid), and 10 
ng/mL TGF-#3 (R&D Systems), and media was changed twice per week. 
 
6.2.3 Fabrication Techniques for Increased Scaffold Porosity 
 Due to the hydrophilicity of HA, fibrous HA scaffolds were noticeably swollen in PBS. 
Thus, as a possible method to increase scaffold porosity, scaffolds were swollen in PBS at 37°C 
for a minimum of 48 hours, and either used directly or after freeze-drying for cell seeding. Ethanol 
dehydration was explored as an alternative method to dehydrate scaffolds after swelling; briefly, 
swollen scaffolds were incubated in increasing concentrations of ethanol (30%, 50%, 70%, 95%, 
and 100% ethanol concentrations) for 1 hour each and then either air-dried or placed within a 
vacuum-desiccator. For sacrificial fiber incorporation, PEO was dissolved at 10% w/v in 90% 
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ethanol and electrospun in a dual jet setup as in [12], with the opposing jet spinning HA instead of 
PCL.  
Photopatterning and laser ablation were utilized to create pores throughout the scaffold 
depth. For photopatterning, custom photomasks with a circular pattern were placed directly on top 
of fibrous scaffolds prior to crosslinking. Crosslinking was then performed as described previously 
with UV light, except with a shorter time (2 minutes) and a higher intensity (25 mW/cm2). 
Unreacted MeHA (areas under the mask blocked from UV light) washed away after incubation of 
the scaffold in PBS. As an alternative method of pore formation, laser ablation was performed 
using a laser cutting machine (Universal Laser System X-660), and Solidworks 3D design 
software was used to create the pattern with an array of pores. 
 
6.2.4 Imaging of Acellular and Cell-seeded Scaffolds 
Dry fibrous scaffolds were imaged using scanning electron microscopy (SEM, JEOL 
7500F HRSEM, Penn Regional Nanotechnology Facility). To visualize swollen fibers, 
methacrylated rhodamine dye (MeRho, Polysciences) was incorporated into the electrospinning 
solution at a concentration of 10 µM. After electrospinning and swelling, MeRho-incorporated 
fibers were imaged using confocal microscopy (Zeiss Axioobserver Inverted microscope, Penn 
CDB Microscopy Core). To image cellular morphology and infiltration depth, cell-seeded scaffolds 
were fixed in 10% neutral buffered formalin and stained with FITC- or TRITC-phalloidin and DAPI 
(Invitrogen) prior to confocal imaging. 
 
6.2.5 Chondrogenic Gene Expression 
 For gene expression studies, cell-seeded scaffolds were transferred to 1.5 mL Eppendorf 
tubes containing Trizol reagent (Invitrogen) and manually homogenized after 3, 7, or 14 days of 
culture in CM+. RNA was obtained through phenol-chloroform extraction as per standard 
protocol, and RNA concentration was determined using a ND-1000 spectrophotometer (Nanodrop 
Technologies). RNA was then reverse transcribed using Superscript Reverse Transcriptase 
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(Invitrogen) to obtain cDNA, and then PCR was performed on an Applied Biosystems 7300 Real-
Time PCR system (n = 4). Relative gene expression levels were calculated using the $$CT 
method with GAPDH as a housekeeping gene. Sequences used for primers and probes can be 
found in [27]. 
 
6.2.6 Long-term in vitro Culture, Histology, and DNA Quantification of Cell-seeded Fibrous 
HA Scaffolds 
 For long-term in vitro culture, MSCs were seeded onto fibrous HA scaffolds with medium 
RGD density using the direct and dynamic seeding methods. As before, samples were switched 
to CM+ after the initial overnight incubation in growth media. For the “Growth ! CM+” condition, 
samples were switched to CM+ after 2 weeks of culture in growth media. All scaffolds were 
cultured for a total period of 6 weeks, with media changes twice a week. After 6 weeks, samples 
were rinsed with PBS, and cut in half; one half of the samples was placed immediately in a 
papain digestion buffer and incubated overnight at 65°C for biochemical analyses, and the other 
half was fixed in 10% neutral buffered formalin and processed for histology. Picogreen 
(Invitrogen) and a modified DMMB-based assay were used to quantify DNA and GAG, 
respectively, from the papain-digested halves. 
 
6.2.7 Statistical Analysis 
For comparison of two groups, a student’s t-test with a p-value of 0.05 was used to 
measure statistical significance. For analyses with more than one comparison, a one-way 
ANOVA was performed, followed by a Tukey post hoc test.  
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6.3 Results and Discussion 
 Fibrous HA hydrogels have great potential in cartilage tissue engineering, and previous 
chapters illustrated our ability to fabricate these scaffolds through electrospinning and to control 
features such as mechanics and adhesion. One method for utilizing these scaffolds in a tissue 
engineering application involves seeding cells and promoting in vitro growth of cartilaginous 
tissue that can be implanted into defects. However, as described previously, limited cell infiltration 
into fibrous scaffolds remains a challenge in translating electrospun scaffolds to mature, tissue-
engineered constructs. In this study, we explored a combination of cell seeding methods 
designed to both increase scaffold porosity and to provide a stimulus for MSC migration. 
Furthermore, we also investigated how those parameters affect MSC infiltration in response to 
RGD density.  
 
6.3.1 Static Cell Seeding of Fibrous HA Scaffolds 
 MSCs seeded directly onto dry, as-polymerized fibrous HA scaffolds (i.e. no modification 
to the scaffold after electrospinning and crosslinking) and then incubated under static conditions 
remained on the scaffold surface over 14 days of in vitro culture in CM+ (data not shown). With 
these seeding conditions, RGD density of the fibrous scaffolds did not affect cellular infiltration but 
did have a significant effect on cellular morphology (Figure 6.1B). Surface-bound MSCs were 
rounded on low RGD density scaffolds (conjugated with 0.3 mM RGD) and spread on high RGD 
density scaffolds (conjugated with 3 mM RGD) after an overnight culture in growth media. Over 
14 days of culture in CM+, MSCs began to aggregate and spread on low RGD scaffolds but 
remained evenly distributed and spread on high RGD scaffolds. MSCs cultured on fibrous 
scaffolds without RGD did not stay attached past 24 hours of culture (results not shown). As 
shown in Figure 6.1C, MSCs on low RGD scaffolds also exhibited significantly increased 
expression of genes associated with chondrogenesis (i.e. Sox-9 and Aggrecan), which agreed 
well with literature on the inhibitory effects of RGD on MSC chondrogenesis in isotropic hydrogels 
[28, 29]. 
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6.3.2 Dynamic Cell Seeding of Fibrous HA Scaffolds 
To increase cellular infiltration without significantly altering the scaffold itself, dynamic cell 
seeding (i.e. through use of an orbital shaker) was investigated as a stimulus for cell infiltration 
into the scaffold [25]. Freeze-drying scaffolds after swelling significantly increased porosity while 
retaining scaffold alignment (Figure 6.2B), and freeze-dried scaffolds swelled rapidly upon 
rehydration. This rapid influx of cell solution into the scaffold was thought to possibly pull and 
entangle cells into at least the outer portion of the scaffold. With these techniques in mind, MSCs 
    
Figure 6.1 (A) Schematic of static cell seeding of fibrous scaffolds using a custom-built clamping 
system. (B) Staining for actin cytoskeleton (green) and nuclei (blue) of MSCs seeded directly onto 
as-polymerized fibrous scaffolds with different levels of RGD under static conditions. (C) MSC 
gene expression of typical chondrogenic markers after 3, 7, and 14 days of culture in CM+ on 
fibrous scaffolds with different levels of RGD. 
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Figure 6.2 (A) Schematic of dynamic cell seeding of fibrous scaffolds. (B) SEM images of aligned 
fibrous scaffolds either as-polymerized or after freeze-drying. (C) Cell morphology and infiltration 
of MSCs (actin cytoskeleton – green, nuclei – blue) seeded directly onto dry fibrous scaffolds 
under dynamic conditions after 3 days of culture in CM+. (D) Cell morphology and infiltration of 
MSCs (actin cytoskeleton – red, nuclei – blue) seeded as a cell suspension onto as-polymerized 
fibrous scaffolds under dynamic conditions after 1 and 7 days of culture in CM+. 
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were seeded onto as-polymerized or freeze-dried scaffolds, either directly onto the scaffold or as 
a cell suspension and placed onto an orbital shaker (Figure 6.2A). Direct seeding, in which a 
higher cell concentration was dripped directly onto the scaffold surface, resulted in ~150 µm 
infiltration depth with unaligned scaffolds after 3 days of culture in CM+. However, infiltration into 
aligned scaffolds was minimal, and cell distribution was highly heterogeneous on the surface of 
the scaffold with both unaligned and aligned scaffolds (Figure 6.2C). This heterogeneity was 
especially apparent with freeze-dried scaffolds in comparison to as-polymerized scaffolds. 
 For cell suspension seeding, as-polymerized fibrous scaffolds were immersed in the cell 
solution and then placed on an orbital shaker as before. The cell seeding solution contained the 
same total number of cells used with the direct seeding method (i.e. 2 million cells) but in a larger 
volume (i.e. 20 mL). With this method, MSC distribution along the surface of the scaffold was 
more homogeneous than with direct seeding (Figure 6.2D). After an overnight period of culture, 
MSCs seeded on aligned scaffolds spread according with the predominant axis of fiber alignment. 
After 7 days of culture in CM+, MSCs infiltrated to an average depth of ~350 µm with unaligned 
scaffolds and an average depth of ~250 µm with aligned scaffolds. With this same cell seeding 
method, MSCs were cultured on MeHA fibrous scaffolds with varying RGD densities (0, 0.3 or 
“Low”, 1 or “Medium”, and 3 mM or “High” RGD concentrations during MeHA-RGD conjugation). 
As before, MSCs on the scaffold surface were rounded on fibrous scaffolds with lower RGD 
densities and spread on fibrous scaffolds with higher RGD densities (Figure 6.3A). Infiltration into 
low RGD scaffolds was limited to ~100 µm over 14 days of culture in CM+, which was a 
significant decrease compared to infiltration into high RGD scaffolds (Figure 6.3B).  
In contrast to gene expression trends of MSCs seeded onto the same scaffolds using the 
direct, static seeding methods, MSCs seeded using the cell suspension, dynamic seeding method 
surprisingly showed increased chondrogenic gene expression with the highest RGD density 
condition compared to all other conditions (Figure 6.3C). Importantly, the cell suspension seeding 
method significantly increased initial cell levels on high RGD scaffolds compared to low RGD 
scaffolds. During cartilage development, cell condensation and initial cell-cell interactions are 
important for chondrogenesis [30], and thus differences in cell density and cellular interactions 
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Figure 6.3 (A) Cell morphology, (B) infiltration, and (C) gene expression levels of MSCs seeded 
onto as-polymerized fibrous scaffolds with varying levels of RGD using the cell suspension and 
dynamic seeding methods (actin cytoskeleton – red, nuclei – blue).  
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may have been a confounding factor with the cell suspension and dynamic seeding method, 
leading to higher chondrogenic gene expression with the high RGD scaffolds.  
Although swelling dry or freeze-dried scaffolds during cell seeding (either through direct 
or cell solution methods) may increase initial cell infiltration depth, the distribution along the 
scaffold surface was heterogeneous with large aggregates of cells mixed with void spaces. The 
uneven distribution could possibly be due to uneven swelling at early times or heterogeneities to 
the scaffold introduced during fabrication or freeze-drying, and these confluent-like cell 
aggregates may be less prone to infiltrate due to strong cell-cell interactions. Thus, the previously 
described seeding conditions (direct vs. cell suspension and static vs. dynamic) were also 
explored with swollen scaffolds (Figure 6.4A). As expected, direct or cell suspension seeding 
methods with static culture resulted in limited cell infiltration. The addition of the orbital shaker 
(i.e. dynamic seeding) in conjunction with the cell solution method led to minimal cell attachment. 
 
Figure 6.4 (A) Schematic of various cell-seeding methods used with swollen scaffolds. (B) Cell 
morphology and infiltration of MSCs (actin cytoskeleton – red, nuclei – blue) seeded using various 
methods onto swollen scaffolds and cultured for 24 hours in growth media. 
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However, direct and dynamic seeding conditions allowed for significant cellular infiltration (~300 
µm) even after an overnight period of culture (Figure 6.4B). Also, the latter condition resulted in 
the most homogeneous cellular distribution along the scaffold surface, with little to no cell 
aggregation. 
 
6.3.3 The Effect of a Heterogeneous Distribution of Cells on Long-term, in vitro Construct 
Maturation 
 Using the direct, dynamic seeding conditions with swollen, fibrous HA scaffolds, cellular 
infiltration, DNA, and matrix production were assessed after 6 weeks of in vitro culture. Seeding 
conditions were chosen based on previous studies, as direct and dynamic seeding conditions 
with swollen scaffolds had led to the most homogeneous distribution of cells along the scaffold 
surface and the most infiltration through the scaffold depth. Samples were moved from dynamic 
to static conditions after the initial overnight incubation in growth media, as extended periods of 
dynamic culture can result in decreased GAG and collagen retention, most likely due to diffusion 
of the cell-secreted matrix out of the scaffold [25]. Both unaligned and aligned scaffolds were 
explored, along with three different media conditions: growth media, CM+, and growth ! CM+ 
(i.e. 2 weeks in growth media followed by 4 weeks in CM+).  
MSCs infiltrated in a relatively similar manner between all media conditions with 
unaligned scaffolds but stayed restricted to the surface in all conditions with aligned scaffolds 
(Figure 6.5A). When cultured in growth media, cells proliferated and formed a relatively confluent 
layer on the surface of the scaffold, and this confluent cell layer eventually caused the scaffold to 
roll up on itself within the first few weeks of culture (Figure 6.5A). Quantification of DNA also 
confirmed increased cell numbers with culture in growth media compared to both CM+ and 
Growth ! CM+ conditions (Figure 6.5B). Immunohistochemistry revealed increased staining of 
type I and II collagen and chondroitin sulfate in the growth media condition, which was most likely 
attributed to the differences in cell numbers and not a difference in chondrogenesis. Interestingly, 
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type I collagen was upregulated mainly in the confluent, contractile layer on the scaffold surface, 
implying that MSCs on the scaffold surface had differentiated into a more fibroblastic phenotype.  
 
 
 
 
     
Figure 6.5 (A) H&E staining and IHC for type II collagen, type I collagen, and aggrecan and (B) 
DNA levels of MSC-seeded fibrous scaffolds (seeded using direct, dynamic seeding conditions) 
cultured for 6 weeks. (C) H&E staining of acellular fibrous scaffolds and aligned, cell-seeded 
scaffolds after 6 weeks of culture. 
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6.3.4 Alternative Methods of Scaffold Preparation for Improved Cell Infiltration 
 Thus far, attempts to increase cellular infiltration have been mainly focused on cell 
seeding conditions. Alterations to the scaffold material itself to increase scaffold porosity were 
also explored, including ethanol dehydration, vacuum-assisted seeding, sacrificial (i.e. PEO)  
fibers, photopatterning, and laser ablation. Both ethanol dehydration and vacuum-assisted 
seeding resulted in a flat, collapsed scaffold structure with minimal porosity and cell infiltration;  
the scaffold would not successfully rehydrate after ethanol dehydration, and the fibrous structure
 
              
Figure 6.6 (A) SEM image of ethanol-dehydrated fibrous scaffold and confocal microscopy 
images of MSCs (actin cytoskeleton – red, nuclei – blue) seeded onto ethanol-dehydrated 
scaffolds and cultured for 24 hours in growth media. (B) SEM images of photopatterned fibrous 
scaffolds of different thicknesses. (C) Infiltration of MSCs (actin cytoskeleton – red, nuclei – blue) 
vacuum-seeded onto fibrous scaffolds after 24 hours of culture in growth media. 
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collapsed into a flat surface with even low levels of vacuum pressure (Figure 6.6A and C). MSCs 
seeded onto ethanol-dehydrated scaffolds formed sheet-like, confluent aggregates (Figure 6.6A) 
without any significant infiltration into the scaffold (data not shown). Similarly, MSCs vacuum-
seeded onto fibrous scaffolds showed minimal infiltration after 24 hours of culture (Figure 6.6C). 
Incorporation of sacrificial fibers resulted in mixed HA/PEO scaffold composites that were 
extremely weak upon swelling and difficult to handle after only one week of culture. Moreover, 
MSCs seeded on HA/PEO composites exhibited minimal attachment, spreading, and infiltration 
after an overnight incubation regardless of seeding conditions (data not shown).  
Both photopatterning and laser ablation created micro-scale pores throughout the 
scaffold depth. Photopatterning with higher UV intensities and shorter times resulted in scaffolds 
with the highest level of pattern integrity. However, scaffolds thicker than 0.5 mm would not allow 
for successful pore formation throughout the scaffold depth, as even collimated UV light spreads 
with increasing distance (Figure 6.6B). On the other hand, laser ablation resulted in pore 
formation throughout the entire depth of thick scaffolds, and changes in power, intensity, and 
other parameters allowed for tunable control over pore shape, size, and pore-to-pore distance 
(Figure 6.7A and B). One concern was that the pore walls would not be stable and would turn into 
a solid wall during laser ablation, in which case cells would be able to infiltrate through the pores 
but not out of the pore into the rest of the scaffold. However, high magnification confocal imaging 
of pore walls showed that the fibrous structure was maintained after laser ablation (Figure 6.7C). 
To assess cellular infiltration, MSCs were seeded on one side of the laser-ablated scaffold using 
the direct, static seeding method after swelling. After 7 days of culture in CM+, MSCs were 
visualized on the non-seeded side of the 1 mm thick scaffold. Although MSCs were restricted 
within the pores on the non-seeded side, the fibrous pore walls would allow for cells to infiltrate 
throughout the rest of the scaffold over an extended period of culture. Also, as with non-ablated 
scaffolds, dynamic seeding conditions could be utilized for increased MSC migration. 
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6.4 Conclusions 
 While much progress has been made towards enhancing the cellularity of electrospun 
scaffolds, many methods require significant changes to the fibrous architecture, which can 
introduce undesirable heterogeneities. Moreover, even the most promising methods require 
extended periods of in vitro culture before cells reach the central portion of the scaffolds, and the 
scaffold should ideally have a homogeneous distribution of cells as soon as possible so that the 
produced matrix is distributed evenly throughout the entire scaffold. This chapter demonstrated 
             
Figure 6.7 (A) SEM images and (B) confocal microscopy images of laser-ablated pores in fibrous 
scaffolds incorporated with MeRho. (C) High magnification confocal microscopy image of laser-
ablated pore wall (left) and cell infiltration of MSCs (actin cytoskeleton – green) seeded onto one 
side of laser-ablated fibrous scaffolds and cultured for 1 week in CM+ (middle and right). 
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the importance of cell seeding method and scaffold porosity on MSC infiltration depth and 
chondrogenesis. A multitude of different seeding methods and scaffold alterations were explored, 
with varying levels of resulting MSC infiltration (Table 6.1). Higher RGD densities and dynamic 
seeding conditions both significantly increased cell infiltration, and seeding onto swollen scaffolds 
was necessary to avoid significant cell aggregation along the scaffold surface.  Specifically, 
MSCs infiltrated most significantly (~300 µm after an overnight period of culture) when seeded 
with the direct, dynamic method onto swollen, fibrous HA scaffolds. However, the distribution of 
cells was still insufficiently homogeneous to create a cartilage-like tissue over 6 weeks of in vitro 
culture. The addition of laser ablation created an array of pores through the scaffold, resulting in 
cell infiltration through the depth of the scaffold within just one week of culture. Although cell 
 
Table 6.1 Overview of fibrous HA scaffold cell seeding methods and subsequent outcomes. 
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infiltration with laser-ablated scaffolds was promising, subsequent chapters will explore the utility 
of acellular fibrous HA hydrogels combined with microfracture for in vivo cartilage repair.  
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Chapter 7 
 
Fabrication and Characterization of Fibrous Scaffolds for in vivo Cartilage 
Repair 
 
Adapted from: IL Kim, CG Pfeifer, MB Fisher, V Saxena, GR Meloni, M Kwon, M Kim, DR 
Steinberg, RL Mauck, and JA Burdick, “Investigation of Implantable Fibrous Scaffolds with Varied 
Chemistry and Growth Factor Delivery in a Porcone Cartilage Defect Model“, in preparation. 
 
7.1 Introduction 
Chapters 4 and 5 described the development of hyaluronic acid (HA)-based fibrous 
hydrogels with tunable mechanical and adhesive properties and demonstrated that these 
properties affect the chondrogenesis of mesenchymal stem cells (MSCs) in vitro. As described in 
Chapter 6, the limited cellular infiltration with these fibrous scaffolds is a significant barrier to the 
long-term maturation of these constructs in vitro. Moreover, the issue of cell choice for 
engineering cartilage in vitro is also problematic. For instance, chondrocytes are limited in 
number, require a separate surgery to harvest, and tend to dedifferentiate when expanded in vitro 
[1]. Although a promising alternative cell source, MSCs undergoing chondrogenesis in vitro 
generally produce constructs with inferior cartilage-like matrix and mechanics when compared to 
chondrocytes [2].  Furthermore, MSCs have also been shown to have an unstable phenotype and 
can eventually become hypertrophic [3-6]. Due to these issues, this chapter and subsequent 
chapters explore an alternate path in tissue engineering, the combination of an acellular 
biomaterial with the body’s endogenous repair mechanisms (i.e. microfracture), for cartilage 
repair. Specifically, the focus of this chapter is to fabricate and characterize fibrous scaffolds with 
a wide range of material properties for eventual use in an in vivo cartilage defect model. 
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Hyaline cartilage is avascular and alymphatic with a low population of cells, which leads 
to low regenerative capabilities. One of the most prevalent clinical therapies for cartilage repair is 
microfracture, in which the subchondral bone is violated to fill the damaged/void cartilage area 
with bone marrow [7]. However, in many cases, the blood clot is unstable and the tissue formed is 
inferior in its biochemical and mechanical properties to native, healthy cartilage. For this reason, 
autologous matrix-induced chondrogenesis (AMIC), in which an acellular collagen scaffold is 
placed within the cartilage void directly after microfracture, has become increasingly utilized [8, 9]. 
Due to the lack of versatility with this collagen scaffold, other materials have been investigated 
through in vivo studies in various animal models. With more tunable materials, the implanted 
scaffold can provide both increased mechanical stability and also stimulatory cues (either through 
the release of growth factors or through the material itself) to cells recruited from the bone 
marrow in order to produce a more cartilage-like tissue [10-12]. For instance, when combined 
with microfracture, the release of transforming growth factor ! (TGF!) from biomaterial scaffolds 
in in vivo studies has been shown to significantly improve cartilage formation [12, 13], and 
material choice has also been shown to affect both biochemical and mechanical outcomes in vivo 
[13, 14]. 
We hope to improve on this by using a tunable, fibrous material based on electrospun HA 
and poly("-caprolactone) (PCL) that provides biological and mechanical cues and also releases 
stimulatory factors (here, we focus on TGF!3) to eventually form a more cartilage-like matrix in 
both biochemical composition and mechanical properties. Through differences in material choice 
and extent and type of modification, the scaffolds developed and characterized in this chapter 
vary greatly in swelling, degradation, mechanical properties, and TGF!3 release rates, and the 
effects of these variables will be investigated in an in vivo cartilage defect model in the following 
chapter. 
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7.2 Materials and Methods 
7.2.1 Macromer Synthesis and Fibrous Scaffold Fabrication 
  HA (64 kDa, Lifecore) was modified with methacrylates (MeHA) and with hydroxyethyl 
methacrylates (HeMA-HA) as described in Chapter 4. Extent of modification was assessed using 
1H NMR. The electrospinning solution for both MeHA and HeMA-HA was composed of 4% w/v 
HA macromer and 2% w/v poly(ethylene oxide) (PEO; 900 kDa, Sigma) with 0.05% w/v Irgacure 
2959 (Sigma) in dI H2O and was dissolved over 48 hours. For scaffolds with TGF!3, 100 µg of 
recombinant human TGF!3 (R&D Systems) was added to the HeMA-HA solution (immediately 
prior to electrospinning). The resulting HA/PEO solution was electrospun at a voltage of +22.5 kV, 
flow rate of 1.4 mL/hr, and a needle tip to grounded collector distance of 16 cm. To electrospin 
PCL, a 14.3% w/v solution of PCL (80 kDa, Sigma) was first dissolved in 1:1 tetrahydrofuran and 
N,N-dimethylformamide overnight at 40°C. The PCL solution was then electrospun at a voltage of 
+13 kV, flow rate of 2.0 mL/hr, and a needle tip to grounded collector distance of 15 cm. To 
fabricate scaffolds with two separate fiber populations, dual jet electrospinning was performed, in 
which two electrospinning jets were directly opposed on either side of the grounded mandrel 
(Figure 7.1A). All scaffold conditions were electrospun to an overall thickness of ~1 mm. After 
electrospinning, HA-containing fibrous scaffolds were purged under nitrogen and crosslinked with 
UV light (320-390 nm collimated, Omnicure S1000 UV Spot Cure Systems) for 15 minutes on 
both sides. 
 
7.2.2 Imaging of Fibrous Scaffolds 
 Dry scaffolds were imaged using scanning electron microscopy (SEM, JEOL 7500F 
HRSEM, Penn Regional Nanotechnology Facility), and dry fiber diameters were quantified using 
ImageJ (NIH). To visualize swollen scaffolds, fluorescent dyes were incorporated prior to 
electrospinning. To create dyes that were covalently-bound to the HA fibers, cysteine-containing 
peptides were coupled to multiple dyes (i.e. FITC and coumarin) using solid-phase peptide 
synthesis. Rhodamine B (Sigma), a cysteine-conjugated FITC, and a cysteine-conjugated 
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coumarin dye were added to PCL, HeMA-HA, and MeHA electrospinning solutions, respectively, 
prior to electrospinning. The solutions were then electrospun and crosslinked as described in the 
previous section onto methacrylated coverslips, and swollen scaffolds were imaged with confocal 
microscopy (Zeiss Axioobserver Inverted microscope, Penn CDB Microscopy Core). 
 
7.2.3 Mass Swelling and Compressive Moduli of Fibrous Scaffolds 
 For all in vitro characterization measurements, 4-mm biopsy punches were used to obtain 
samples from the fibrous scaffold mats. Samples were weighed both dry and after swelling in 
PBS at 37°C for 16 hours, and the mass swelling ratio was calculated as in Equation 7.1: !"##!!"#$$%&'!!"#$%!!!! !! !!"##!"#$$%&!!"##!"#!"##!"#   (Equation 7.1) 
After incubating fibrous samples in PBS at 37°C, compressive testing was performed at desired 
timepoints with a dynamic mechanical analyzer (Q800 TA Instruments) at a strain rate of 10% per 
minute. Moduli were calculated from stress-strain data collected between 10% and 20% strain. 
 
7.2.4 Degradation of Fibrous Scaffolds 
 For all HA-containing conditions, samples were incubated in PBS at 37°C, and releasate 
was collected at desired timepoints. Total HA within the samples was quantified by degrading 
scaffolds with hyaluronidase (Sigma). Releasates were then analyzed for HA content using the 
uronic acid assay as in [15]. For all PCL-containing conditions, samples were weighed dry and 
then incubated in PBS at 37°C. At each timepoint, separate samples were then snap-frozen, 
freeze-dried, and weighed. Mass loss was quantified by comparing those weights to the initial 
weight of the samples before swelling, as in Equation 7.2: !"##!!"#!! !"!!"#$!! ! !!"##!"!#!$%!! "##!!"##!"!#!$% ! !!""  (Equation 7.2) 
 
7.2.5 Characterization of TGF!3 Release and Activity  
Samples with TGF!3 were incubated in PBS with 1% w/v bovine serum albumin (R&D 
Systems), and releasate was collected and refreshed at each timepoint. The amount of TGF!3 
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released was quantified using a DuoSet® ELISA kit (R&D Systems). To measure activity of 
electrospun and released TGF!3, MSC pellets were cultured within the same wells as scaffolds 
releasing TGF!3, and biochemical and histological assays were performed to assess the 
resulting extent of MSC chondrogenesis.  
MSC pellets were formed through centrifugation of 250,000 MSCs (Lonza) in 1 mL of 
incomplete chondrogenic media (ICM; high glucose DMEM with 1X penicillin/streptomycin, 0.1 
mM dexamethasone, 50 mg/ml ascorbate 2-phosphate, 40 mg/ml L-proline, 100 mg/ml sodium 
pyruvate, 6.25 mg/ml insulin, 6.25 mg/ml transferrin, 6.25 ng/ml selenous acid, 1.25 mg/ml BSA, 
and 5.35 mg/ml linoleic acid) in 15 mL conical tubes, which were loosely capped to allow for gas 
exchange. Pellets were allowed to form over 3 nights before transferring to 24-well plates. 
Scaffolds, which had been sterilized with germicidal UV for 45 minutes on either side, were then 
added to the appropriate wells along with 1 mL of ICM. For a positive control, 10 ng/mL 
recombinant human TGF!3 (R&D Systems) was added to the ICM to create complete 
chondrogenic media (CM+), and ICM without any supplement was used as a negative control. 
Media was refreshed for all conditions once per week. 
After two and four weeks of in vitro culture, MSC pellets were rinsed in PBS and digested 
with papain (Sigma) overnight at 65°C. The digested samples were then quantified for GAG using 
the 1,9-dimethylmethyle blue dye-binding assay, DNA using Picogreen (Invitrogen), and collagen 
using the hydroxyproline assay with a 1:7.14 hydroxyproline:collagen ratio as described in [16, 
17]. Pellets were also processed for histology (i.e. ethanol dehydration and paraffin embedding) 
after four weeks of culture. Samples were sectioned at a thickness of 6 µm and were stained with 
Alcian Blue (Sigma) for GAG, picrosirius red for total collagen, and immunohistochemistry for type 
2 collagen. For type 2 collagen staining, sections were predigested in 0.5 mg/mL hyaluronidase 
for 30 minutes and protease K (Dako) for 4 minutes before incubating with the primary antibody 
(mouse monoclonal anti-collagen type II, Developmental Studies Hybridoma Bank) and then 
secondary antibody (Millipore). CellProfiler (Broad Institute) was then used to quantify percent 
stained area and stain intensity.  
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7.2.6 Statistical Analysis 
For comparison of two groups, a student’s t-test with a p-value of 0.05 was used to 
measure statistical significance. For analyses with more than one comparison, a one-way 
ANOVA was performed followed by a Tukey post hoc test.  
 
7.3 Results and Discussion 
 The choice of material combined with microfracture in chondral defects has been shown 
to significantly affect tissue formation in in vivo studies [13-14]. Although AMIC utilizes a 
decellularized collagen scaffold, a variety of materials have been successfully implemented 
similarly (i.e. with microfracture) in in vivo animal models, including alginate, peptide amphiphiles, 
poly(lactic-co-glycolic) acid, and others. Here, we chose HA as the main component of our fibrous 
scaffolds for reasons described in previous chapters, including its synthetic versatility and natural 
ability to enhance MSC chondrogenesis in vitro. The following fibrous scaffolds were investigated: 
MeHA, HeMA-HA (HH), MeHA/HH, MeHA/HH + TGF!3 (TB3), PCL, PCL/HH, and PCL/HH+TB3, 
in which the scaffolds fabricated with two materials were dual polymer scaffolds (i.e. separate 
fiber populations) and the TGF!3, when present, was always encapsulated within the HeMA-HA 
fibers.  
 These groups were chosen specifically to investigate the effects of degradation, 
mechanics, and growth factor release. Specifically, the HeMA-HA portion degrades relatively 
quickly, allowing for increased porosity and possibly enhanced integration, whereas both MeHA 
and PCL were explored as a more stable fiber population, which would ideally stay within the 
defect longer for increased stability and to provide a scaffold within which cells could adhere, 
migrate, and produce extracellular matrix. Thus, the presence or absence of HeMA-HA will 
highlight the effects of faster degradation on integration and cellular infiltration, and the 
comparison between HA-only and PCL or PCL/HA composite scaffolds will provide insight into 
differences in mechanical properties and material chemistry of the biomaterial scaffold during 
tissue formation. Finally, we chose to encapsulate TGF!3 within the HeMA-HA fibers based on 
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preliminary studies with encapsulated FITC-conjugated bovine serum albumin as discussed in 
Chapter 4.  
 This chapter describes the fabrication and in vitro characterization of these HA and PCL-
based dual polymer fibrous scaffolds with an emphasis on the activity of electrospun and 
released TGF!3. The characterization detailed here was important to validate theorized 
differences in degradation, mechanical stability, and TGF!3 prior to implantation in vivo. 
Subsequent chapters will then focus on the application of these scaffold groups in an in vivo 
cartilage defect model. 
  
7.3.1 Scaffold Fabrication and Morphology 
 MeHA and HeMA-HA macromers were synthesized with 35% and 10% of the primary 
hydroxyl groups on the HA modified, respectively, as characterized with 1H NMR. All scaffold 
groups, listed previously, were then electrospun, and SEM images showed that all scaffolds had 
fibers that were consistently smooth with no apparent beading (Figure 7.1B). The average dry 
fiber diameter for HA-only scaffolds (i.e. MeHA, HeMA-HA, MeHA/HH, MeHA/HH+TB3) was ~160 
nm, whereas the average dry fiber diameters for PCL/HA composites (i.e. PCL/HH and PCL/HH+ 
TB3) and PCL scaffolds were 230 and 310 nm, respectively (Figure 7.1D). To image swollen 
fibers, different fluorescent dyes were incorporated into the electrospinning solutions prior to 
electrospinning, and then samples were electrospun onto methacrylated coverslips and swollen in 
PBS. Confocal microscopy images of these swollen fibers indicated that the fibrous morphology 
was retained after swelling for all groups and also that composite scaffolds had a relatively even 
number of both fiber populations (Figure 7.1C). Dual polymer scaffolds can be tuned to have 
varying ratios of each fiber population by offsetting the two opposing electrospinning jets [18], but 
in this study all dual polymer scaffolds were electrospun to have about a 50:50 ratio between the 
two fiber populations. 
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7.3.2 Mass Swelling and Mechanical Properties 
The effect of the hydrophobicity of PCL was apparent when samples were immersed in 
PBS, as HA-only scaffolds became more transparent and swelled to approximately twice their 
original thickness, whereas PCL/HA and PCL-only scaffolds retained their opaque or white 
appearance and initial dimensions (Figure 7.2A). These differences were also reflected in the 
mass swelling ratios, with HA-only scaffolds swelling significantly more (~25-30) than PCL/HA 
(~5) and PCL (~2) scaffold conditions (Figure 7.2B). Compressive moduli of swollen scaffolds 
were significantly lower for all HA-only scaffolds (~2-3 kPa) compared to the PCL condition (22.5 
            
 
Figure 7.1 (A) Schematic of all scaffold groups fabricated through dual jet electrospinning. (B) 
SEM images and (D) average fiber diameter of dry fibrous scaffolds, and (C) confocal images of 
swollen fibers incorporated with fluorescent dyes for visualization. 
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kPa).  As expected, the moduli of PCL/HA composites (~8-9 kPa) were in between the two 
extremes, significantly higher than the HA-only scaffolds and significantly lower than the PCL 
condition (Figure 7.2C). These differences in swelling and compressive moduli may both play 
significant roles in outcomes when applied in vivo with microfracture, as increased swelling may 
lead to an increased concentration of bone marrow (i.e. growth factors, possibly cells, etc.) within 
the scaffold, and increased mechanical properties may help in initially bearing some of the load 
but may be play negatively impact chondrogenic differentiation [19]. 
 
7.3.3 Degradation of Fibrous Scaffolds 
 For biomaterial-based tissue engineering strategies, degradation of the scaffold is an 
important parameter; ideally, the scaffold will degrade at the same rate that new extracellular 
matrix is deposited. Here, we utilize HeMA-HA, which degrades through hydrolytic degradation at 
various rates depending on the extent of modification, to increase porosity and possibly 
     
Figure 7.2 (A) Macroscopic images of swollen HA-only and PCL/HA composite scaffolds. (B) 
Mass swelling ratio and (C) compressive moduli of all scaffold groups after swelling overnight in 
PBS at 37°C. 
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integration and also to fully release encapsulated TGF!3. Scaffold degradation was measured 
both through the uronic acid assay for HA degradation and mass loss for PCL-containing 
scaffolds. Mass loss for both PCL/HA composites steadily increased with time, whereas mass 
loss of PCL-only scaffolds stayed close to 0 over the 12 weeks in PBS (Figure 7.3A), indicating 
that most of the mass loss from PCL/HA composites was from the HA component. Interestingly, 
mass loss values for PCL-only scaffolds were all slightly negative, possibly due to an 
accumulation of salts from the PBS [20].  
HA degradation profiles were similar for most HA-containing scaffolds (except for the 
HeMA-HA group), with an initial burst release during the overnight swelling period and a steady
 
 
Figure 7.3 (A) Degradation (i.e. % mass loss) of PCL-containing scaffolds, (B) Degradation (i.e. 
% HA release) of HA-containing scaffolds, and (C) compressive moduli for all scaffold groups 
over time. (D) Combined plot of degradation profiles for all scaffold groups. 
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degradation profile that plateaued at later timepoints. This initial burst release was most likely due 
to a combination of unreacted HA macromers swelling out of the scaffold and some of the PEO 
on the surface of the fibers dissolving into solution. The HeMA-HA group exhibited much higher 
HA degradation rates, and HeMA-HA only scaffolds were fully degraded by ~6 weeks in PBS.  
The difference in degradation profiles between HeMA-HA and MeHA/HH composites possibly 
suggests that the HeMA-HA macromer chains were unable to be released from the scaffold after 
degradation, either due to covalent crosslinks with nearby MeHA chains (e.g. intra-fiber 
crosslinks) or slowed diffusion through the still highly crosslinked MeHA fiber network.  
The values for percent of total scaffold weight or HA amount degraded were combined 
into a single plot to compare degradation over all groups, as shown in Figure 7.3D. As expected, 
degradation profiles of PCL/HA composites were in between that of HA-only and PCL-only 
conditions. Due to the inability of hyaluronidase to fully degrade all HA within the PCL/HA 
composites, it was not possible to determine the exact HA:PCL ratio within the composites. Still, 
as discussed previously, swollen fibrous samples imaged with confocal microscopy had relatively 
even populations of both fibers for all dual polymer conditions. Compressive moduli of all scaffold 
groups were also tracked over time and overall seemed to correlate well with degradation. The 
profiles of compressive moduli of both PCL/HA composite groups stayed relatively steady over 
the entire 12 weeks, whereas the HA-only groups were too soft to be tested after only 1 week. 
The moduli of PCL-only samples steadily increased over the first 4 weeks, most likely due to 
crystallization [20], and then decreased slightly and stabilized around 8 weeks.  
 
7.3.4 TGF!3 Release and Activity 
 The TGF!3 release profiles from both PCL/HH and MeHA/HH scaffold groups were 
relatively similar, with a short burst release period followed by a plateau region  (Figure 7.4A).  
Interestingly, the burst release was more significant from the MeHA/HH scaffold, most likely due 
to differences in swelling between the two conditions. Still, in both conditions, most of the TGF!3 
(~80-90%) within the scaffold was released within the first 10 days, which has been shown to be 
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beneficial for MSC chondrogenesis in vitro [21-23]. Electrospinning can be detrimental to growth 
factor stability and activity, since most polymers are electrospun from organic solvents with high 
voltages. Thus, a major benefit to our system is that HA is dissolved in water prior to 
electrospinning. To measure TGF!3 activity, scaffolds releasing TGF!3 were cultured in the 
same wells as MSC pellets, and the resulting biochemical and histological properties of the 
pellets were analyzed and compared to the negative (i.e. 0 ng/mL TGF!3) and positive  (i.e. 10 
ng/mL TGF!3) controls.  
After 4 weeks of in vitro culture, biochemical analysis for total glycosaminoglycan (GAG) 
content showed a significant (p<0.05) increase in GAG levels between all groups with TGF!3 
(either exogenously added or released by scaffolds) compared to all groups without TGF!3. 
       
Figure 7.4 (A) Release of TGF!3 over time from both TGF!3-containing scaffolds at 37°C. Total 
(B) GAG, (C) DNA, and (D) collagen per MSC pellet when cultured with (i.e. in the same well as) 
fibrous scaffolds for 4 weeks. * denotes statistical significance (p<0.05). 
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Analysis of DNA content resulted in similar trends, although the difference was only statistically 
significant between the MeHA and MeHA/HH+TB3 conditions. The increase in both GAG and 
DNA in the presence of TGF!3 was expected, as TGF!3 is one of the most potent growth factors 
to induce MSC chondrogenesis and can also have positive effects on cell survival and 
                     
Figure 7.5 Immunohistochemistry for type 2 collagen and staining with picrosirius red (collagen), 
alcian blue (GAGs), and hematoxylin & eosin of MSC pellets cultured with (i.e. in the same well 
as) fibrous scaffolds for 4 weeks in vitro. 
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growth [24]. Total collagen content of the MSC pellets was not significantly different between any 
of the conditions.  
To further assess TGF!3 activity, the MSC pellets were also processed for histology and 
stained with hematoxylin & eosin (H&E), alcian blue, picrosirius red, and immunohistochemistry 
for type 2 collagen (Figure 7.5). Images of stained pellets (n=3) were also quantified with 
CellProfiler and compared for statistical significance (Figure 7.6). Interestingly, MSC pellets in 
groups without TGF!3 seemed slightly smaller than those in groups with TGF!3. Also, pellets 
from groups without TGF!3 had pockets without cells interspersed through the matrix, which is 
possible indicator of necrosis. As expected from biochemical analysis, quantification of alcian 
blue staining showed that pellets cultured with TGF!3 had higher levels of GAG, with significant 
differences of mean intensity values between all TGF!3-containing groups versus all groups 
without TGF!3. Although only significant between the negative and positive controls, the values 
for percent of total area stained with alcian blue also exhibited similar trends.  
The biochemical and histological results for total collagen did not correlate as well as 
those for GAG content. Specifically, histology (both through representative images and the 
quantification) showed significant differences between groups with and without TGF!3, and, as 
stated previously, the biochemical (i.e. hydroxyproline) assay for total collagen showed no 
significant differences between any groups. Still, type 2 collagen is a more specific and relevant 
marker for chondrogenesis compared to overall collagen content, and immunohistochemistry for 
type 2 collagen showed significantly increased type 2 collagen in groups with TGF!3. However, 
the only statistically significant difference, as seen through quantification of % type 2 collagen 
positive area, was between the negative and positive control groups. Still, through the 
combination of biochemical and histological assays, it was clear that the TGF!3 released from 
fibrous scaffolds was still active and had a clear, positive effect on MSC chondrogenesis. 
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Figure 7.6 (A) Example of quantification through CellProfiler of a representative image of alcian 
blue staining. (B) Quantification (i.e. % total area and mean intensity) of staining of MSC pellets 
cultured in the same well with (i.e. in the same well as) fibrous scaffolds for 4 weeks. * denotes 
statistical significance (p<0.05). 
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7.4 Conclusions 
 Cartilage tissue engineering strategies that utilize biomaterials generally incorporate 
either in vitro construct maturation before implantation or stimulation of the body’s endogenous 
repair pathway for tissue formation in vivo. In contrast to Chapter 6, this and the subsequent 
chapter focus on implementing the latter pathway with engineered, tunable fibrous HA- and PCL-
based scaffolds. This chapter specifically investigated various material parameters (i.e. material 
composition and type and extent of modification) to achieve a significant range of scaffold 
swelling, mechanical properties, degradation, and TGF!3 release. Specifically, the incorporation 
of PCL significantly decreased the mass swelling ratio, increased the compressive moduli, 
decreased overall % mass loss, and slowed down release of encapsulated TGF!3. Additionally, 
the activity of the released TGF!3 was demonstrated through the ability to induce 
chondrogenesis of MSC pellets, as assessed by biochemical and histological analysis.  
Due to the limited healing capacity of hyaline cartilage, the scaffolds developed here will 
be translated to in vivo studies using a method similar to AMIC, in which an acellular collagen 
scaffold is combined with microfracture. With this technique, the blood and bone marrow that 
results through microfracture is rich with endogenous cells and stimulatory factors which, when 
combined with an acellular scaffold releasing growth factors, could potentially lead to improved 
cartilage-like tissue formation. We believe that the differences detailed here in degradation, 
mechanical properties, and TGF!3 release between the HA- and PCL-based fibrous scaffold 
groups will provide insightful results when applied in an in vivo cartilage defect model in the 
following chapter. 
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Chapter 8 
 
Investigation of Fibrous Scaffolds with Controlled Physical Properties and 
Growth Factor Delivery in a Porcine Cartilage Defect Model  
 
Adapted from: IL Kim, CG Pfeifer, MB Fisher, V Saxena, GR Meloni, M Kwon, M Kim, DR 
Steinberg, RL Mauck, and JA Burdick, “Investigation of Implantable Fibrous Scaffolds with Varied 
Chemistry and Growth Factor Delivery in a Porcone Cartilage Defect Model“, in preparation. 
 
8.1 Introduction 
Damage to articular cartilage, either through traumatic injuries or chronic osteoarthritis, 
can lead to significant pain and reduced joint mobility. These cartilage defects or degenerated 
areas tend to heal poorly, as cartilage is an avascular tissue with a low population of cells. One of 
the most common treatments for small, local cartilage defects is microfracture, in which the 
subchondral bone is violated to fill the damaged/void cartilage area with blood and bone marrow 
[1]. However, in many cases, the resulting blood clot is unstable and the tissue formed is inferior 
in its biochemical and mechanical properties when compared to native, healthy cartilage. For this 
reason, autologous matrix-induced chondrogenesis (AMIC), in which an acellular collagen 
scaffold is placed within the cartilage void directly after microfracture, has become increasingly 
utilized [2, 3].  
Despite positive advances with AMIC, a decellularized collagen scaffold may not meet 
the ideal scaffold properties with respect to degradation and growth factor delivery to optimize 
repair. Also, synthetic materials would avoid the need to identify an acceptable source of collagen 
that could be used without any concerns of immunogenicity. Thus, engineered fibrillar scaffolds 
may present beneficial properties for repair of cartilage tissue in combination with microfracture.  
Moreover, as described in Chapter 6, the limited ability to achieve cellular infiltration and thus a 
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homogeneous distribution matrix throughout electrospun scaffolds is a significant barrier to the 
long-term maturation of these constructs in vitro. These issues provide motivation for the direct 
application and acellular implantation of the fibrous scaffolds developed in this thesis into the 
cartilage defect.  
When scaffold implantation is combined with microfracture (such as with AMIC), the 
blood and bone marrow released can act as a source of biomolecules and cells. In turn, the 
implanted scaffold is thought to increase the stability of the blood clot and also may provide pro-
chondrogenic cues (either through the release of biomolecules or through the material itself) to 
cells recruited from the bone marrow [4-6]. For instance, the release of TGF! from the biomaterial 
in conjunction with microfracture has significantly improved cartilage formation [6, 7], and the 
material used in this approach affected both biochemical and mechanical outcomes in vivo [7, 8]. 
We hope to further advance these findings with a tunable material based on the electrospun 
hyaluronic acid (HA) and poly("-caprolactone) (PCL) scaffolds fabricated and characterized in 
Chapter 7. These scaffold groups span a wide range of mechanical properties, degradation 
behaviors, and growth factor release profiles, which will enhance our understanding of how these 
variables affect outcomes when studied in an in vivo setting. 
An important factor when designing in vivo studies is the choice of animal model. For 
cartilage studies, larger, pre-clinical animal models, such as pig, goat, sheep, and horse, are 
more appropriate for evaluation of biomaterials or clinical treatments for later translation towards 
use with humans [9-10]. Although commonly used and less expensive, smaller animal models 
such as rabbits and rats can be problematic; cartilage defects tend to heal spontaneously with 
rabbits, and it is difficult to create purely chondral defects (i.e. without extending into the 
subchondral bone) with rats due to the extremely thin cartilage layer [9-10]. Moreover, gait and 
movement characteristics of rats and rabbits are significantly different than those of humans. 
Equine cartilage defect models are considered the gold standard for translation towards human 
therapies; however, the high cost of such studies can be prohibitive without prior successful 
results in vivo. Porcine models have been relatively under-utilized in research due to the large 
size and slightly aggressive tendencies of adult pigs. However, the use of mini-pig strains can 
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overcome both of these issues, and the porcine joint size, weight-bearing requirements, and 
cartilage thickness much better imitate those of humans in comparison to rodents, rabbits, and 
canines [10]. 
For these reasons, we chose to utilize a juvenile mini-pig model, in which chondral 
defects were created within the hind limb trochlear grooves to assess cartilage repair. This 
intermediate-level model is especially appropriate for our materials, since they have not yet been 
tested in vivo and also due to the large number of scaffold conditions. Moreover, the results 
obtained in this Chapter with the porcine model will allow us to not only further our knowledge on 
how material parameters affect cartilage repair in vivo, but will also help to narrow down scaffold 
groups or improve on the existing scaffolds for future longer-term studies or larger animal models.  
 
8.2 Materials and Methods 
8.2.1 Macromer Synthesis and Fibrous Scaffold Fabrication 
  HA (64 kDa, Lifecore) was modified with methacrylates (MeHA) and with hydroxyethyl 
methacrylates (HeMA-HA) as described in Chapter 4. The following fibrous scaffolds were 
fabricated as described in Chapter 7: MeHA, HeMA-HA, MeHA/HeMA-HA (MeHA/HH), MeHA/HH 
+ TGF!3 (TB3), PCL, PCL/HH, and PCL/HH+TB3, in which the scaffolds fabricated with two 
materials were dual polymer scaffolds (i.e. separate fiber populations) and the TGF!3, when 
present, was always encapsulated within the HeMA-HA fibers (~35 ng TGF!3 total per sample). 
Fibrous samples were obtained using a 4-mm biopsy punch and sterilized prior to surgery using 
germicidal ultraviolet light.  
 
8.2.2 Surgical Procedure and Sample Recovery 
 All animal procedures were performed under protocols approved by the Institution Animal 
Care and Use Committee and in accordance with policies set forth by the National Institutes of 
Health. Overall, 16 juvenile (3-5 months old), castrated male Yucatan mini-pigs (Sinclair 
Bioresources) were utilized. Animals were sedated with ketamine and xylazine, and then using 
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sterile technique, hind limb trochlear grooves were exposed with a medial skin incision followed 
by a lateral arthrotomy. Chondral defects were created using a 4-mm biopsy punch to outline the 
defect, followed by the use of a scalpel to create a cross-hatch within that outline and then a 
curved, blunt probe to remove cartilage from the defect area. The cartilage was removed down to 
the level, but without penetration, of the subchondral bone plate. For defects with microfracture, a 
small awl was used to create 3 equally spaced, 2-mm deep holes in the subchondral bone. For 
defects with fibrous scaffolds, the material was placed into the defect after microfracture and 
allowed to swell for 2-5 minutes prior to closure (Figure 8.1). When sutures were applied (as 
detailed later), 2 opposing sutures were placed through the scaffold center and the surrounding 
cartilage without damage to the subchondral bone. 
All animals underwent bilateral surgery (i.e. both hind limbs) for a total of 8 cartilage 
defects per animal. After defect treatments were completed, the arthrotomy and skin incisions 
were closed using absorbable sutures, and then buprenorphine and carprofen were provided for 
2 and 5 days post-surgery, respectively. At 2, 6, and 12 weeks post-surgery, animals were 
euthanized with an overdose of pentobarbital. The stifle joints were carefully opened to expose 
the trochlear groove, and images were taken of the entire trochlear groove prior to sample 
harvest. These gross images were later used for scoring of macroscopic cartilage repair by three 
independent, blinded observers using the scoring system developed and validated by Goebel, et 
    
Figure 8.1 Example images of surgical procedure, in which fibrous scaffolds were implanted 
post-microfracture into cartilage defects in the trochlear groove of mini-pigs.  
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al. [11]. Samples were then separated from the groove using a handsaw and were immediately 
immersed in PBS with protease inhibitors (Sigma) and then frozen at -80°C until mechanical 
testing. The normal cartilage controls (1-2 from each hind limb) were taken at sample harvest 
from either the proximal or distal area of the trochlear grooves. 
 
8.2.3 Mechanical Testing 
 Prior to mechanical testing, frozen samples were thawed to room temperature and potted 
using PMMA. After the PMMA had cured for at least one hour, samples were tested while 
immersed in PBS using a custom microindentation setup, which allowed for rotation and 
movement along multiple axes. The indentation probe consisted of a 2-mm diameter, spherical 
stainless steel tip. Sample position and rotation were adjusted such that the indenter was at the 
center of the defect, and that the cartilage surface at the testing point was perpendicular to the 
indenter. A three-step stress-relaxation curve was then obtained using a 0.1%/sec strain ramp for 
50 seconds, followed by a hold period of 600 seconds. The data was then fit using a Hertzian 
model for spherical contact to obtain the Young’s modulus [12]. After mechanical testing, samples 
were fixed in 4% paraformaldehyde for 5-6 nights at 4°C. 
 
8.2.4 MicroCT Scanning and Analysis 
 After fixation, samples were rinsed in PBS and imaged using micro-computed 
tomography (microCT) with a Viva CT75 (Scanco). Samples were scanned at 70 kVp and 110 uA 
to image the bone, and then placed in an iodine-based contrast solution (Lugol solution, Sigma) 
for 48 hours at 4°C. Lugol-immersed samples were then imaged again with microCT to visualize 
cartilage. Afterwards, samples were placed into a formic-acid, EDTA-containing decalcification 
solution at room temperature for 1.5 to 2 weeks (Formical 2000, Decal Chemical Corporation) 
with orbital shaking. To evaluate bone remodeling, bone density (i.e. % bone volume/total 
volume) was calculated for a 4-mm diameter circle 0-1, 1-2, 2-3, and 3-4 mm below the defect. 
The Lugol-enhanced microCT images were utilized to evaluate total defect fill. 
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8.2.5 Histology and Scoring 
 Following sufficient decalcification, samples were processed for histology (i.e. dehydrated 
and paraffin embedded). Sections (6 um thick) were stained with hematoxylin and eosin to 
visualize cellular morphology and either Safranin O and fast green for GAGs or Alcian Blue and 
Picrosirius Red for GAGs and collagen. Immunohistochemistry was also performed to assess 
type 2 collagen levels within defects. To this end, samples were deparaffinized and rehydrated, 
digested with proteinase K, and incubated with a primary antibody for type 2 collagen 
(Developmental Studies Hybridoma Bank, University of Iowa). Afterwards, the signal was 
detected using a DAB kit (Vectastain). Quantification of % positive stained area and staining 
intensity was performed for both Safranin O and type 2 collagen using ImageJ (NIH) and 
CellProfiler (Broad Institute). Briefly, the defect area was outlined and a mask was created in 
ImageJ. CellProfiler then quantified both the % positive stained area and staining intensity of the 
masked defect area using a custom script. Each image was treated equally, with the same 
threshold used for quantification of % positive stained area for all samples. Histology was scored 
from the Safranin O/Fast Green and H&E stained images using the ICRS-II scoring system by 
three independent, blinded observers. 
 
8.2.6 Statistical Analysis 
For comparison of two groups, a student’s t-test with a p-value of 0.05 was used to 
measure statistical significance. For analyses with more than one comparison, a one-way 
ANOVA was performed followed by a Tukey post hoc test.  
 
8.3 Results and Discussion 
 This chapter describes the application of unique fibrous scaffolds with engineered 
material properties and controlled growth factor delivery for in vivo cartilage repair. Even with 
recent advances in scaffold development, there is a limited number of studies applying acellular 
biomaterials with microfracture to cartilage defects, and thus the effect of material parameters 
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with this technique on cartilage repair outcomes in vivo are still not fully understood. As described 
in the previous chapter, the following fibrous scaffolds were fabricated and characterized: MeHA, 
MeHA/HH, MeHA/HH+TB3, PCL, PCL/HH), and PCL/HH+TB3. These groups were chosen 
specifically to investigate the effects of properties such as degradation, mechanics, and growth 
factor release in combination with microfracture in an in vivo cartilage defect model. 
 It is important to note the significant impact the choice of an in vivo model can have. For 
instance, the choice between juvenile and adult or small and large animal models can affect the 
overall outcomes for all groups significantly, as juvenile models may tend to heal better and large 
animal models may be a more appropriate translation model towards application in humans [9, 
10]. We included two defect controls (i.e. empty and microfracture groups) and a positive control 
of normal cartilage tissue to compare to our scaffold treatments, for a total of 9 conditions. The 
choice of study length is also important, as shorter timepoints may be necessary for preliminary 
studies to identify any major issues with scaffold design or surgical procedures, whereas 
intermediate or long-term studies are necessary to assess the true impact and cartilage repair 
outcomes (especially through mechanical testing) for further translation. Here, we investigate a 
subset of our entire scaffold cohorts at shorter timepoints (i.e. 2 and 6 weeks after surgery) to 
assess scaffold stability, short-term cartilage repair and scaffold remodeling, and activity of 
released TGF!3 and then move to an intermediate timepoint (i.e. 12 weeks after surgery) for full 
cartilage repair assessment. 
 Typical in vivo cartilage-focused repair studies only use a few outcomes for assessment, 
with histology being the most common. Surprisingly, mechanical testing is still an infrequent 
consideration for cartilage repair assessment, which is unfortunate since cartilage predominantly 
serves as a load-bearing tissue. Still, even mechanical testing alone is not sufficient as an 
assessment of cartilage repair, and ideally a plethora of outcomes should be evaluated to fully 
understand the impact of treatment. A strong point of this study is that samples are all tested over 
multiple measures, including macroscopic imaging and scoring, mechanical testing, subchondral 
bone remodeling, defect fill, and histology. Thus, this study is powerful in both the number of 
material parameters investigated (i.e. mechanical properties, degradation, and growth factor 
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release) and the number of outcomes used for evaluation. Further, we seek to compare how well 
commonly used outcomes (such as histology) correlate with less commonly investigated, but still 
important, outcomes (such as mechanical properties). 
  
8.3.1 Short-term Scaffold Stability within Defects 
 To assess whether scaffolds would be stable within cartilage defects without sutures in 
vivo, a preliminary 2-week study was performed with only two scaffold groups: MeHA/HH and 
PCL/HH. Thus, a total of four conditions were tested: MeHA/HH with and without sutures and 
PCL/HH with and without sutures (n=4 for all groups). These two scaffold groups were chosen 
because they represent a range of properties in terms of swelling, degradation and other 
measures, as described previously in Chapter 7. It was thought that the differences in initial 
swelling might affect scaffold stability within the defect, as the HA-only scaffolds swell significantly 
more than all PCL-containing groups. These differences in swelling were clear even during 
surgery, with the HA-only scaffolds immediately swelling with blood and turning red after scaffold 
placement, whereas the PCL/HA composites stayed relatively white (Figure 8.1A).  
Two weeks after surgery, animals were sacrificed and samples were harvested as 
described previously. Gross macroscopic images taken during sample harvest showed a 
significantly different appearance between the HA-only and PCL/HA composites; the HA-only 
defects were predominantly red and slightly depressed below the surrounding cartilage, whereas 
the PCL/HA composites were lighter in color and in-level or slightly proud above the surrounding 
cartilage (Figure 8.2A). Neither HA-only or PCL/HA groups showed any macroscopic differences 
when implanted with or without sutures, and all scaffold groups appeared to be present at two 
weeks. Histological analysis validated that scaffolds remained present in all conditions, as 
staining with alcian blue at a pH of 2.5 stained the non-sulfated GAG (i.e. HA) component within 
the scaffolds. Further, the HA-only scaffolds stained much darker blue with the alcian blue in 
comparison to the PCL/HA composite scaffolds, reflecting the increased density of HA in the HA-
only groups (Figure 8.2A). As with macroscopic images, there were no significant differences in 
scaffold presence, placement, or morphology when assessed histologically between scaffolds 
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with and without sutures, although in some samples with sutures, the suture track could clearly be 
observed within the center of the defect (Figure 8.2A). Likely, the blood clot stabilized all scaffolds 
at the time of surgery to prevent subsequent failure with loading. Thus, due to this lack of 
difference with and without sutures and also the increased time of surgery and possible damage 
to the scaffold during suturing, all following in vivo studies did not include sutures to secure the 
scaffolds. 
 
8.3.2 Validation of TGF!3 Activity in vivo 
A six-week timepoint was chosen to validate the activity of released TGF!3. For this 
study, two scaffold groups, MeHA/HH and MeHA/HH+TB3 along with defect controls (i.e. empty 
and microfracture) and positive controls were investigated (n=5 for all groups). Six weeks after 
surgery and scaffold implantation, samples were harvested as described previously. There were 
no differences based on gross, macroscopic images during sample harvest. Also, staining with 
alcian blue/picrosirius red and hematoxylin and eosin staining did not show any significant 
histological differences between the scaffold groups. At this point, it was difficult to identify the 
fibrous scaffolds at six weeks with alcian blue, perhaps due to significant degradation of the HA or 
masking of the HA component with other extracellular matrix components. Immunohistochemistry 
for type 2 collagen importantly showed significantly increased deposition with the TGF!3-
releasing condition (Figure 8.2B) when compared to the same groups without TGF!3, validating 
that the TGF!3 released from the fibrous scaffolds was still active in vivo.  
 
8.3.3 Gross Appearance of 12-week Samples  
 A total of 10 groups were investigated for the 12-week in vivo study: MeHA (n=7), 
MeHA/HH (n=8), MeHA/HH+TB3 (n=10), PCL (n=7), PCL/HH (n=8), PCL/HH+TB3 (n=10), empty 
(i.e. defect created without violation of subchondral bone and left empty, n=8), microfracture (i.e. 
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defect created and microfracture performed, n=8), and normal cartilage (n=18) as a positive 
control.  After 12 weeks, animals were sacrificed and samples were harvested as described 
previously.  Gross, macroscopic images were taken immediately after exposure of the trochlear 
groove. The macroscopic appearance of defects ranged widely for each treatment group, with 
most defects appearing relatively opaque, white-blue, and in-level with the surrounding cartilage. 
Moreover, staining of the adjacent patellar cartilage with india ink showed no significant cartilage 
lesions (data not shown). In almost all defects, the center of the defect appeared less opaque and 
slightly reddish in comparison to the surrounding areas. In addition, the PCL/HH group had an 
         
Figure 8.2 (A) Gross images of representative trochlear groove (left) and staining with alcian 
blue/picrosirius red of cartilage defects after 2 weeks in vivo (right) (n=4), (B) staining with alcian 
blue/picrosirius red and immunohistochemistry for type 2 collagen (images and quantification) of 
cartilage defects after 6 weeks in vivo (n=5). * denotes statistical significance (p<0.05). 
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inferior gross appearance (both in terms of color and blood vessels with surrounding cartilage) 
(Figure 8.3). These differences were validated through scoring of the gross, macroscopic images 
with the system developed by Goebel, et al. [11], although the gross overall score did not show 
any significant differences between conditions. All groups also scored relatively well in terms of 
surface appearance, adjacent cartilage, and defect fill.  
 
 
 
   
Figure 8.3 (A) Median (as quantified by gross overall score) gross images of cartilage defects 
after 12 weeks in vivo (n=7-10). Gross overall score shown in inset.  (B) Scoring of gross images 
using the system developed by Goebel, et al. [10]. * denotes statistical significance (p<0.05) 
between indicated groups. 
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8.3.4 Subchondral Bone Remodeling and Defect Fill 
  Although not commonly quantified in literature, remodeling of the subchondral bone 
following cartilage defect creation has previously been reported [13, 14]. In this study, remodeling 
of the subchondral bone was analyzed through microCT imaging and quantified in two ways, 
through bone density (i.e. % bone volume/total volume) and the area underneath the defect 
without bone (Figure 8.4A). After the initial remodeling phase, the subchondral bone plate begins 
to migrate back upwards into the depleted bone area and, sometimes, eventually into the 
cartilage [14]. This front of bone re-growth tends to have a very high bone density, and thus the 
average bone density directly under the defect can appear to be normal. Due to this artifact, 
quantifying the area without bone directly may be a better measure of this remodeling response 
for longer timepoints (i.e. 12 weeks). For instance, although all groups exhibited some level of 
bone remodeling (as seen by the area without bone), most groups had bone density levels similar 
to normal tissue even directly under the defect (i.e. 0-1 mm underneath) (Figure 8.4B and C).  
Still, it was clear from both the average bone density and the area without bone that the 
PCL-containing scaffolds (i.e. PCL, PCL/HH, and PCL/HH+TB3) exhibited significantly more 
subchondral bone remodeling. The reason behind the significant bone remodeling with PCL 
scaffolds is unclear, although it is possible that it was due to differences in degradation or even a 
heightened immune response. These differences in subchondral bone remodeling may 
significantly impact mechanical properties, as a softer underlying surface may lead to lower 
mechanical properties even with microindentation testing. Whereas significant differences were 
seen with subchondral bone remodeling, overall defect fill, as measured through contrast-
enhanced microCT imaging, was high and relatively the same between all groups (~80-90%) 
(Figure 8.4D).   
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Figure 8.4 (A) Representative cross-section views of microCT 3D reconstructions depicting both 
cartilage (orange) and bone (green), with examples of zones used for bone density (middle) and 
quantification of the area without bone (right). Quantification of microCT scans for (B) overall 
bone density, (C) area without bone (mm3) and (D) cartilage defect fill (%) (n=7-10 for all 
measures). In B, * denotes statistical significance (p<0.05) between indicated and normal groups, 
and in C, * denotes statistical significance between specified groups and ** denotes statistical 
significance over all other groups. 
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8.3.5 Histological Analysis 
  Histological analysis is considered one of the most important metrics of cartilage repair 
and is the most common outcome presented in in vivo cartilage treatment studies. Here, we 
stained with Safranin O/fast green, hematoxylin & eosin (H&E), and IHC for type 2 collagen and 
also scored the resulting histology using the well-validated ICRS-II scoring system. Again, as with 
other metrics, Safranin O/fast green revealed a wide variability in cartilage repair, ranging from a 
high level of Safranin O stained area within the defect to a complete lack of GAG or even 
incomplete defect fill (Figures 8.5). All defects had clearly been well-infiltrated with cells, as seen 
by H&E staining (Figure 8.5, middle and right columns). H&E also suggested that the PCL 
scaffolds in particular had sunken into the remodeling subchondral bone, which may have 
contributed to the increased remodeling and lower mechanical properties of the PCL and PCL/HH 
scaffold groups. Scoring of histology through the ICRS-II scoring system revealed high levels of 
integration and defect fill for most groups (Figure 8.6). Both TGF!3 groups performed significantly 
better in comparison to the PCL/HH group in terms of overall histological score, and these 
differences were even more apparent in the superficial zone score, with MeHA and the two 
TGF!3 groups scoring significantly higher than the PCL/HH group. Scoring of subchondral bone 
remodeling validated the differences seen from microCT data, with both the PCL and PCL/HH 
groups having significantly more remodeling compared to most other groups. 
Furthermore, both TGF!3 and the MeHA groups also had improved type 2 collagen 
staining, as these 3 groups were the only ones similar (i.e., not statistically different) from the 
normal condition in terms of both % type 2 collagen positive area and staining intensity (Figure 
8.7). These differences were observed both visually (Figure 8.7A) and through quantification of % 
stained area and staining intensity within the defect (Figure 8.7B). The increase in type 2 collagen 
highlights the importance and stimulatory effect of TGF!3, whereas the MeHA group may have 
had elevated levels of type 2 collagen in comparison to the MeHA/HH group due to the prolonged 
presence of HA, which has been shown to have a positive effect on mesenchymal stem cell 
chondrogenesis and cartilaginous matrix production [15, 16].  
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Figure 8.5 Median (as quantified by histological overall score shown in inset) Safranin O/fast 
green (left) and hematoxylin and eosin (H&E, middle and right) images of cartilage defects after 
12 weeks in vivo (n=7-10). 
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8.3.6 Mechanical Properties 
 As stated previously, mechanical testing is an important outcome to assess repair of 
load-bearing tissues. In this study, we were able to mechanically test samples prior to all other 
metrics with low strains that should not cause any irreversible damage to the tissue. Moreover, it 
has been found previously that freeze-thawing does not significantly impact mechanical 
properties of cartilage and other tissues in most cases [17, 18], and the values we calculated from 
our normal ostechondral samples were similar to those reported previously in literature. Although 
 
Figure 8.6 Histological scoring of cartilage defects using the ICRS-II scoring system (n=7-10). * 
denotes statistical significance (p<0.05) between indicated groups, and ** denotes significance 
over all other groups unless that group is specified by “n.s.”. 
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the values obtained through the Hertz model are dependent on testing parameters, this method 
has been used commonly in literature as an estimate of stiffness. Moreover, we only compare 
values between samples tested with the same exact method [19-21].  
      
Figure 8.7 (A) Median images (as quantified by % type 2 collagen area and shown in inset) and 
(B) quantification of staining for type 2 collagen in cartilage defects after 12 weeks in vivo (n=7-
10). ** denotes significance over all other groups unless that group is specified by “n.s.”. 
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  Microindentation testing of the samples resulted in a high standard deviation within all 
groups. Indeed, even the Young’s modulus for normal tissue ranged from 0.7 to 3.5 MPa (Figure 
8.8). Generally, most treatment groups had similar mechanical properties to both the empty and 
microfracture groups. Still, although there were no significant differences due to the high spread 
of data, the MeHA group did have an average modulus of 299 kPa, which was twice that of many 
other groups, including microfracture (151 kPa) and MeHA/HH (157 kPa). Also, the PCL and 
PCL/HH groups had markedly lower moduli than most other groups (82 kPa and 37 kPa, 
respectively), which could be due to increased subchondral bone remodeling and inferior matrix 
composition, as described previously. Although all treatment groups had mechanical properties 
significantly lower than normal tissue, these differences may not have been as drastic if other 
areas within the defect had been tested, as the center portion generally had a worse gross 
appearance and matrix composition. Moreover, the slight differences seen in moduli may have 
been more significant with later timepoints, as differences seen with histology may have needed 
more time to become sufficient enough to affect mechanical properties. 
 
      
Figure 8.8 Microindentation testing setup (left) and Young’s moduli of cartilage defects after 12 
weeks in vivo (right) (n=7-10). ** denotes significance over all other groups. 
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8.3.7 Principal Component and Correlative Analyses 
 Most commonly, studies involving in vivo analysis of cartilage repair only report histology, 
although sometimes macroscopic imaging or scoring is also reported. The thoroughness of this 
study highlights the importance of having multiple outcomes in addition to histology in order to 
gather a full assessment of cartilage repair. To our knowledge, this study is one of the most 
comprehensive in terms of number of outcome measures for in vivo cartilage repair, and because 
of this, we thought it would be beneficial to quantify how well commonly-used outcomes actually 
correlate to mechanical properties. As seen in Figure 8.9A, most metrics correlated quite well with 
mechanical properties, with significant p-values between mechanics and all outcomes except 
defect fill and gross overall score. The normal samples were not included in these linear 
correlative analyses, as their inclusion made the relationships non-linear. Although histology and 
gross appearance are two of the most commonly reported outcomes for cartilage repair, this data 
suggests that histology (through scoring, GAG and type 2 collagen composition) was a much 
better predictor of mechanical properties. 
Principal component analysis was also performed in order to combine and reduce all 
assessment variables into two principal components that accounted for most of the variability 
within the entire dataset. Thus, PCA provided a strong tool to reduce multiple metrics into a 
visually simple method for overall assessment of how each sample performed. The level of 
cartilage repair could then be assessed by the relative distance of each sample or treatment 
group to the normal group, with samples closer to the normal group thus more similar to native 
cartilage in terms of all metrics. Interestingly, the data followed a trajectory, with normal samples 
clustering at one end and the PCL/HH samples generally clustering at the other end (Figure 
8.9B). As expected with the high spread of data for each metric, there was also a high spread of 
samples across the trajectory within each group. Even with this high variability, it was clear that 
the HA groups were generally more similar to the normal condition than the PCL groups. Also, the 
inclusion of TGF!3 seemed to have a greater effect with the PCL groups than with the HA 
groups, as there was a greater shift in terms of proximity to the normal group cluster for 
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Figure 8.9 (A) Relationships between various, commonly reported outcomes and moduli, (B) 
principal component analysis of entire dataset (i.e. all outcome measures) for all 12-week in vivo 
cartilage defect samples. 
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the PCL group with TGF!3 (compared to the other PCL groups) compared to the HA group with 
TGF!3 (compared to the other HA groups).   
 
8.4 Conclusions 
 Even though biomaterials have been increasingly investigated for cartilage repair, the 
effect of important material parameters, such as degradation and mechanical properties are still 
not fully understood in an in vivo setting. Chapter 7 detailed the fabrication and characterization of 
multiple scaffold groups, validating differences in various material parameters, and this Chapter 
applies the scaffolds characterized in Chapter 7 to an in vivo cartilage defect model. Here, we find 
that the choice of material, either due to differences in surface chemistry, swelling, or 
degradation, and the inclusion of TGF!3 most significantly affected cartilage repair. Through 
gross appearance and scoring, mechanical properties, and subchondral bone remodeling, almost 
all groups performed similarly with the exception of the PCL and PCL/HH groups, which generally 
had inferior cartilage repair. Interestingly, with the addition of TGF!3 to the PCL/HA composite 
scaffold (i.e. PCL/HH+TB3), levels for multiple outcomes recovered more towards that of other 
scaffold groups.  
Through histology and histological scoring, it was found that the MeHA and two TGF!3-
releasing groups had increased levels of type 2 collagen. It is unclear whether the improved 
repair with HA-only scaffolds was due to biological signaling, swelling properties, or differences in 
degradation. Still, both groups with faster degradation profiles compared to their more stable 
counterpart (i.e. MeHA/HH compared to MeHA alone and PCL/HH compared to PCL alone) 
resulted in inferior cartilage repair across a range of metrics. Moreover, as MeHA/HH also had 
similar swelling properties to MeHA, this suggests that the sustained presence of HA may have 
acted as a positive biological signaling factor for increased cartilaginous matrix deposition, 
matching levels of cartilage repair seen with scaffolds releasing TGF!3. These histological 
differences may have needed additional time to fully develop and become significant in terms of 
mechanical properties. 
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In many cases, in vivo findings for cartilage tissue engineering studies are limited to 
histology and one or two other outcomes. Here, we assessed cartilage repair using a plethora of 
metrics and found that the correlations between many commonly used measures and mechanical 
properties were relatively strong. However, the correlation between gross overall score and 
moduli was poor, even though gross assessment is a commonly used and widely accepted 
outcome for cartilage repair studies. Finally, principal component analysis allowed all variables to 
be collapsed into two principal components and suggested that the HA groups clustered more 
closely to the normal samples in comparison to the PCL groups. In conclusion, this chapter 
describes the investigation of how various material parameters affect cartilage regeneration in 
vivo and also highlights the necessity for multiple outcome measures to more fully assess 
cartilage repair. 
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CHAPTER 9 
 
Incorporation of Sulfated Hyaluronic Acid Macromers into Degradable 
Hydrogel Scaffolds for Sustained Molecule Delivery 
 
Adapted from: BP Purcell, IL Kim, V Chuo, T Guinen, SM Dorsey, and JA Burdick, “Incorporation 
of Sulfated Hyaluronic Acid Macromers into Degradable Hydrogel Scaffolds for Sustained 
Molecule Delivery“ Biomaterials Science, 2014, 2: 693-702. 
 
9.1 Introduction 
Previous chapters utilized a single growth factor (i.e. transforming growth factor !3, 
TGF!3) for enhanced production of cartilage-like matrix in both in vitro and in vivo studies. In this 
chapter, we explore the ability to further modify hyaluronic acid (HA) with sulfates in order to 
control the release of multiple biomolecules at once. Specifically, we focus on the addition of 
SDF-1", a potent chemoattracting cytokine that mobilizes multiple cell types including 
mesenchymal stem cells (MSCs), to potentially increase the cellularity of, and thus matrix 
production within, fibrous HA hydrogels for ongoing and future in vivo work. Here, we exhibit the 
ability to specifically tune the release profile of SDF-1" (i.e. independently of TGF!3 release) by 
taking advantage of differences in electrostatic interactions of both biomolecules to charged HA 
macromers. 
HA-based hydrogels have been used widely in recent years for applications in drug 
delivery and tissue engineering [1]. HA is a ubiquitous biological polymer composed of repeating 
D-glucuronic acid [!-1-3] and N-acetyl-D-glucosamine [!-1-4] disaccharides and is found 
abundantly in the extracellular matrix (ECM) of many tissues. During endogenous tissue 
remodeling, HA plays a critical role in regulating cell motility through CD44 receptor interactions 
and provides a hydrated microenvironment for growth factor and cytokine stability and diffusion 
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[2]. HA is unique among glycosaminoglycans (GAGs) in that it is produced and secreted from 
cells as a linear polymer unattached to a polypeptide. This feature makes HA production 
amendable to typical genetic engineering approaches using microbial fermentation [3]. These 
recombinant HAs are nonimmunogenic, available in a wide range of well-defined molecular 
weights, and have been used in numerous biomedical applications. Further, due to the 
abundance of hydroxyl and carboxylic acid groups, HA is readily modified with reactive groups to 
form hydrogels [1]. In particular, modification of HA with methacrylate groups permits hydrogel 
formation through free-radical initiated crosslinking. This approach has allowed spatiotemporal 
control of network architectures to direct stem cell differentiation in vitro [4, 5], in situ gelation to 
localize therapeutic protein delivery in vivo [6], and construction of nanofibers to mimic fibrous 
tissue architectures [7]. 
While protein binding to methacrylate-modified HA macromers has been observed [6], 
HA lacks the sulfate groups typically associated with high protein-ECM binding affinities. For 
example, sulfated glycosaminoglycans have been shown to bind, stabilize, and control the activity 
of hundreds of proteins through electrostatic interaction between sulfates and basic amino acid 
residues [8]. These interactions are critical to regulating tissue remodeling processes by localizing 
protein activity in a temporally controlled fashion (i.e., protein presentation) [9, 10]. In order to 
control protein presentation and therefore engineer tissue remodeling, sulfated polymers have 
been incorporated into biomaterial scaffolds. Heparin isolated from animal tissues is most 
commonly incorporated into these scaffolds due to its high degree of sulfation [11-13]; however, 
synthetically produced heparin mimetics have recently been developed as an alternative source 
of protein-binding polymers that provide greater chemical versatility for incorporation into 
scaffolds.  
Heparin mimetics are highly sulfated polymers that are structurally distinct from naturally 
occurring GAGs, but perform some of the same functions as heparin (e.g., protein presentation) 
[8,14]. These sulfated polymers have been shown to bind proteins with high affinity and when 
delivered in vivo significantly enhance tissue repair, presumably by replacing degraded heparin 
and heparan sulfate and increasing the bioavailability of proteins [15]. While HA is unique among 
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GAGs in that it lacks sulfate groups, researchers have sulfated HA through nucleophilic 
substitution of primary hydroxyl hydrogens on HA with SO3 by simply reacting SO3 complexes 
with HA in an organic solvent [16-18]. Reaction of an SO3/DMF complex with HA results in a 
specific sulfation pattern that binds heparin-binding proteins (HBPs) with a high affinity [17, 19]. 
Further, sulfated HA polymers exhibit good cytocompatibility and enhance HBP presentation to 
cells in vitro [20]. Also, sulfated HA polymers themselves have been shown to influence cell 
activity in vitro, including stimulating Wnt and Notch signaling [16] and enhancing cell-cell 
junctions [18]. While sulfated HA has been covalently modified to functionalize biomaterial 
surfaces [21, 22], it has not been previously modified for covalent incorporation into hydrogels to 
alter features such as protein interactions and diffusion within three-dimensional networks.  
Here, we synthesized sulfated and methacrylate-modified HA macromers to incorporate 
protein-binding sulfate groups into radically-crosslinked HA hydrogels. Further, hydrolytically 
unstable ester groups were included between the reactive methacrylate group and the sulfated 
HA backbone to liberate bound proteins in a controlled fashion as the hydrogel degrades. This 
technology was investigated in bulk hydrogels as well as with electrospun HA nanofibers to mimic 
heparin binding in a complex three-dimensional scaffold. 
 
9.2 Materials and Methods 
9.2.1 Materials 
  Sodium hyaluronate (NaHy) was purchased from Lifecore (100 and 440 kDa, as 
measured with GPC). Recombinant stromal cell-derived factor-1" (rSDF-1"), ELISA kits, and 
ELISA reagents were purchased from R&D Systems. Heparin binding plates were purchased 
from BD Biosciences. Polyethylene glycol standards were purchased from Waters. All other 
materials and chemicals were purchased from Sigma Aldrich. 
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9.2.2 Macromer Synthesis and Characterization 
 NaHy (100kDa) was chemically modified with a hydroxyethyl methacrylate (HeMA) group 
to incorporate methacrylate reactivity for free-radical initiated crosslinking, as well as hydrolytic 
degradation through ester group hydrolysis as previously described [6]. Briefly, HeMA was 
reacted with succinic anhydride via a ring opening polymerization in the presence of N-
methylimidazole to obtain HeMA-COOH, which was then coupled to a tetrabutylammonium (TBA) 
salt of HA in the presence of 4-dimethylaminopyridine (DMAP) and di-tert-butyl dicarbonate 
(BOC2O). The resulting HA macromer with HeMA group modification (HeMA-HA) was purified 
with dialysis and characterized by 1H NMR.  
For HeMA-SHA synthesis, a 440kDa NaHy was first synthesized to HeMA-HA as 
described above and then converted to a TBA salt through resin exchange (Dowex 50x8w 
hydrogen form) and TBA-OH titration to pH 7.02 to permit polymer solubility in DMF for the 
sulfation reaction. HeMA-HA TBA was then frozen and lyophilized. Dry HeMA-HA TBA was 
dissolved in N,N-dimethylformimide (DMF) at 0.25% w/v under N2 at room temperature (RT). 
SO3/DMF complex in DMF solution (10% w/v) was added to the reaction at a 20:1 (mol/mol) 
SO3/DMF:HA repeat unit ratio and reacted for 1 hr at RT under N2. The reaction solution was then 
dialyzed against dI H2O for 14 days at 4°C to remove solvent and TBA salts, frozen and 
lyophilized.  
Molecular weights were determined with gel permeation chromatography (GPC) analysis 
using a Waters 1525 Binary HPLC Pump, Waters 2414 Refractive Index (RI) Detector, and 
Waters Ultrahydrogel 1000 columns. The eluent was PBS buffer and the flow rate was 0.5 
mL/min. Size calibrations for molecular weight determination were made with polyethylene glycol 
standards. Polymers were dissolved in MilliQ H2O at 3.5% w/v for HeMA-HA and 4% w/v for 
HeMA-SHA and loaded into folded capillary cells (Malvern). Zeta potential measurements were 
made on a ZetaSizer Nano ZS (Malvern).  
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9.2.3 Dimethylmethylene Blue Assay 
 Serial dilutions of each polymer were prepared in MilliQ H2O (50 µg/mL#0 µg/mL) and 
assayed for the presence of sulfate groups using a previously developed dimethylmethylene blue 
(DMMB) assay [23]. Absorbance at 520 nm was measured using a cuvette reader (Tecan). To 
visualize sulfate groups, 50 µL hydrogels were formed (see subsequent methods), washed for 2 
days in PBS, incubated in DMMB solution overnight at 37°C, rinsed and photographed. 
 
9.2.4 Solid-phase Binding Assay 
 HeMA-HA, HeMA-SHA and heparin at 2.5 µM in phosphate buffered saline (PBS) were 
coated overnight at 25°C onto heparin binding plates [24]. Wells were washed in TNC buffer (50 
mM Tris/HCl, 150 mM NaCl, 10 mM CaCl2, 0.05% Brij-35 and 0.02% sodium azide) containing 
0.1% Tween 20 between each subsequent incubation. Wells were blocked with 0.2% gelatin in 
TNC buffer and then incubated with rSDF-1" (300-5 ng/mL in blocking solution for 2 h at 37°C). 
Bound rSDF-1" was detected using a biotin-labeled antibody for rSDF-1" (R&D Systems, part 
no. 840932, 2 hr incubation at 37°C), followed by streptavidin coupled to horseradish peroxidase 
(R&D Systems) for 20 min at 37°C. Hydrolysis of a 1:1 mixture of H2O2 and tetramethylbenzidine 
(R&D Systems) was measured at 450 nm using a microplate reader (Tecan infinite m200). 
 
9.2.5 Hydrogel Formation and Swelling 
For crosslinking, a redox initiator system consisting of ammonium persulfate (APS) and 
N,N,N$,N$-tetramethylethylenediamine (TEMED) was utilized. APS and TEMED were mixed with 
polymers dissolved in PBS to initiate crosslinking at final concentrations of 10 mM APS, 10 mM 
TEMED, and 4% w/v macromer. HeMA-HA/HeMA-SHA blends were formed by mixing different 
volumetric ratios of the respective polymers dissolved at the same concentrations in PBS. 
Kinetics of the crosslinking reaction was characterized with rheometry by monitoring the storage 
(G’) and loss (G”) moduli with time (20mm 1o cone geometry, 1% strain, 1Hz, TA Instruments AR 
2000ex). 50 µL hydrogels (4% w/v polymer, 10 mM APS/TEMED) were formed in cylindrical 
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molds at 37°C for 30 min after mixing APS/TEMED initiators. Hydrogels were then incubated in 
PBS for 2 days at 37°C. Hydrogel diameters were measured after 30 min of crosslinking and 
again after 2 days in PBS. Swelling changes were reported as a percent change in diameter after 
2 days in PBS. 
 
9.2.6 Protein Release from Isotropic Hydrogels 
rSDF-1" or FITC-BSA were dissolved in the polymer solutions at 200 ng and 10 µg of 
protein per 50 µL hydrogel, respectively. 50 µL hydrogels (4% w/v polymer, 10 mM APS/TEMED) 
were formed in cylindrical molds at 37°C for 30 min after mixing APS/TEMED initiators. After a 
wash in PBS, hydrogels were incubated in PBS supplemented with 1% w/v BSA (R&D Systems) 
at 37°C. Hydrogels were moved to fresh buffer every 2 days and samples were stored at -20°C 
until the end of the study. After the final time point, hydrogels were degraded in 0.3 mg/mL 
hyaluronidase to release remaining protein. FITC-BSA was quantified using fluorescence while 
rSDF-1" was quantified using ELISA. 
 
9.2.7 Electrospinning and Nanofiber Characterization 
Solutions for electrospinning were prepared as follows: 4% w/v HeMA-HA/HeMA-SHA 
blends, 2% w/v poly(ethylene oxide) (900 kDa), and 0.5% w/v Irgacure 2959 in dI H2O. 
Electrospinning was performed as previously described in Chapter 4. Briefly, a syringe was 
connected to a 12” long 18G blunt-ended needle positioned 16 cm away from a grounded 
aluminum mandrel. Using a high voltage power source (Gamma High Voltage Research) and a 
syringe pump (KD Scientific), the potential difference between the needle and mandrel was 
adjusted to 21 kV, and the solution flow rate was set to 1.4 mL/hour. After collection, electrospun 
fibers were purged under N2 and then crosslinked for 10 minutes with 12 mW/cm2 UV light (320-
390 nm collimated, Omnicure S1000 UV Spot Cure Systems).  
Average diameters of dry and swollen HA fibers were measured as described previously 
[7]. Briefly, samples were imaged in the dry state with scanning electron microscopy (SEM, JEOL 
 145 
7500F HRSEM, Penn Regional Nanotechnology Facility) or after swelling in PBS for 48 hours at 
37°C with confocal microscopy (Zeiss AxioObserver Inverted microscope, Penn CDB Microscopy 
Core). For confocal images, methacrylated rhodamine was added to the electrospinning solution 
at a final concentration of 25 µM to visualize fibers. Fiber diameters were then quantified using 
ImageJ (NIH, n=80-90 fibers per group). 
 
9.2.8 Protein Encapsulation and Release from Fibrous HA hydrogels 
rSDF-1" or rTGF!3 was added to each polymer solution at a concentration of 1.67 µg/mL 
prior to electrospinning. After electrospinning and crosslinking as described in the section above, 
1.5 x 1.5 cm square samples were cut from the electrospun mats and incubated in PBS 
supplemented with 1% BSA (R&D Systems) at 37°C. Samples were moved to fresh buffer at 
each timepoint and then stored at -20°C. After the final time point, hydrogels were degraded in 2 
mg/mL hyaluronidase to release remaining protein. Released rSDF-1" and rTGFb3 were 
quantified using ELISA. 
 
9.2.9 Statistical Analysis 
Statistical comparisons between groups were performed with a two-tailed student’s t-test; 
p<0.05 was considered statistically significant for comparison between two groups. The results 
are reported as mean values ± standard deviations. 
 
9.3 Results and Discussion 
9.3.1 Sulfation of HeMA-modified HA 
HA has been previously modified with sulfate groups through nucleophilic substitution of 
primary hydroxyls along the HA backbone [17]. When the reaction was performed with the 
SO3/DMF complex at a 20:1 SO3/DMF:HA ratio, a high degree of sulfation was observed, 
estimated at 2.8 sulfate groups per HA disaccharide, leading to high protein binding affinities. We 
applied this sulfation reaction to our previously developed hydroxyethylmethacrylate (HeMA)- 
 146 
modified HA (HeMA-HA) in order to incorporate protein-binding features into degradable, radically 
crosslinked hydrogels. Sulfated HeMA-HA macromers (HeMA-SHA) could be incorporated into 
HeMA-HA hydrogels by simply blending the HeMA-SHA and HeMA-HA macromers at a desired 
ratio and initiating crosslinking with one of many free-radical initiator systems (Figure 9.1). Using 
this strategy, sulfate groups are incorporated into the hydrogels without introducing additional 
chemistries and crosslinking steps often required for heparin incorporation into hydrogels. In 
addition, fundamental features of the networks are maintained (% w/v, crosslinking density, chain 
length), allowing independent variation of sulfate group content for controlled biological studies. 
Further, degradation kinetics of the system can be controlled through HeMA group modification to 
release bound proteins in a temporally controlled fashion.  
 HeMA-HA was synthesized as previously reported by first converting sodium hyaluronate 
(NaHy, 100kDa) to a tetrabutylammonium (TBA) salt and then coupling HeMA succinate to 
primary hydroxyls on HA through an esterification reaction [6] (Figure 7.2A). The modification 
process decreased the number average molecular weight (Mn) of the HA polymer by 20% and 
 
Figure 9.1 Hydroxyethylmethacrylate (HeMA) modified HA macromers were synthesized with or 
without sulfate groups to control sulfated polymer concentration in hydrogels by simply blending 
the two macromers together and crosslinking with free-radical initiators. Release of encapsulated 
proteins in these networks is controlled by electrostatic interactions with the negatively charged 
polymers and by gel degradation through ester group hydrolysis of the HeMA crosslinks. 
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slightly increased the HA polydispersity, as determined by GPC (Fig 1b). The decrease in Mn is 
likely due to acid hydrolysis of the polysaccharide backbone during HA-TBA synthesis as a 
proton-rich exchange resin was used for protonation of NaHy. The final HeMA-HA had a Mn of 
~80 kDa and a HeMA modification of ~16%. 
To synthesize HeMA-SHA, HeMA-HA was synthesized starting with NaHy of 440kDa and 
converted to a TBA salt through a protonated resin exchange. This step did not affect the HeMA 
modification as indicated by peak integration of methacrylate protons on the methacrylate group 
(approximately 5.8 and 6.2 ppm) via 1H NMR (Figure 9.3A). Next, the TBA salt of HeMA-HA was 
reacted with SO3 in DMF, which also did not affect HeMA modification as indicated by the 
 
Figure 9.2 Synthesis of HeMA-modified HA.  (a) Sodium hyaluronate (NaHy) was converted to 
a tertbutylammonium (TBA) salt and reacted with HeMA-succinate in dimethyl sulfoxide using 
dimethylaminopyridine (DMAP)/di-tert-butyl dicarbonate (BOC2O) catalyzed esterification.  HEMA 
modification was quantified by methacrylate group 1H NMR peaks (green circle).  (b) This 
modification slightly reduced the number average molecular weight (Mn) and increased the 
polydispersity index (PDI) as measured with GPC when compared to unmodified NaHy. 
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methacrylate proton integrations before and after the reaction (Figure 9.3A). Also, there was an 
obvious shift in hydroxyl proton peaks along the HA backbone (approximately 3 to 4 ppm) 
following the sulfation reaction as expected due to substitution of these protons with sulfate 
groups (Figure 9.3A). Although there was no change in HeMA modification (~16%) there was an 
expected and significant reduction of the macromer Mn following the sulfation reaction, which is 
likely due to acid hydrolysis of HA from H2SO4 formed from reaction of SO3/DMF and water vapor 
or from non-specific nucleophilic substitution (Figure 9.3B). By starting with a 440 kDa NaHy, the 
final Mn of HeMA-SHA was maintained at ~80 kDa so that HeMA-HA and HeMA-SHA could be 
blended at approximately the same molecular weight and modification. Naturally sulfated GAGs 
 
Figure 9.3 Synthesis of sulfated HEMA-HA.  (a) HeMA-HA was converted to a TBA salt and 
reacted with SO3/dimethylformamide (DMF) complex in DMF.  This reaction altered hydroxyl 
group 1H NMR peaks as expected, but did not affect methacrylate 1H NMR peaks (green circles).  
(b) Sulfation reduced the Mn of HeMA-HA by almost 80% as measured by GPC, so a larger 
440kDa NaHy was used to generate HeMA-SHA macromers with comparable Mn to HEMA-HA 
macromers (~80kDa). 
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are typically much smaller than 80 kDa; therefore, our approach allows generation of sulfated and 
crosslinkable polymers with larger molecular weights for covalent incorporation into hydrogels. In 
addition, the wide range of HA molecular weights available commercially provides control over 
the molecular weight of the final sulfated HA macromer. Using this approach, the sulfate group 
content within hydrogels can be easily controlled by blending sulfated and non-sulfated polymers 
at the desired ratios without altering network crosslink densities. 
 
9.3.2 Sulfating HeMA-HA Alters Polymer Charge and Increases HBP Interactions 
Heparin has been shown to bind hundreds of proteins through electrostatic interaction 
between negatively charged sulfate groups on heparin and positively charged amino acid 
residues on proteins [8]. While intermolecular forces such as hydrogen bonding and van der 
Waals interactions involving other chemistries on heparin have been shown to contribute to some 
highly specific binding events [25], charge interactions from sulfate groups are the major force 
driving heparin-protein binding [26]. Similarly, the addition of sulfate groups to HA has been 
shown to dramatically increase binding of proteins that are rich in basic amino acid residues [17, 
19]. While the degree of sulfation of HA was shown to directly correlate with protein binding 
affinity, over-sulfation of polysaccharides can inhibit protein binding [27] and the distribution of 
sulfate groups along the polysaccharide is important in protein binding affinity [17, 19].  
 The sulfate content on HeMA-SHA macromers was compared to HeMA-HA and heparin 
using a modified dimethylmethylene blue (DMMB) assay [23]. Using this assay, a significant 
increase in sulfate content was observed on HeMA-SHA compared to HeMA-HA, confirming 
success of the sulfation reaction (Figure 9.4A). Further, the sulfate content on HeMA-SHA was 
comparable to that of heparin. To quantify the effect of the sulfate groups on polymer charge, an 
important contributor to protein binding affinity, zeta potentials of the polymers were measured 
from pH 2 to 10. HeMA-SHA polymers possessed a more negative charge when compared to 
HeMA-HA polymers across the entire pH range (Figure 9.4B). Further, a clear difference was 
observed in the protonation states characteristic of sulfate groups on HeMA-SHA polymers 
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Figure 9.4 Characterization of HeMA-SHA macromers. (a) Sulfate content was increased in 
HeMA-SHA macromers when compared to HeMA-HA macromers, as determined by 
dimethylmethylene blue assay. Sulfate content of HeMA-SHA macromers was comparable to that 
of heparin. (b) Addition of sulfate groups enhanced the negative charge of carboxylic acid-
containing HeMA-HA macromers via zeta potential measurements and (c) enhanced binding to 
the heparin binding protein SDF-1!. rSDF-1! binding of HeMA-SHA macromers was comparable 
to that of heparin. (n=3 replicates per group, mean±SD).   
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compared to carboxylate groups on HeMA-HA polymers. The sulfate groups remained 
deprotonated across all pHs, while the carboxylate groups were protonated at lower pH.  
 To assess the protein-binding characteristics of the polymers, recombinant stromal cell-
derived factor-1 alpha (rSDF-1") was used as a model HBP. SDF-1" is a chemoattracting 
cytokine that plays a critical role in regulating progenitor cell trafficking between the bone marrow 
and remodeling tissues [28, 29]. Studies have shown that SDF-1" binds to sulfated GAGs with a 
high affinity through an abundance of basic amino acids on the surface of SDF-1" [30]. To 
assess SDF-1" binding to HeMA-SHA, rSDF-1" was incubated in wells with GAG polymers 
adsorbed to the surface, and rSDF-1" bound to the polymer-coated wells was quantified using 
ELISA. Using this technique, a significant increase in rSDF-1" binding was observed with HeMA-
SHA polymers compared to non-sulfated HeMA-HA polymers (Figure 9.4C). Further, HeMA-SHA 
polymers had comparable rSDF-1" binding to heparin, although more rSDF-1" was bound to 
HeMA-SHA. This observation could be explained by the greater Mn of HeMA-SHA compared to 
heparin (80kDa versus 20kDa by GPC) as both polymers were adsorbed to the wells at the same 
molar concentration. In addition, differences in the sulfation pattern could affect HBP binding. For 
example, Hintze and coworkers showed that sulfated HA binds human transforming growth factor 
beta-1 (TGF-!1) with a stronger affinity than synthetically sulfated chondroitin sulfate, despite 
having the same degree of sulfation [19]. Further, sulfated HA was shown to have different 
binding specificities for human plasma proteins than heparin [31]. Therefore, while HeMA-SHA 
was shown to bind a HBP (rSDF-1") in this study, further investigation into protein binding 
specificity of HeMA-SHA polymers is warranted for specific HBPs.  
 
9.3.3 HeMA-SHA Incorporates into Radically Crosslinked Hydrogels and Alters HBP 
Presentation 
While a number of heparin mimetics have been developed as antithrombotic 
therapeutics, very few have been crosslinked into hydrogels for application in drug delivery or 
tissue engineering [32-34]. After demonstrating successful synthesis of a methacrylate-modified 
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and sulfated HA macromer and its ability to bind a HBP, we crosslinked these macromers into 
hydrogels to encapsulate and localize HBPs. HeMA-SHA polymers were blended with HeMA-HA 
polymers at 10% (w/w) HeMA-SHA and 90% (w/w) HeMA-HA with a total polymer concentration 
of 4% w/v and crosslinking was initiated with APS and TEMED redox initiators. Rheometry was 
used to quantify gelation, and HeMA-SHA blended hydrogels were compared to 100% HeMA-HA 
hydrogels. Incorporation of 10% HeMA-SHA did not significantly alter gelation, as both groups 
had similar storage modulus (G’) profiles over time and crosslinking reached the same G’ plateau 
after 30 minutes (Figure 9.5A-B). Other ratios were also investigated (higher HeMA-SHA 
 
Figure 9.5 Crosslinking of HeMA-HA/HeMA-SHA hydrogels.  HeMA-HA/HeMA-SHA hydrogels 
were crosslinked using APS/TEMED free-radical initiators and 4% w/v macromers in PBS at 
100/0 or 90/10 HeMA-HA/HeMA-SHA compositions (wt/wt).  (a) Representative storage (G’) and 
loss (G’’) moduli profiles over time with and without 10% HeMA-SHA incorporation.  (b) 
Incorporation of 10% HeMA-SHA did not significantly affect G’ after crosslinking had reached a 
plateau at 30 min.  (c) Incorporation of sulfate groups in the hydrogels was visualized using 
dimethylmethylene blue with purple indicative of sulfate groups (scale bar = 5 mm).  (d) 
Incorporation of sulfate groups slightly increased swelling of the hydrogels after 2 days in PBS.  
(n=3 replicates per group, mean±SD, *p<0.05 between groups). 
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Figure 9.6 Hydrogel degradation and encapsulated protein release.  (a) Hydrogel mass loss 
as determined by uronic acid content. Incorporation of HeMA-SHA macromers enhanced 
hydrolytic degradation of the hydrogels over 2 weeks. (b) Encapsulated FITC-BSA and (c) 
heparin-binding SDF-1! release from hydrogels of HeMA-HA alone or incorporating HeMA-SHA 
macromers. Encapsulated SDF-1! release was reduced by over 50% with incorporation of 
HeMA-SHA macromers. (n=3 hydrogels per group, mean±SD).  
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content); however, they led to hydrogels with statistically different mechanical properties, likely 
due to extensive sulfate charge repulsion and were not pursued further (results not shown). To 
visualize incorporation of sulfate groups into the HeMA-SHA blended hydrogels, they were 
incubated with DMMB after 2 days of swelling in PBS. HeMA-SHA blended hydrogels exhibited a 
purple color compared to blue HeMA-HA hydrogels, indicating the presence of sulfate groups 
(Figure 9.5C). Further, HeMA-SHA blended hydrogels swelled slightly more than HeMA-HA 
hydrogels, likely due to charge repulsion within the sulfate rich hydrogels or increased water 
content due to sulfate hydrophilicity (Figure 9.5D).  
 Finally, to illustrate the influence of sulfate group incorporation on HBP presentation 
within the hydrogels, networks were formed that encapsulated either a model HBP, rSDF-1", or 
bovine serum albumin (BSA) and protein release and hydrogel degradation were monitored over 
12 days. HeMA-SHA blended hydrogels degraded in a slightly more rapid fashion compared to 
HeMA-HA hydrogels (Figure 9.6A). This observation is likely due to the increased water content 
of the hydrogels, which enhances ester group hydrolysis of the HeMA groups. BSA release from 
HeMA-SHA blended hydrogels was similar to HeMA-HA hydrogel release, indicating little 
influence of sulfate groups on BSA presentation and release (Figure 9.6B). This is not surprising 
as previous studies also found that albumin does not bind to sulfated HA with a high affinity [31]. 
However, rSDF-1" release was drastically reduced with incorporation of HeMA-SHA polymers 
into the network (Figure 9.6C). This reduced release of rSDF-1" with the incorporation of HeMA-
SHA polymers demonstrates our ability to control HBP presentation within covalently crosslinked 
and degradable hydrogels, simply through chemical modification of the hydrogel precursors.  
 To demonstrate versatility and other possible applications, HeMA-SHA macromers were 
also incorporated into crosslinked and swollen electrospun nanofibers (Figure 9.7). Electrospun 
scaffolds have been widely explored for their use in tissue engineering applications due to their 
nanoscale fibrous structure that mimics tissue architectures found in the body [35]. In particular, 
photoinitiated crosslinking of electrospun fibers has permitted tuning of the nanoscale structure to 
construct scaffolds with unique properties for control of cell alignment [36], cell motility [37], and 
cell invasion [38]. To incorporate protein-binding sulfate groups into these systems, HeMA-SHA 
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Figure 9.7 Electrospun HeMA-HA/HeMA-SHA nanofibers.  Hydrogels were processed into 
nanoscale fibers using an electrospinning technique. (a) Fibers visualized in the dry state using 
scanning electron microscopy (top, scale bars = 2 µm) and after swelling in PBS using 
fluorescence of incorporated methacrylated rhodamine and optical microscopy (bottom, scale 
bars = 10 µm). (b) Fiber diameter quantification showed no significant difference between 100/0 
and 90/10 HeMA-HA/HeMA-SHA ratios (w/w) in either dry or swollen states (n=80-90 fibers, 
mean±SD, p>0.05).   
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macromers were blended with non-sulfated HeMA-HA macromers, electrospun, and crosslinked 
with UV light exposure. Fiber diameters were visualized and quantified in the dry, pre-swelled 
state and after swelling in PBS to assess the effects of HeMA-SHA incorporation on the 
nanoscale structure of the fibers (Figure 9.7A-B). There was no significant difference in fiber 
diameter in the dry state or swollen state with incorporation of HeMA-SHA macromers into HeMA-
HA fibers.  
To visualize the charge of the crosslinked fibers, scaffolds were incubated with DMMB 
dye. As with the 50 µL hydrogels, electrospun nanofibers were purple with HeMA-SHA 
incorporation compared to blue HeMA-HA fibers, confirming incorporation of sulfate groups into 
the fibers (Figure 9.8A). Importantly, encapsulated rSDF-1" release was significantly reduced 
with HeMA-SHA incorporation, indicating a higher protein-binding capacity of the chemically 
incorporated sulfate groups within the fibers (Figure 9.8B). Moreover, the release of encapsulated 
rTGF!3 was unaltered with HeMA-SHA incorporation (Figure 9.8D), displaying the ability to 
independently tune release of one growth factor over another by exploiting differences in binding 
affinities between rSDF-1" and rTGF!3 to sulfated and non-sulfated HA macromers (Figure 
9.8C). 
To incorporate heparin-binding features into electrospun nanofibers, heparin is often 
physically encapsulated into electrospun fibers in its low molecular weight form or conjugated to 
larger polymers [39-41], and recent studies have chemically conjugated heparin to crosslinked 
fibers after electrospinning, decorating the outside of the fibers with sulfate groups [42, 43]. In the 
HeMA-HA/HeMA-SHA fibers, sulfate groups are chemically crosslinked throughout the fibers in a 
process amenable to protein encapsulation, allowing further control of encapsulated protein 
release with hydrolytic degradation of the fibers. This approach can be used with a variety of 
radically crosslinked scaffolds for drug delivery and tissue engineering applications, either for the 
controlled release of proteins or to alter the accumulation of proteins surrounding cells.  
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Figure 9.8 Electrostatic interactions in nanofibers.  (a) Sulfation of electrospun nanofibers 
was visualized with dimethylmethylene blue staining.  Incorporation of sulfated HeMA-SHA 
macromers gave the fibers a more negative charge as indicated by the uniform purple stain of the 
electrospun mat compared to the blue unsulfated HeMA-HA mat (top, scale bar = 10 mm).  
DMMB staining was localized to individual nanofibers (bottom, scale bars = 50 µm).  (b) 
Incorporation of sulfated HeMA-SHA macromers reduced the release of encapsulated rSDF-1! 
from the nanofibers by over 50%, indicating stronger electrostatic interactions between the 
heparin-binding rSDF-1! and sulfated HA (n=3 hydrogels per group, mean±SD). (c) There was 
relatively no difference in binding of rTGF!3 between HeMA-SHA and HeMA-HA macromers, 
except for a slight increase with HeMA-SHA at extremely high rTGF!3 concentrations. (d) 
Incorporation of sulfated HeMA-SHA macromers had no effect on release of rTGF!3. 
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9.4 Conclusions 
 In summary, sulfated and HeMA modified HA macromers were synthesized and 
incorporated into covalently crosslinked hydrogels. The sulfated HA macromers had a similar 
sulfate content and HBP binding capacity as heparin and could be blended with non-sulfated HA 
macromers to form hydrogels that are also degradable. In addition, the sulfated HA macromers 
could be incorporated into electrospinning processes to control sulfate content in nanofibrous 
architectures. Therefore, these macromers provide a useful system to introduce heparin mimetic 
features into covalently-crosslinked hydrogels to control HBP presentation for a variety of drug 
delivery and tissue engineering applications. Although release of SDF-1" was significantly 
delayed from sulfated HA fibers compared to non-sulfated HA fibers without altering TGF!3 
release, the following chapter still focuses on non-sulfated HA macromers to stay consistent with 
previous in vivo studies (i.e. Chapters 7 and 8). Moreover, SDF-1" release from non-sulfated HA 
fibers was sustained over two weeks, which may be sufficient for the early recruitment of cells to 
fibrous scaffolds implanted in vivo. 
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CHAPTER 10 
 
Summary, Limitations, and Future Directions 
 
10.1 Summary 
Cartilage-related pain, resulting from osteoarthritis or acute trauma, is the leading cause 
of disability among adults, and the number of people affected is predicted to double by the year 
2020 [1-3]. Chapters 1 and 3 describe current research and clinical techniques for cartilage repair 
and motivate the need for improved cartilage repair strategies. Specifically, Chapter 1 describes 
the most common clinical methods of treatment, which can generally be categorized into 
palliative, reparative, and restorative, and then describes new promising techniques which focus 
on supplementing existing, established clinical methods with an engineered biomaterial scaffold 
to improve cartilage repair. These techniques include matrix autologous chondrocyte implantation 
(MACI), in which the biomaterial is combined with autologous chondrocyte implantation (ACI), 
and autologous matrix-induced chondrogenesis (AMIC), in which a collagen scaffold is combined 
with microfracture. Chapter 3 focused on approaches to engineer cartilage in vitro through the 
use of the classical tissue engineering paradigm (i.e. scaffold, cells, and soluble factors). The 
development of these parameters for hydrogel-based cartilage tissue engineering was outlined, 
with a focus on how these findings were applied to hyaluronic acid (HA)-based hydrogels. 
Hydrogel parameters discussed included network density, degradation, growth factor delivery, 
and mechanical loading.  
Although many advances have been made in cartilage tissue engineering, stable 
cartilage-like tissue with the appropriate mechanical properties has not been achieved. As 
described in Chapter 2, the goal of this thesis was to develop a novel biomaterial to investigate 
parameters important for cartilage regeneration and repair with in vitro and in vivo studies. 
Chapter 4 outlined the synthesis of HA modified with either methacrylate (i.e. MeHA) or 
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hydroxyethyl methacrylate groups (i.e. HeMA-HA) and processing of these modified HA 
macromers into fibrous scaffolds using electrospinning. Multiple electrospinning parameters, 
including ambient humidity, flow rate, voltage, and solution composition, were found to 
significantly affect the stable formation of HA fibers. Specifically, ambient humidity was the most 
significant parameter investigated, with a narrow range of ~15 to 35% humidity within which HA 
could be successfully electrospun. The parameter ranges for acceptable fiber formation found in 
Chapter 4 formed the basis for the material fabrication and application described in the remainder 
of the thesis. Chapter 4 also explored the tunability of the HA electrospinning system, exhibiting 
controlled release of a model protein (i.e. bovine serum albumin) through modification of the 
degree and type of HA modification and the ability to control fiber alignment to create depth-
dependently aligned scaffolds that mimic the microarchitecture of native cartilage. 
Chapters 5 and 6 then described the investigation of cell-material interactions with the HA 
fibrous scaffolds in vitro. In Chapter 5, through changing the extent of HA macromer modification 
and RGD density, both fiber mechanics and fiber adhesivity were controlled, respectively. 
Specifically, increasing the degree of MeHA modification from 35% to 100% increased the single 
fiber moduli from ~1 to 8.6 GPa. When mesenchymal stem cells (MSCs) were seeded onto thin 
fibrous HA films with varying levels of mechanics and adhesion, cell spreading and focal 
adhesion formation increased with increasing RGD density, but no significant differences were 
observed between the two fiber stiffness conditions. MSC proliferation also increased with higher 
RGD densities and stiffer fibers, although the trends were more significant for the former. 
Moreover, adhesion also significantly affected traction forces, with cell-induced bead 
displacements significantly increasing within the same fiber stiffness condition. Importantly, gene 
expression analysis showed significant up-regulation of typical chondrogenic markers (i.e. type 2 
collagen, aggrecan, and sox-9) for the softer and less-adhesive fiber conditions, indicating that 
lower mechanics and adhesive ligand densities may be better suited for MSC chondrogenesis.  
In order to translate these thin fibrous films towards engineering cartilage in vitro, Chapter 
6 focused on the effects of various cell-seeding methods and post-fabrication techniques on 
cellular infiltration. Specifically, static seeding (i.e. no orbital shaker) resulted in limited cell 
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infiltration for all fabrication conditions, whereas dynamic seeding (i.e. with an orbital shaker) 
improved infiltration but only when scaffolds were swollen prior to seeding (as opposed to as-
polymerized or freeze-dried scaffolds). In addition, it was found that MSC chondrogenesis (as 
assessed through expression of typical chondrogenic genes) was dependent on both adhesion 
and seeding method. For instance, lower RGD densities promoted increased chondrogenesis 
when cells were seeded statically; however, the highest RGD density was best for 
chondrogenesis when cells were seeded dynamically, possibly due to an increased cell density 
with higher RGD from dynamic seeding as a confounding factor. Finally, multiple post-fabrication 
techniques, including ethanol dehydration, photopatterning, and laser ablation were explored to 
increase cell infiltration. Of these methods, only laser ablation, which created an array of small, 
fibrous pores throughout the depth of the scaffold, increased cell infiltration. However, even the 
most promising cell seeding and post-fabrication techniques were not sufficient to achieve a 
homogeneous distribution of cells at early timepoints, which was found to be necessary for 
successful long-term in vitro culture and matrix formation. 
Due to these limitations with cell infiltration and to exploit the tunability of engineered 
fibrous scaffolds, Chapters 7 and 8 shifted towards an alternate strategy for translation of the 
fibrous HA scaffolds. As described previously, AMIC is a promising technique in which an 
acellular collagen scaffold is implanted into the cartilage defect region after microfracture has 
been performed. Collagen was used mainly due to previous utility as an implantable scaffold; yet, 
this collagen scaffold lacks versatility and was not designed specifically for application in cartilage 
repair. Thus, Chapter 7 started with the investigation of fibrous HA scaffolds for implantation with 
microfracture by the fabrication and characterization of multiple scaffold groups with a range of 
material properties and the ability to release a growth factor. Importantly, the main goal of 
Chapter 7 was to validate theorized differences in degradation, mechanical properties, and 
transforming growth factor !3 (TGF!3) release. The scaffold groups characterized in Chapter 7 
(and later in Chapter 8) included: MeHA, MeHA/HeMA-HA (HH), MeHA/HH+TGF!3, poly("-
caprolactone) (PCL), PCL/HH, PCL/HH+TGF!3, in which scaffolds with two components were 
composed of separate fibers, and the TGF!3, when included, was encapsulated within the HH 
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fiber population. PCL was used as an alternative to HA, since it has higher mechanical properties, 
degrades very slowly, and also has a history of clinical use. Fibers designed to degrade through 
hydrolytic degradation (i.e. HH fibers) did indeed degrade much more rapidly than MeHA or PCL 
fibers. Also, fibrous scaffolds with PCL had significantly reduced mass swelling ratios, increased 
compressive moduli, and delayed release of TGF!3. Moreover, TGF!3 released from both HA-
only and PCL/HA composites retained bioactivity, as seen by biochemical and histological 
analysis of MSC pellets cultured in the same wells as TGF!3-releasing scaffolds. 
The scaffolds developed in Chapter 7 were then explored in an in vivo cartilage defect 
model in juvenile minipigs as described in Chapter 8. In a preliminary 2 week in vivo study, no 
differences were observed in scaffold presence or morphology with or without sutures for both 
HA-only and PCL/HA scaffolds. Moreover, a 6-week preliminary study provided evidence that 
TGF!3 remained active after implantation in vivo, with increased deposition of type 2 collagen 
with the MeHA/HH+TGF!3 group in comparison to the MeHA/HH group. A comprehensive 12-
week study was then performed with all scaffold groups, and outcome metrics included gross 
appearance, defect fill, subchondral bone remodeling, mechanical properties, and histology. All 
scaffold groups performed similarly in most outcome measures except for the PCL and PCL/HH 
groups, which had significantly increased bone remodeling, inferior macroscopic appearance, and 
lower mechanical properties. Histological scoring was improved for the MeHA and both TGF!3 
groups, as these were the only groups similar to (i.e., not significantly different from) normal 
cartilage in terms of most scoring metrics. Moreover, type 2 collagen was also significantly 
increased for these groups, suggesting that the sustained presence of HA or the release of 
TGF!3 were beneficial for cartilaginous matrix production. 
Chapter 9 then focused on the addition of another biomolecule, stromal cell-derived 
factor 1 alpha (SDF-1). SDF-1 is a chemokine known to induce cell recruitment, and in many 
cases is released from damaged or diseased tissues to recruit cells for repair. Although SDF-1 
has been implicated in osteoarthritis progression, release of SDF-1 has also been shown to 
improve outcomes through in vivo cartilage studies. Chapter 9 describes the synthesis and 
characterization of sulfated HA macromers, with sulfation validated through a modified DMMB-
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binding assay and zeta potential measurements. Hydrogels with and without sulfated HA 
macromers were not significantly different in terms of gelation, mechanical properties, and 
degradation; however, the sulfated HA gels significantly delayed the release of SDF-1, but not 
bovine serum albumin (BSA) or TGF!3, from both isotropic and fibrous hydrogels. Although a 
powerful technique to control the release of growth factors based simply on their known heparin-
binding affinities, the release of encapsulated SDF-1 from fibrous HA gels was already sustained 
without the incorporation of sulfated HA. As described in the next section, ongoing and future 
work includes the investigation of SDF-1-releasing fibrous HA scaffolds in the same in vivo 
cartilage defect model used in Chapter 8. 
 
10.2 Limitations and Future Directions 
10.2.1 Specific Aim 1: To Develop and Characterize the Electrospinning of HA Macromers 
into Fibrous Scaffolds. 
 Electrospinning has been described as an art, in that the slightest differences in ambient 
humidity, temperature, and other processing parameters can create large differences in scaffold 
structure and fiber morphology [4]. One major limitation specifically for the HA electrospinning 
system is the dependence of successful fiber formation on ambient humidity, as described in 
Chapter 4. Part of this dependence is due to the negative charge of HA [5], and future work could 
explore the use of different buffers to shield some of these effects with higher humidity levels. 
Another possible future direction is to expand upon the depth-dependently aligned scaffolds, 
which closely mimic the microarchitecture of native cartilage. Scaffold fiber alignment has been 
shown to direct cell alignment, and in response, the alignment of cell-deposited matrix [6]. As 
structure and mechanical function are closely tied [7], the ability to control depth-dependent 
matrix architecture may be beneficial in reaching the complex mechanical properties of native 
cartilage. 
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10.2.2 Specific Aim 2: To Investigate the Effects of Mechanics, Adhesion, and Cell-seeding 
Method of Fibrous HA Scaffolds on MSC Response in vitro. 
 Towards engineering cartilage in vitro, a clear limitation with fibrous HA scaffolds is the 
inability to achieve sufficient cell infiltration at early timepoints even with various cell-seeding and 
post-fabrication techniques. Moreover, although investigation of the effects of mechanics and 
adhesivity in a more 2D environment allows for control over the system (i.e. no issues with 
uneven cell density and other confounding factors), a 3D environment is more appropriate to 
understand how these variables affect MSCs in the body [8]. Even though an exhaustive number 
of techniques were explored to increase cell infiltration, possible future work could include 
optimization of the laser ablation technique and long-term maturation of laser ablated, cell-seeded 
constructs. If sufficient infiltration is achieved, an investigation of the effects of mechanics and 
adhesion on MSC behavior in a 3D environment would also be beneficial. 
 
10.2.3 Specific Aim 3: To Translate Fibrous HA Scaffolds to in vivo Studies and Analyze the 
Effects of Scaffold Properties and TGF!3 Release in an in vivo Cartilage Defect Model. 
 Many in vivo models for cartilage repair involve the use of juvenile animals. However, this 
work has shown that significant subchondral bone remodeling occurs with juvenile mini-pigs, 
which may cause the scaffold to sink down into the remodeled area. Our colleagues in the Mauck 
group have recently found that the creation of a full-thickness cartilage defect in juvenile mini-
pigs, even with an autologous cartilage transplant, had significant bone remodeling after 6 weeks 
in vivo [9]. This subchondral bone remodeling may be reduced with skeletally mature adult mini-
pigs [10]. Additionally, cartilage in juvenile animals is quite dissimilar from that of adults, with a 
poorly-developed calcified layer and increased vasculature and cell population, and thus an 
increased ability to regenerate. Both of these reasons may necessitate the need to investigate 
possible clinical treatments in adult animal models for future work, although the expense and size 
of such adult animals may be slightly prohibitive for preliminary or pilot studies.  
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Another limitation was the heterogeneity of mechanical properties within the cartilage 
defect. We chose to test the center of the defect in order to stay consistent between samples; 
however, additional testing closer to the defect edge showed clear differences in mechanical 
properties. Ideally, it may be best to test an array of locations within the defect to better 
approximate the mechanics of the entire repair tissue, using linear stages for movement and 
positioning of the indenter tip. Even testing within the center of the defect was problematic, as 
many times the surface of the defect was uneven, grooved, or tilted, which drastically changes 
the contact surface area. Ongoing and future work includes the use of a fibril-reinforced, biphasic 
finite element model [11-13], which will also take into account the cartilage surface architecture 
and thickness (based on the Lugol-contrasted microCT scans), for a more accurate assessment 
of mechanical properties. Still, this heterogeneity was also seen over all other outcome 
measures, which may be an inherent limitation with large animal studies, perhaps necessitating 
even larger sample sizes for future translational studies. Future studies may also benefit from 
extended study lengths, as differences seen through histology may have needed more time to 
significantly affect other outcome measures, such as mechanical properties. Additionally, 
although the level of outcome measures described in this study was much greater than with most 
in vivo cartilage repair studies, other outcomes, such as MRI and arthroscopic assessment, may 
be beneficial for translation to human clinical studies. 
 
10.2.4 Specific Aim 4: To Exhibit Specific, Controlled Release of SDF-1 and TGF!3 through 
the Incorporation of Sulfated HA Macromers. 
Although TGF! has been shown to also stimulate migration, other biomolecules may be 
helpful to increase cell infiltration, and thus matrix deposition, within the acellular scaffold 
implanted after microfracture. Stromal derived factor-1 (SDF-1) is a potent chemoattracting 
chemokine that plays a critical role in regulating the migration of progenitor cells to remodeling 
tissue. Chapter 9 describes the incorporation of sulfated HA macromers to control release of 
heparin-binding cytokines such as SDF-1. Release of SDF-1 in partial chondral and 
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osteochondral defects has been shown to improve histological outcomes in vivo [14, 15]. 
However, SDF-1 has also been associated with osteoarthritis and can cause significant 
degeneration of human osteoarthritic cartilage explants in vitro [16-18]. Thus, it is still unclear 
whether SDF-1 release would improve outcomes by recruiting cells that deposit more matrix or if 
SDF-1 would increase MMP expression of neighboring chondrocytes to then cause cartilage 
degeneration.  
It is also possible that the release of TGF!3 could overcome of the possible negative 
effects of SDF-1, and that the release of both growth factors would cause significant infiltration 
and then increased cartilaginous matrix deposition. Moreover, we have recently found that the 
addition of SDF-1 to juvenile porcine cartilage explants did not cause significant cartilage
 
                     
Figure 10.1 (A) Histology and (B) GAG quantification of juvenile, porcine cartilage explants 
incubated for 4 days in vitro with biomolecules (i.e. SDF-1 or both SDF-1 and TGF!) either added 
exogenously or released from fibrous HA hydrogels. 
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degeneration, unlike with human osteoarthritic cartilage explants [16], as seen by histology and 
quantification of GAG within the tissue (i.e. digested) and in the media (i.e. soluble) (Figure 10.1).  
As described previously, ongoing and future work is now focused on the investigation of SDF-1-
releasing fibrous HA hydrogels in vivo, using the same animal model as in Specific Aim 3. Thus 
far, we have found that the mechanical properties of both MeHA/HH+SDF and 
MeHA/HH+SDF/TGF!3 were not significantly different than any of the other previously tested HA-
only groups (Figure 10.2). However, as before, histology may be necessary to discover 
differences between conditions, with possible improvements in cellularity, matrix deposition, and 
matrix morphology, and these analyses are still ongoing.  
 
 
10.3 Conclusions 
 Although research into clinical and tissue engineering approaches for cartilage repair are 
numerous, clinical treatments are still limited. To date, there is no reproducible, long-term strategy 
to completely restore and regenerate cartilage, and millions of Americans suffer from 
osteoarthritis and acute cartilage lesions every year. This thesis focused on developing, 
          
Figure 10.2 Young’s moduli from microindentation testing of normal, empty, microfracture, and 
HA-only scaffold treatment groups after 12 weeks in vivo. 
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characterizing, and applying a novel fibrous HA-based hydrogel to further our knowledge of 
biomaterial-based cartilage repair strategies. Specifically, after the development of the HA 
electrospinning system, the fibrous HA hydrogels were applied using both in vitro and in vivo 
approaches towards cartilage repair. Although in vitro studies with MSCs showed that softer and 
less adhesive fibers generally enhanced MSC chondrogenesis, the lack of cell infiltration into 
such scaffolds even with extensive cell-seeding and post-fabrication methods reduced their 
potential as in vitro cultured, cell scaffolds.  
The remainder of the thesis exploited the tunability of fibrous HA hydrogels towards 
translation and application with microfracture in a porcine cartilage defect model. Importantly, 
although these scaffolds were difficult to infiltrate with cells in vitro, cellularity was high in vivo 
even after 2 weeks, confirming the decision to directly implant the scaffolds in vivo without prior in 
vitro culture. Through these in vivo studies, material choice (i.e. HA or PCL) and the inclusion of 
TGF!3 were found to be the most influential parameters, and other important findings were the 
heterogeneity of samples over all outcome measures and the extensive subchondral bone 
remodeling (especially with PCL scaffolds) in juvenile mini-pigs. Finally, the incorporation of 
sulfated HA macromers allowed for specific control over release of SDF-1 and TGF!3 due to 
differences in electrostatic interactions, and ongoing and future work includes the investigation of 
SDF-1-releasing fibrous HA hydrogels through in vivo studies for improved cellularity and matrix 
production. Overall, the work described in this thesis represents a significant advancement in the 
development of novel biomaterials for cartilage repair. 
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